SUMMARY
Bacteria in the genus Brucella are important human and veterinary pathogens. The abortion and infertility they cause in food animals produce economic hardships in areas where the disease has not been controlled, and human brucellosis is one of the world’s most common zoonoses. Brucella strains have also been isolated from wildlife, but we know much less about the pathobiology and epidemiology of these infections than we do about brucellosis in domestic animals. The brucellae maintain predominantly an intracellular lifestyle in their mammalian hosts, and their ability to subvert the host immune response and survive and replicate in macrophages and placental trophoblasts underlies their success as pathogens. We are just beginning to understand how these bacteria evolved from a progenitor alphaproteobacterium with an environmental niche and diverged to become highly host-adapted and host-specific pathogens. Two important virulence determinants played critical roles in this evolution: (i) a type IV secretion system that secretes effector molecules into the host cell cytoplasm that direct the intracellular trafficking of the brucellae and modulate host immune responses and (ii) a lipopolysaccharide moiety which poorly stimulates host inflammatory responses. This review highlights what we presently know about how these and other virulence determinants contribute to Brucella pathogenesis. Gaining a better understanding of how the brucellae produce disease will provide us with information that can be used to design better strategies for preventing brucellosis in animals and for preventing and treating this disease in humans.
KEYWORDS: Brucella, pathogenesis, virulence determinants
INTRODUCTION
Members of the bacterial genus Brucella colonize a variety of mammals (1, 2). They have also been found in reptiles (3, 4) and fish (5, 6). There are currently 12 recognized Brucella species (https://www.bacterio.net/brucella.html), and although these bacteria are highly related at the genetic level, they display a remarkable degree of host specificity (Fig. 1). Comparative genomic analyses have provided us with a fascinating picture of how these bacteria evolved from an ancestral alphaproteobacterium to become host-adapted pathogens, and several excellent reviews describe this evolutionary path (7–11).
FIG 1.
Natural hosts and zoonotic potential of Brucella strains. The Brucella species shown in blue are recognized zoonotic pathogens, and the thickness of the solid arrows represents the relative frequency with which these hosts serve as sources of human infection. The dashed arrows indicate that these Brucella strains have been isolated from human disease but direct transmission from the corresponding natural host to humans has not been documented. The question mark indicates that the natural host for B. inopinata is unknown.
The best characterized Brucella species, B. melitensis, B. abortus, B. suis, B. canis, and B. ovis, cause abortion and infertility in goats and sheep, cattle, pigs, dogs, and sheep, respectively. These strains have long been recognized as economically important pathogens by the agricultural and veterinary communities (1, 2). B. melitensis, B. abortus, B. suis, and B. canis can also cause a chronic debilitating febrile illness in humans exposed to infected animals or animal products (12), and human brucellosis is one of the world’s leading zoonotic diseases (13, 14). B. melitensis, B. suis, and B. abortus are also of considerable concern from a biodefense perspective, because they have biological characteristics that make them attractive for use as biowarfare or bioterrorism agents (15).
The Brucella strains that infect domestic animals are highly host adapted and do not survive for prolonged periods in the external environment (1, 2). The infections caused by these strains also have distinctive characteristics. One is the highly infectious nature of these bacteria for their natural hosts and their high degree of host specificity (2, 16, 17). Another is the chronic nature of these infections, which in some cases can be lifelong. The remarkable capacity of the brucellae to survive and replicate for prolonged periods in host macrophages underlies this persistence (18). Brucella infections predominantly cause abortion and infertility in their natural hosts, where these bacteria replicate prolifically in association with placental trophoblasts (Fig. 2). Exposure to aborted fetuses and vaginal secretions serve as major routes of transmission, and venereal transmission is also important in some of these hosts. Offspring can also be infected in utero or by consumption of contaminated milk. Although some Brucella strains are highly infectious for humans, humans are an incidental host, and human-to-human transmission is extremely rare (19).
FIG 2.
Natural disease cycle of brucellosis in domestic animals. The blue triangles denote the oral, nasal, and venereal routes of infection.
Wildlife also serve as natural hosts for Brucella strains (Fig. 1), but we know much less about the interactions of these strains with their hosts than we do about the Brucella strains that infect domestic animals. Brucella ceti, B. microti, B. papionis, and the unnamed Brucella species in the so-called BO2 clade appear to be overt pathogens (3, 4, 20–24), for instance, but whether B. neotomae, B. pinnipedialis, or B. vulpis cause disease in their natural hosts is presently unclear (25–27). B. ceti, B. neotomae, and BO2 strains including B. inopinata (28–35) have also been isolated from human infections, which suggests that wildlife represent a potential zoonotic source of human brucellosis.
Over the past century, the importance of the Brucella spp. as veterinary and human pathogens has prompted a considerable amount of research aimed at determining how these bacteria produce disease. The implementation of molecular biology-based approaches in the 1980s led to an acceleration of these efforts (36), and we now have almost 800 complete genome sequences of Brucella strains from a wide range of hosts available for study. One thing that has become clear as we have examined the molecular basis of Brucella pathogenesis is that these bacteria have followed an evolutionary pathway to virulence that is different from the pathways followed by other well-characterized mammalian pathogens (8, 9, 37–39). Ignacio Moriyón and Edgardo Moreno articulated this unique evolutionary pathway very well in a commentary entitled “Brucella melitensis: a nasty bug with hidden credentials for virulence” (40) that accompanied the paper describing the completion of the B. melitensis 16M genome sequence in 2002 (41). The intent of this review is to inform the reader of the progress that has been made over the past 2 decades toward uncovering some of these “hidden credentials” of Brucella virulence.
VIRULENCE DETERMINANTS ACTING AT THE HOST-PATHOGEN INTERFACE
Type IV Secretion System
The most extensively studied Brucella virulence determinant has been their type IV secretion system (T4SS) (42). The Brucella T4SS consists of 11 proteins, 8 of which make up the core of the transporter (VirB2, VirB3, and VirB5 through VirB10), 2 ATPases (VirB4 and VirB11) that provide energy to drive effector secretion, and a lytic transglycosylase (VirB1) that remodels the bacterial cell peptidoglycan layer during T4SS assembly (43–52). The genes encoding the T4SS reside in an operon (42, 53) that is conserved across Brucella strains, and B. abortus, B. melitensis, B. suis, B. canis, B. ovis, B. microti, and B. neotomae virB mutants are highly attenuated in cultured mammalian cells and experimental and natural hosts (42, 53–75). Brucella proteins that assist in the assembly and function of the T4SS are also encoded by genes residing outside the virB operon. The secretor activator gene A (SagA) protein, for instance, is a muramidase that is thought to play an important role in remodeling the peptidoglycan layer during assembly of the T4SS (76). The precise function of VirJ is unknown, but this periplasmic protein interacts directly with T4SS substrates that have a periplasmic intermediate during their export and is also required for proper assembly of the T4SS (77). B. abortus sagA and virJ mutants both display significant attenuation in cultured mammalian cells, but only the virJ mutant has been shown to be attenuated in the mouse model (76, 77).
The brucellae maintain predominantly an intracellular residence in their mammalian hosts (18), and one of the primary functions of the T4SS is to control the intracellular trafficking of the Brucella-containing vacuoles in host macrophages so that these bacteria avoid killing and degradation in phagolysosomes (56–59). Upon entry into host cells, the brucellae reside in acidified phagosomal compartments known as endosomal Brucella-containing vacuoles (eBCVs), which undergo limited interaction with the lysosomal pathway (78, 79). The intracellular brucellae do not replicate in the eBCVs, but the acidic pH of these compartments serves as a signal for the induction of the genes encoding the T4SS (80). T4SS-mediated secretion of effectors into the host cell then orchestrates a series of events that redirects the intracellular trafficking of the eBCVs, diminishing their interactions with the endolysosomal pathway and initiating their extensive interaction with the host cell endoplasmic reticulum (ER) (Fig. 3). This series of events leads to the formation of the so-called replicative BCVs (rBCVs), which are slightly acidic/neutral pH compartments where the intracellular brucellae sustain their chronic intracellular persistence in the host (78). These rBCVs eventually interact with components of the host cell’s autophagy pathway, resulting in the formation of autophagic BCVs (aBCVs), which are thought be important for bacterial egress and cell-to-cell spread in the host (79).
FIG 3.
Contributions of the T4SS effectors, the LPS O-chain, Omp22, Omp25d, and cyclic β-1,2-d-glucan (CβG) to the development of the replicative Brucella-containing vacuole in host macrophages. The empty black and orange circles represent membrane vesicles trafficking from the endolysosomal pathway, endoplasmic reticulum, and Golgi apparatus to the Brucella-containing vacuoles (BCVs). The change in the colors of the BCV membranes represents their change in composition as they transition from eBCVs to rBCVs. The outermost blue membrane of the aBCV represents engulfment of the rBCV by the host cell autophagosomal pathway. eBCV, endosomal BCV; rBCV, replicative BCV; aBCV, autophagosomal BCV.
The recent identification and characterization of several T4SS effectors have helped us begin to understand how the T4SS controls the intracellular trafficking of Brucella strains (81–86) (Table 1). BspB, for example, directly interacts with the conserved oligomeric Golgi (COG) complex in host cells (87). This multimeric protein complex controls vesicle trafficking between the Golgi apparatus and the ER, and the interaction of BpsB with the COG complex redirects Golgi apparatus-derived vesicles to the rBCV. The T4SS effector RicA directly interacts with Rab2, a small GTPase that also modulates ER-Golgi apparatus interactions in mammalian cells (82, 88). The exact mechanism by which RicA contributes to rBCV development is unclear, but it has recently been shown that the BCV traffic-altering function of BspB is totally dependent upon the activity of RicA (89). Another T4SS effector, SepA, plays a role in exclusion of the lysosomal marker LAMP-1 from eBCVs during their conversion to rBCVs (86), but the host cell target of this effector has not been identified.
TABLE 1.
Brucella T4SS effectors and their proposed functions
| Effector | ORFa | Proposed function | Reference(s) |
|---|---|---|---|
| VceA | BAB1_1652 | Unknown | 81 |
| VceC | BAB1_1058 | Modulation of host immune response | 81, 95–97 |
| RicA | BAB1_1279 | Intracellular trafficking of BCVs | 82, 89 |
| BPE005 | BAB1_2005 | Modulation of collagen deposition by hepatocytes | 83, 106, 107 |
| BPE043 | BAB1_1043 | Unknown | 83 |
| BPE123 | BAB2_0123 | Modulation of host cell enolase activity | 83, 108 |
| BPE275 | BAB1_1275 | Unknown | 83 |
| BtpA | BAB1_0279 | Modulation of host immune response, stabilization of host cell microtubules, depletion of host cell NAD | 84, 98–100, 102–105 |
| BtpB | BAB1_0756 | Modulation of host immune response, stabilization of host cell microtubules, depletion of host cell NAD | 84, 103, 105 |
| BspA | BAB1_0678 | Unknown | 85 |
| BspB | BAB1_0712 | Intracellular trafficking of BCVs | 85, 87, 89 |
| BspC | BAB1_0847 | Unknown | 85 |
| BspE | BAB1_1675 | Unknown | 85 |
| BspF | BAB1_1948 | Unknown | 85 |
| BspJ | BAB2_0119 | Inhibition of host cell apoptosis | 85, 110 |
| SepA | BAB1_1492 | Intracellular trafficking of BCVs | 86 |
Open reading frame (ORF) designation in B. abortus 2308 genome sequence.
Another way that the Brucella T4SS contributes to virulence is by modulating the host immune response (90–94) (Fig. 4 and 5). The T4SS effector VceC, for instance, interacts with the host cell ER chaperone BiP (95). This interaction causes ER stress and induces an unfolded protein response (UPR) in Brucella-infected cells, which stimulates production of the inflammatory cytokines interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α). VceC-induced production of these cytokines by macrophages induces granuloma formation, which facilitates chronic infection. VceC-mediated inflammatory cytokine production by placental trophoblasts also leads to host cell death and fetal pathology in the pregnant mouse model, which has led investigators to postulate that this T4SS effector may play an important role in transmission in natural hosts (96, 97). Unlike VceC, the T4SS effectors BtpA and BtpB inhibit inflammatory cytokine production by dendritic cells by interfering with the TLR-Myd88-MAL signaling pathway (84, 98–100). This ability of the T4SS effectors to both stimulate and inhibit host immune responses has been proposed to allow the brucellae to stimulate enough of a response to benefit their long-term intracellular persistence in the host and sufficient immunopathology to facilitate their spread to other hosts but not elicit a strong enough immune response in the host to result in sterilizing immunity and resolution of the infection (101).
FIG 4.
Brucella virulence determinants that influence the capacity of macrophages to modulate the host immune response. →, activation; ⊣, inhibition. The dashed arrow indicates that the Brucella LPS does not signal strongly through the TLR4 pathway and stimulates a diminished inflammatory response. The red X indicates that the Brucella flagellin is not recognized by TLR5.
FIG 5.
Brucella virulence determinants that impact the ability of dendritic cells to modulate the host immune response. →, activation; ⊣, inhibition. The dashed arrow indicates that the Brucella LPS does not signal strongly through the TLR4 pathway and stimulates a diminished inflammatory response.
Evidence suggests that the Brucella T4SS effectors may also contribute to virulence in other ways. BtpA and BtpB, for instance, stabilize microtubules, which likely has impacts on host cell physiology beyond their ability to directly interfere with Myd88-MAL signaling (102, 103), and BtpA induces the unfolded protein response in infected macrophages by an undefined mechanism (104). BtpA and BtpB have recently been shown to have NAD+ hydrolase activities that allow the brucellae to reduce NAD+ levels in host cells during infection (105). Because NAD+ plays such a broad-based role in the physiology of eukaryotic cells, the NAD+ hydrolase activities of BtpA and BtpB may help explain the multiple contributions that these T4SS effectors appear to be making to Brucella virulence. Studies with a human hepatic cell line and mice experimentally infected with B. abortus 2308 have also established a link between the T4SS effector BPE005 and collagen deposition and liver fibrosis (106, 107). In addition, the T4SS effector BPE123 directly interacts with the host cell glycolytic enzyme α-enolase during HeLa cell infection and stimulates its activity (108). Normal levels of host cell α-enolase are required for the wild-type replication of B. abortus 2308 in HeLa cells. This raises the intriguing possibility that by modulating the activity of a host cell enzyme involved in carbohydrate metabolism, the intracellular brucellae may be able to improve their access to glucose. Experimental evidence suggests that glucose is the preferred carbon source for these bacteria when they reside in alternatively activated macrophages during the chronic stage of infection in mice (109). Finally, recent studies suggest that BspJ may inhibit host cell apoptosis by directly interacting with NME/NM23 nucleoside diphosphate kinase 2 and creatine kinase B in the nucleus of these cells (110).
The genes encoding the T4SS are tightly regulated (111, 112), and proper temporal and stochiometric expression of these genes is essential for virulence (113, 114). The same is presumably true for the T4SS effectors, although the expression patterns of the individual genes encoding these effectors have not been as well characterized as those of the virB genes. Strict temporal regulation of the genes encoding the T4SS and its effectors makes sense, considering the orderly progression of the intracellular life cycle of the brucellae in host cells (78, 79) and the observation that the T4SS effectors contribute to the virulence of Brucella strains by means other than directing their intracellular trafficking. Not surprisingly, multiple regulators control virB expression in Brucella (115) (Fig. 6). The two-component regulator BvrRS, for instance, allows the brucellae to recognize the acidic pH and nutrient deprivation they encounter in the eBCV and to activate expression of the gene encoding the quorum-sensing (QS) regulator VjbR, which in turn activates virB expression (112). The transcriptional regulator HutC and stringent response regulator Rsh are also thought to allow Brucella strains to modulate virB expression in response to their nutritional status (116, 117). Other regulators, including MdrA (118), BabR (119–122), LovhK (123), MucR (124, 125), NolR (126), OtpR (127), and small regulatory RNAs (sRNAs) (122, 128), have been implicated in regulating virB expression in Brucella, but precisely how these regulators contribute to coordinating the proper expression of these genes and the environmental stimuli to which they are responsive remains to be determined. There is also evidence that the individual contributions of specific regulators to virB regulation may differ between the Brucella species (129). B. ovis, for example, does not require acidic conditions to elicit expression of its virB operon (70).
FIG 6.
Genetic regulators and the corresponding stimuli that control expression of the genes encoding the T4SS in Brucella. →, activation; ⊣, repression. The question mark indicates that the environmental stimuli recognized by these regulators have not been determined. Both activation and repression of virB expression have been reported for BabR.
Lipopolysaccharide
Like most Gram-negative bacteria, Brucella strains produce a lipopolysaccharide (LPS) molecule that plays an important role in maintaining the integrity of their cell envelope (130, 131). With two notable exceptions, they have a smooth LPS (S-LPS) consisting of a polysaccharide O-chain, core, and lipid A. The exceptions are B. ovis and B. canis, which naturally produce a rough LPS lacking the O-chain. The importance of the O-chain for the virulence of naturally occurring smooth Brucella strains is well documented (132–145). One way that the LPS O-chain contributes to virulence is by protecting smooth Brucella strains from the bactericidal activities of complement (139, 143, 146) and the antimicrobial peptides they encounter during their interactions with host phagocytes (147, 148). Another is by serving as an adhesin (Fig. 3). The interaction of the O-chain with lipid rafts on the surface of mammalian cells allows smooth Brucella strains to enter these cells by an endocytic pathway that avoids extensive fusion of the BCVs with lysosomes (149). This route of entry is the first required step for the formation of the replicative BCV by smooth strains that occurs prior to the participation of the T4SS effectors (150, 151).
O-chain-mediated uptake of smooth Brucella strains also plays an important role in immune evasion, because this route of entry stimulates low levels of proinflammatory cytokine production in macrophages and dendritic cells (152, 153) (Fig. 4 and 5). Smooth LPS shed by Brucella strains into BCVs is also resistant to degradation by macrophages (154) and forms complexes with major histocompatibility complex class II (MHC-II), inhibiting the capacity of these phagocytes to present antigens to T lymphocytes (155, 156) (Fig. 4). Still another way that O-chain-mediated entry of smooth Brucella strains into macrophages contributes to virulence is by inhibiting caspase 2-mediated apoptosis in these phagocytes (157–161). The precise mechanisms behind this inhibition have not been determined, but the capacity of smooth strains to extend the life span of macrophages likely enhances their ability to avoid immune clearance and disseminate to different organs in their mammalian hosts.
Lipid A is often referred to as “endotoxin” because it is the component of LPS that is recognized by the host pattern recognition receptor Toll-like receptor 4 (TLR4), and the lipid A’s of many Gram-negative bacteria induce strong inflammatory responses (162). It has long been known that Brucella strains produce an LPS with low endotoxin activity (163–167). One reason that the lipid A of Brucella strains does not stimulate a strong inflammatory response is that unlike its enteric counterparts, the Brucella lipid A contains very-long-chain fatty acids (VLCFAs) (168, 169). These VLCFAs presumably prevent the Brucella lipid A from forming the same strong interactions that other bacterial lipid A molecules form with TLR4 (170) (Fig. 4 and 5). This poor recognition of the Brucella lipid A by the innate immune response plays a critical role in the so-called stealthy mode of virulence employed by these bacteria (167). Interestingly, the Brucella lipid A also induces premature cell death in human neutrophils (171). Dead neutrophils carrying intracellular brucellae are subsequently engulfed by macrophages and dendritic cells via mechanisms that do not stimulate an inflammatory response. This has been proposed to be yet another strategy that Brucella strains can employ to avoid detection by the host immune system during the early stages of infection.
In many bacteria, the LPS core serves primarily as a structural link between the O-chain and the lipid A. It also performs this function in Brucella (142), but in addition, recent studies have shown that the LPS core plays an essential role in allowing these bacteria to evade detection by the host immune response (172–175). Specifically, the brucellae produce a core structure containing a lateral oligosaccharide side chain that sterically shields the lipid A and inhibits its binding to TLR4 on host macrophages and dendritic cells (Fig. 4 and 5). This lateral side chain and the positive charge it imparts on the LPS core also appear to be important for the resistance of both smooth and rough Brucella strains to killing by complement and bactericidal peptides (172, 173, 175, 176).
The essential role that the LPS O-chain plays in the virulence of smooth Brucella strains raises the intriguing question of why the naturally occurring rough strains are such virulent pathogens in their natural hosts. Brucella ovis, for instance, is a major veterinary pathogen in sheep-producing countries, where it causes epididymitis and infertility in rams (177, 178). Brucella canis causes abortion and infertility in dogs, and B. canis infections can have a severe impact on commercial breeding operations (179). B. canis is also being increasingly recognized as a source of human infection (180). A considerable amount of work has been done over the past 20 years to address how the naturally occurring rough Brucella species compensate for the lack of an LPS O-chain. One particularly informative finding is that despite their lack of an O-chain, B. ovis and B. canis strains are almost as resistant to complement as smooth Brucella strains (181). The pattern of expression of the Omp25/Omp31 proteins (which will be discussed later) in the outer membrane of B. ovis and B. canis is different than that observed in smooth strains (182), and experimental evidence suggests that it is this distinctive Omp25/Omp31 composition that makes the rough strains resistant to complement and other antimicrobial peptides (183). Unlike rough mutants derived from naturally occurring smooth strains, B. ovis and B. canis strains are also fully competent for intracellular replication in macrophages (70, 184, 185), and both establish and maintain chronic spleen infections in experimentally infected mice (70, 183, 186–188). One observation that might explain this difference is that B. ovis and B. canis employ a lipid raft-mediated route of entry into macrophages that follows a different endocytic pathway than smooth strains (189) (Fig. 3), and this unique route of entry appears to be important for allowing the BCVs containing B. canis and B. ovis strains to avoid fusion with lysosomes (150, 190). This alternative pathway of entry into macrophages may also explain why B. ovis and B. canis strains induce limited and ineffective inflammatory responses in their natural hosts (71, 191–193).
The organization and composition of the LPS biosynthesis genes are highly conserved across the Brucella species that infect domestic animals and many of the strains that infect wildlife, and the absence of the O-chain from the B. ovis and B. canis LPS is due to well-described genomic deletions (194–197). But a subset of the so-called early diverging Brucella strains found in amphibians and isolated from human disease employ an operon consisting of four genes, rmlABCD, to produce an LPS with a rhamnose-based O-chain instead of the perosamine O-side chain that is found universally in other smooth Brucella strains (198). Based on the documented role of the perosamine O-chain in virulence, it has been postulated that acquisition of the genes encoding this latter type of LPS O-chain played an important role in the evolution of Brucella strains as mammalian pathogens (7, 199). Interestingly, serologic studies suggest that the LPS core of some of the early diverging strains may also differ from that of the classical Brucella strains (200).
A couple of gene products that play auxiliary roles in LPS production and are important for Brucella virulence have also been identified. B. abortus ba14k (201) and romA (202) mutants produce LPS with altered levels of O-chain, and both mutants display significant attenuation in mice. RomA is a periplasmic protein thought to stabilize the components of the LPS biosynthetic complex. BA14K is lectin-like protein, but the precise role that it plays in modulating LPS O-chain content has not been determined.
Omp25/Omp31
Brucella strains produce a family of highly conserved outer membrane proteins (OMPs) known as Omp25, Omp25b, Omp25c, Omp25d, Omp31, Omb31b, and Omp22 that play important roles in maintaining the integrity of their cell envelope (203, 204). These 25- to 30-kDa β-barrel OMPs work in conjunction with the LPS O-chain to protect these bacteria from complement and other antimicrobial peptides encountered in the host, and their contributions to virulence appear to be especially important for the naturally occurring rough strains such as B. ovis (181, 183, 205–207). This distinction, however, is not absolute, as B. abortus and B. melitensis omp25 mutants have been shown to be attenuated in mice (205) and natural hosts (208, 209), and a B. melitensis omp31 mutant is attenuated in cultured mammalian cells and mice (210, 211).
Beyond their structural roles in maintaining cell envelope integrity, the Brucella Omp25/Omp31 proteins have also been shown to mediate direct interactions between the brucellae and mammalian cells that are important for virulence. These latter functions may help explain some of the disparate phenotypes reported for Brucella omp25 and omp31 mutants in virulence assays. Omp25d and Omp22, for instance, play important roles in the entry of B. ovis into mammalian cells (207) (Fig. 3), but there is no evidence that they perform this function in smooth strains (206), where the LPS O-chain seems to be the predominant determinant in mammalian cell entry, as described in the previous section. The Omp25 protein of B. abortus, a smooth strain, also directly interacts with the SLAMF1 protein on the surface of dendritic cells and inhibits their maturation and capacity to produce inflammatory cytokines (212) (Fig. 5). The capacity of Omp25 to inhibit TNF-α production during Brucella infection was first reported by Jubier-Maurin et al. (213), but only recently has the molecular basis for this activity been clearly defined. There is also evidence suggesting that the Brucella Omp25 and Omp31 proteins have the capacity to modulate other aspects of host cell function during infection (214–219), but precisely how these other proposed Omp25/Omp31 functions contribute to virulence remains to be determined.
One of the interesting features of the Omp25/Omp31 proteins is that they are highly conserved across the Rhizobiaceae, and the Omp25/Omp31 orthologs are also important for the successful interactions of other alphaproteobacteria with their respective eukaryotic hosts. The Omp25 ortholog AopB, for instance, is required for the wild-type virulence of Agrobacterium tumefaciens in plants (220). The Bartonella heme-binding proteins (Hbps) are also Omp25/Omp31 orthologs (221), and Bartonella henselae hbp knockdown strains are attenuated in endothelial cell cultures (222). Notably, the Brucella Omp31b has also been shown to bind hemin in vitro, and the gene encoding this protein is iron regulated in B. suis (223). This raises the possibility that in addition to their other roles, the Omp25/Omp31 proteins may also contribute to virulence by working in concert with the heme transporter BhuA (224) to allow the brucellae to use heme as an iron source during residence in their mammalian hosts (225).
No single Brucella species has been shown to produce all seven of the Omp25/Omp31 proteins (182). Some species, like B. abortus and B. ovis, lack genes encoding specific Omp25/Omp31 proteins due to large genomic deletions (194, 226). Smaller genetic disruptions appear to be responsible for the distinctive patterns of Omp25/Omp31 production in other Brucella species (182). The global regulators BvrRS, VjbR, and CtrA tightly coordinate the expression of the omp25 and omp31 genes in response to both environmental stimuli and physiological cues (227–230), which is consistent with the critical role that this family of OMPs plays in the basic physiology and virulence of Brucella strains.
Omp10, Omp16, and Omp19
Brucella strains produce three outer membrane lipoproteins: Omp10, Omp16, and Omp19 (231). Omp16 is a homolog of the peptidoglycan-associated lipoprotein (Pal), which is highly conserved in Gram-negative bacteria (232). These proteins interact with the components of the Tol complex and play critical roles in maintaining the structural integrity and function of the outer membrane. The fact that omp16 is an essential gene in Brucella is consistent with Omp16 playing the same role as other Pal homologs (233–235). Omp19, on the other hand, is the most well characterized of the Brucella lipoproteins. Purified Omp19 has strong immunomodulatory activities affecting a wide variety of host cells mediated by its interactions with TLR2, and these activities have been proposed to be important not only for the capacity of the brucellae to evade host immune responses but also their ability to induce immunopathology in selected tissues such as bone and the central nervous system (236–252) (Fig. 4 and 5). In addition, Omp19 shares significant amino acid homology with bacterial protease inhibitors (253), and phenotypic analysis of a B. abortus omp19 mutant indicates that Omp19 protects the parental strain from proteases encountered in the intestinal tract after oral infection and lysosomal proteases encountered during intracellular residence in host macrophages (254). In addition, Omp19 also protects another immunomodulatory protein, Omp25, from degradation by proteases. Unlike Omp16 and Omp19, which show homology to other bacterial proteins, Omp10 homologs only appear to be present in Brucella and a limited number of other alphaproteobacteria (255) and the biological function of this Omp is unknown. Interestingly, while B. abortus omp19 and omp10 mutants exhibit significant attenuation in mice (254, 256, 257), the corresponding B. ovis mutants do not (233). But the fact that B. ovis omp10 omp19 double mutants cannot be constructed suggests that these proteins may have a shared physiologic function (233).
Autotransporter Adhesins
Autotransporter (AT) adhesins play important roles in the attachment of many bacterial pathogens to mammalian cells (258). Five AT adhesins have been described in Brucella. OmaA and BmaC are type I monomeric ATs (259, 260), BtaE and BtaF are type II trimeric ATs (261–263), and BigA (264) shares structural domains with the Escherichia coli adhesin intimin, which is considered an inverse AT adhesin (265). BmaC binds fibronectin on the surface of host cells (260), and BtaE and BtaF bind hyaluronic acid (261, 262), but the receptors for OmaA and BigA have not been described. Interestingly, Brucella mutants lacking these AT adhesins exhibit reduced attachment to epithelial cells but display wild-type intracellular replication in cultured macrophages. These mutants are also attenuated in mice when delivered by the intragastric or nasal routes but not when administered intraperitoneally. These experimental findings suggest that the function of the AT adhesins is to facilitate attachment of the brucellae to the host at mucosal surfaces during the early stages of infection. Notably, BigA appears to have a tropism for eukaryotic cell junctions (264), and adhesion to and disruption of host cell junctions is a strategy that other bacterial pathogens employ to cross mucosal barriers in the host (266). A B. suis btaE btaF double mutant is also considerably more attenuated in mice than a btaE or btaF mutant, indicating that BtaE and BtaF play complementary roles in virulence (262). In addition to its role in attachment, there is also evidence that BtaF protects B. suis from the bactericidal activity of serum (262).
BmaC, BtaE, and BtaF are localized at one specific pole of the bacterial cell (260–262), and the location of these AT adhesins at the new pole, coupled with the observation that Brucella cells in the G1 phase of the cell cycle are the predominant infectious form (267), has led investigators to propose that these AT adhesins form an adhesive pole on the Brucella cell (268, 269). Only a small proportion of the Brucella cells in planktonic cultures produce these adhesins, suggesting that the corresponding genes may be optimally expressed only upon exposure to a host-specific stimulus such as contact with mammalian cells. This is consistent with the fact that several AT-encoding genes appear to be regulated by the quorum-sensing regulator VjbR (119) and the global regulator MucR (270, 271) and that a complex regulatory network has been shown to control btaE expression in B. abortus (272, 273). There appears to be considerable heterogeneity in the Brucella genes that encode AT-type adhesins (273), and as noted previously, there is evidence indicating that these adhesins have overlapping functions (262). Consequently, it will be important to study the contributions of the Brucella AT adhesins in different species and strains and use mutants with multiple disrupted genes to gain an accurate assessment of how these proteins contribute to virulence.
Cyclic β-1,2-d-Glucan
Many Gram-negative bacteria produce polysaccharide polymers and secrete them into their periplasm, where they perform a variety of physiologic functions (274). Brucella spp. and other alphaproteobacteria secrete a cyclic polymer consisting of 17 to 20 glucose residues known as cyclic β-1,2-glucan (CβG) into their periplasmic space (275). In Sinorhizobium and Agrobacterium, the production of CβG is regulated by osmotic conditions, suggesting a role for this molecule in osmoprotection (276). But CβG production is not osmoregulated in Brucella (277, 278), and experimental evidence suggests that this polysaccharide plays only a minor role as an osmoprotectant in these bacteria (279). CβG does, however, play an essential role in Brucella virulence (275, 280). Specifically, studies employing B. abortus CβG synthase mutants and purified CβG indicate that this molecule disrupts lipids rafts on the Brucella-containing vacuoles, which is thought to prevent these vacuoles from sustaining their interactions with lysosomes (281) (Fig. 3). CβG has also been shown to have a strong influence on the capacity of macrophages and dendritic cells to produce both proinflammatory and anti-inflammatory cytokines (279, 282–284) (Fig. 4 and 5). It is presently unclear how CβB is released from its periplasmic location in Brucella cells to perform these biological functions in vivo. Nevertheless, CβG appears to have dual functions in virulence. It plays a critical role in the intracellular trafficking of the brucellae to their replicative niche in host macrophages, and it fine-tunes the host immune response to allow their chronic intracellular persistence. Given the proposed polar nature of the interaction of Brucella cells with their mammalian hosts (268, 269), it is also notable that the CβG synthase (Cgs) and transporter (Cgt) display polar localization on the bacterial cell (285). Whether this polar localization of the CβG biosynthesis and transport machinery plays any role in its contributions to virulence remains to be determined.
Flagella
Despite the fact that most Brucella strains are nonmotile, Halling reported the discovery of flagellar biosynthesis genes in B. abortus in 1998 (286). It was subsequently determined that most, if not all, Brucella strains have the genetic capacity to produce flagella (41, 287–289), but they lack chemotaxis genes and only a limited number of strains in the BO2 clade appear to be able to use the flagella for motility (290). Nevertheless, the isolation of B. melitensis fliF and flgF mutants in signature-tagged mutagenesis screens for attenuation in mice (291) and pregnant goats (62) suggested that these genes might play a role in virulence. The Letesson group demonstrated that B. melitensis 16M does in fact produce a single sheathed polar flagellum that is covered by an extension of the outer membrane (289, 292), and studies have confirmed that flagellar biosynthesis genes are required for the wild-type virulence of B. melitensis and B. abortus strains in the mouse model (289, 293). Interestingly, B. ovis mutants lacking flagellar biosynthesis genes are fully virulent in mice, suggesting that the contributions of flagella to pathogenesis may be strain and possibly host dependent (294).
One mechanism by which the flagella appear to contribute to virulence is by modulating the host immune response (295). Unlike flagella from some other Gram-negative pathogens, the Brucella flagellin is not recognized by TLR5. This contributes to the so-called stealthy nature of Brucella infections. But experimental evidence indicates that the Brucella flagellin ends up in the cytoplasm of infected host cells and stimulates an inflammasome-mediated inflammatory response that is important for “limiting” the extent of Brucella replication. Thus, the flagellum has been proposed to be yet another virulence determinant that allows the brucellae to fine-tune the host immune response in a manner that facilitates the establishment and maintenance of chronic infections. The possibility also exists that these appendages have yet undiscovered roles in pathogenesis, such as serving as adhesins and/or as sensors of surface attachment as they do in other closely related alphaproteobacteria (296, 297). In addition, sheathed flagella are relatively rare in bacteria, but studies have shown that they play a role in the release of outer membrane vesicles (OMVs) (298), which is an interesting relationship considering the roles that have been proposed for OMVs in host-pathogen interactions during Brucella infections (299).
The flagellar biosynthesis genes are tightly regulated in Brucella, and while production of the polar flagellum in B. melitensis 16M has been observed only in vitro in bacterial cells grown to early exponential phase in a rich medium, these genes are readily expressed when this strain is replicating in mammalian cells (289). Subsets of the Brucella flagellar biosynthesis genes are expressed in stages, but the regulatory networks that coordinate the orderly temporal expression of these genes differ from those found in other bacteria (300, 301). The quorum-sensing regulators VjbR and BabR (also known as BlxR), the light-sensing regulator LovhK, the general stress response regulator RpoE1, and cyclic di-GMP-mediated signaling also control flagellar gene expression in Brucella (119, 120, 123, 302–305).
Bacteria that employ flagella for motility almost universally have chemotaxis genes that allow them to control the direction of their flagellar rotation in response to gradients of environmental stimuli (306). This allows them to swim toward nutrients and away from toxic compounds. The fact that no chemotaxis genes have been detected in Brucella strains is not too surprising given that most of these bacteria do not appear to be using their flagella for locomotion. But it does raise some interesting questions about how the motile BO2 strains direct their movements in their natural environments.
Phosphatidylcholine
The phospholipid phosphatidylcholine (PC) is a major component of eukaryotic cell membranes but is not commonly found in prokaryotes (307). Almost 40 years ago, it was reported that Brucella strains contains PC in their cell envelope (308), which led investigators to suspect that the presence of this “eukaryotic” phospholipid in the OM might contribute to virulence. Brucella strains produce PC by two different biochemical pathways—the Pcs pathway, which directly produces PC from choline, and the Pmt pathway, which produces PC by methylating the phospholipid phosphatidylethanolamine (309–311). Independent studies performed in two different laboratories have confirmed that PC plays an essential role in Brucella virulence. However, these studies provided conflicting results regarding the relative contributions of the Pcs and Pmt pathways to virulence, and further studies will be needed to get a clear picture of how PC contributes to virulence. But, in general, the experimental evidence at hand suggests that the PC/PE ratio in the outer membrane of Brucella strains impacts the ability of these bacteria to resist killing by antimicrobial peptides and complement and that PC may also play a role in modulating the host response to infection (309, 310, 312). It is also notable that the incorporation of PC into the outer membrane is a distinctive feature of the alphaproteobacteria in general and that this phospholipid also plays an important role in the interactions of some of the other members of this group (e.g., Agrobacterium and the rhizobia) with their respective plant hosts (313).
Exopolysaccharides
Exopolysaccharides (EPSs) are polysaccharide polymers secreted by bacteria that are either (i) attached tightly to the cell surface and form a capsule or (ii) loosely associated with bacterial cells forming an amorphous “slime layer” (314). EPSs play multiple roles in bacterial pathogenesis. They can serve as adhesins and facilitate the attachment of bacteria to eukaryotic cells (315). They can also protect bacteria from the bactericidal activities of complement, neutrophils, and macrophages (316–318) and/or allow them to evade recognition by host innate and acquired immune responses (316, 319). In addition, these polymers allow bacteria to form biofilms, which contributes to their persistence in the environment and in mammalian hosts (320–322).
Brucella strains have the genetic capacity for EPS production (229, 270, 323), but experimental evidence suggests that the corresponding genes are tightly regulated. B. melitensis 16M, for instance, does not produce a readily detectable EPS during routine in vitro cultivation, but disruption of a putative quorum-sensing pathway causes this strain to produce an apparent EPS detected by calcofluor staining and form “biofilm-like” bacterial cell aggregates in liquid culture (229). EPS production and cellular aggregation have also been described in a B. melitensis virB mutant (324) and a B. abortus strain overexpressing the glycosyltransferase WbkA (325). Reports of “biofilm” formation by Brucella strains (326–328) and enhanced Congo red staining of a B. melitensis mucR mutant (329) are also consistent with EPS production.
Because the specific genes required for EPS production have not been clearly defined, we do not currently know if EPS plays an important role in Brucella virulence. But EPS production is essential for the pathogenic and symbiotic interactions of the agrobacteria and rhizobia with their respective plant hosts (330, 331). Considering the conserved strategies that the alphaproteobacteria employ to sustain successful interactions with their eukaryotic hosts (9), it will be important to determine if EPS production also plays an important role in Brucella virulence.
PHYSIOLOGIC ADAPTATION TO THE HOST ENVIRONMENT
Microaerobic Respiration and Denitrification
Brucella strains rely upon a strictly respiratory type of metabolism for growth (332). Within the tissues of their mammalian hosts, these bacteria reside in microaerobic environments, and bd- and cbb3-type cytochrome oxidases with very high affinities for O2 play important roles in Brucella virulence (333–338). Interestingly, B. abortus 2308 requires the bd-type cytochrome oxidase for wild-type virulence in mice (334). In contrast, a B. suis 1330 mutant lacking the cbb3-type cytochrome oxidase displays marked attenuation in mice, but a derivative of this strain lacking the bd-type cytochrome displays wild-type virulence (337). The basis for this differential requirement for the bd- and cbb3-type cytochrome oxidases for the virulence of these two strains is not known. But what is clear from both studies (334, 337) is that a respiratory chain with a high affinity for O2 is required for successful replication and persistence of the brucellae in mammalian tissues.
Denitrification is a process that allows bacteria to reduce NO3 and use it instead of O2 as a terminal electron acceptor for respiration (339). Most Brucella strains have the four enzymatic pathways needed for the complete reduction of NO3 to N2 (340), and experimental evidence indicates that the denitrification pathway contributes to virulence (335, 340–342). One way it contributes is by allowing the brucellae to employ NO3 as an alternative electron acceptor to sustain the respiration they need for chronic intracellular persistence in the microaerobic environment of host tissues. Experimental evidence also suggests that the denitrification enzymes provide Brucella strains with a defense against the bactericidal activity of NO generated by host macrophages (340, 341, 343) (Fig. 7). In addition, the capacity of the intracellular brucellae to degrade NO protects infected macrophages from apoptosis (343). Interestingly, the degree to which denitrification contributes to virulence appears to differ between Brucella species that have different natural hosts (344).
FIG 7.
Virulence determinants that allow the brucellae to resist the reactive oxygen and nitrogen species they encounter during their intracellular residence in host phagocytes. Reactive oxygen and nitrogen species are shown in red. OM, outer membrane; CM, cytoplasmic membrane.
Expression of the genes encoding the bd- and cbb3-type cytochrome oxidases and denitrification enzymes is tightly coordinated by the two-component regulators PrrAB (also known as RegAB) and NtrYX (345–348). Not surprisingly, PrrB and NtrY are redox sensors, and in conjunction with their cognate regulators, they activate these genes in response to low levels of ambient O2.
Carbon and Nitrogen Metabolism
Until recently, when genes associated with central metabolism were identified in genetic screens for bacterial genes linked to virulence, these genes were often assigned to the “housekeeping” category and not examined further. But it is now widely appreciated that the capacity of bacterial pathogens to adapt their central metabolism to take advantage of the carbon, nitrogen, and energy sources they encounter in the host plays an essential role in their virulence (349). It has also become evident that extensive metabolic reprogramming takes place in bacterial pathogens, the host cells they inhabit, and the cells that modulate the host immune response during the course of bacterial infections and that these metabolic adaptations in both the pathogen and host often dictate the outcome of host-pathogen interactions (350–353). Studies reported by Xavier et al. (109), Czyż et al. (354), and Kerrinnes et al. (355) provide striking examples of how metabolic reprogramming in host cells can influence the course of Brucella infections.
Studies suggest that most Brucella strains rely on a balance of glucose catabolism (55, 109, 356, 357) and the utilization of gluconeogenic substrates such as glutamate and lactate (354, 358) to sustain their intracellular persistence in their mammalian hosts. Selective use of the pentose phosphate pathway for glucose catabolism also appears to have played an important role in the evolution of these bacteria as mammalian pathogens (359). Glucose catabolism appears to be especially important for these bacteria when they reside in alternatively activated macrophages during chronic infection in mice, when these host phagocytes shift from a glycolytic catabolism to one that relies on fatty acid oxidation, which makes glucose more readily available to the intracellular brucellae (109). The enzymes pyruvate kinase (PykM) and pyruvate phosphate dikinase (PpdK) play critical roles in glucose metabolism in Brucella (357, 358). PykM is critical for glucose catabolism, PpdK is required for gluconeogenesis, and both are essential for the wild-type virulence of Brucella strains in mice. But ongoing studies examining the role of glucose metabolism in Brucella virulence indicate that we still have a lot to learn in this area. Experimental evidence, for instance, indicates that the brucellae possess novel enzymes for converting fructose 1,6-bis-phosphate to fructose-6-phosphate during gluconeogenesis in addition to the well-characterized bacterial fructose bis-phosphatases Fbp and GlpX (358, 360). These bacteria also appear to be capable of employing an atypical pathway for converting phosphoenolpyruvate (PEP) to pyruvate during the catabolism of hexoses in the absence of a functional pyruvate kinase (357).
Erythritol is a four-carbon sugar alcohol that serves as a preferred carbon and energy source for many Brucella strains (361–363). Substantial amounts of this carbohydrate are present in the placentas of ruminants during the latter stages of pregnancy, and the capacity to catabolize erythritol has been proposed to be an important virulence determinant for the Brucella spp., e.g., B. abortus and B. melitensis, that cause abortion and infertility in cattle, sheep, and goats (364). Recent studies have better defined the enzymes required for erythritol catabolism and shown that this carbohydrate is metabolized by a pathway that feeds into the pentose phosphate pathway (365). At least one erythritol-responsive transcriptional regulator, EryD, has also been identified (366), and this carbohydrate stimulates the expression of a variety of genes in Brucella, including those involved in the production of the T4SS and flagella (367, 368). But gaining a clear picture of whether erythritol catabolism contributes to Brucella virulence has remained elusive. Genetic studies, for instance, demonstrated a link between production of the siderophore brucebactin, erythritol utilization, and the virulence of B. abortus 2308 in pregnant cattle (369, 370), but a direct link between erythritol catabolism and the virulence of this strain in cattle has not been confirmed experimentally. Erythritol catabolism genes have also been reported to be required for the virulence of B. abortus and B. suis strains in mice and cultured murine and human macrophages (234, 335, 371). But a recent comparative study of the virulence properties of B. abortus mutants blocked at different steps in the erythritol catabolism pathway suggests that the attenuation reported for B. abortus eryC, eryH, and eryI mutants and B. suis eryB and eryC mutants was likely due to erythritol toxicity rather than their inability to catabolize this four-carbon sugar alcohol (372). More importantly, this study showed that a B. abortus eryA mutant which lacks the first enzyme in the erythritol catabolism pathway and cannot catabolize this sugar alcohol displays only limited and early attenuation in nonpregnant mice and wild-type virulence in bovine and human macrophages and trophoblasts and pregnant mice. More extensive studies of the virulence properties of eryA mutants in nonpregnant and pregnant natural hosts will be required before we have a clear picture of the role that erythritol catabolism plays in Brucella virulence.
Evidence suggests that amino acids and NH4+ provide the bulk of the nitrogen the brucellae need to meet their physiologic requirements during residence in their mammalian hosts (373), although host-derived polyamines may serve as an important N source for these bacteria in alternatively activated macrophages (355). Glutamate can serve as both a sole C and N source for Brucella strains (374), and as observed in other bacteria, the enzymes that interconvert α-ketoglutarate, glutamate, and glutamine and the proteins that regulate these enzymes tightly coordinate NH4+ assimilation in the brucellae (373). The importance of this regulatory network for virulence is evidenced by the fact that mutants lacking many of these enzymes (e.g., GlnA, GltB, GltD, and GdhZ) and regulators (e.g., GlnD and GlnE) exhibit attenuation in cultured mammalian cells and mice (54, 55, 234, 335, 342, 375). But one distinctive feature of N metabolism in Brucella is that the two-component regulator NtrBC and alternative sigma factor RpoN, which play central roles in regulating nitrogen metabolism in many other bacteria (376–379), do not appear to be required for wild-type virulence in Brucella (380–382). One caveat here, however, is that the Brucella NtrBC and RpoN regulons have not been extensively characterized, so it is not known if these regulators make significant contributions to nitrogen metabolism or if the typical regulatory functions of these proteins have been supplanted by other regulators.
Classical PEP-phosphotransferase (PTS) systems play both catalytic and regulatory roles in bacterial carbohydrate transport and catabolism (383). The Brucella spp. do not have a classical PTS, but they employ a related PTS known as the nitrogen-related PTS (PTSNtr) (384) to coordinate their C and N metabolism (385), and Brucella mutants with a disrupted PTSNtr are attenuated (234, 335, 375). But determining the precise role that the Brucella PTSNtr plays in virulence is complicated by the fact that the hprK, ptsM, and ptsO genes which encode principal components of the Brucella PTSNtr are cotranscribed with the genes that encode the two-component regulator BvrRS. The observation that Brucella mutants with a disrupted PTSNtr are defective in virB expression (385) suggests that in addition to coordinating C and N metabolism in Brucella, PTSNtr may also be influencing the regulatory activity of BvrR.
Antioxidants
Brucella strains utilize O2 as a terminal electron acceptor during their replication in host tissues (334, 337). This puts these bacteria in a precarious position, because it predisposes them to oxidative damage from both external and internal sources (Fig. 7). During their interactions with neutrophils and macrophages, for instance, the brucellae are exposed to the reactive oxygen species (ROS) generated by the respiratory burst of these phagocytes (386, 387). In addition, they must also detoxify the superoxide (O2−) and hydrogen peroxide (H2O2) generated as by-products of their own aerobic metabolism (388, 389).
Superoxide anion (O2−) does not typically cross the cytoplasmic membrane due to its negative charge (390), and two different superoxide dismutases (SODs) with different cellular locations play distinct roles in detoxifying the exogenous O2− the brucellae encounter during their interactions with host phagocytes and the endogenous O2− they generate via their aerobic metabolism. The periplasmic Cu/Zn SOD SodC (391) is responsible for detoxifying exogenous O2−, and this enzyme plays an important role in protecting the brucellae from the respiratory burst of host macrophages (392). The cytoplasmic Mn SOD SodA, on the other hand, protects these bacteria from the O2− generated by their aerobic metabolism (389). Both enzymes are required for the wild-type virulence of Brucella strains in mice (389, 392, 393).
In contrast to O2−, H2O2 moves freely across cellular membranes (390), and the periplasmic catalase KatE (394) and the cytoplasmic peroxiredoxin AhpC (388) work in concert to ensure that the cellular levels of H2O2 generated by the aerobic metabolism of Brucella strains are maintained below toxic levels. It should be noted, however, that neither of these enzymes plays a major role in protecting the brucellae from the respiratory burst of host macrophages (388). Brucella strains lacking KatE exhibit wild-type virulence in mice (388, 395) and pregnant goats (396), and Brucella ahpC mutants are also fully virulent in mice (388). On the other hand, B. abortus ahpC katE double mutants are extremely attenuated in mice. These experimental findings coupled with the attenuation observed with a B. abortus sodA mutant in mice indicate that the brucellae must be able to protect themselves from ROS of both exogenous and endogenous origin to produce infection in their mammalian hosts.
The transcriptional activator OxyR directly regulates katE expression in Brucella in response to exposure to H2O2 (397, 398). But how ahpC, sodC, and sodA are regulated is less clear. The redox-responsive two-component regulator RegAB and the stringent response regulator Rsh have been reported to regulate sodC expression (348, 399), Hfq (and presumably sRNAs) have been implicated in ahpC and sodC regulation (392, 400, 401), and VjbR has been linked to sodA regulation (119). Whether these regulatory links are direct or indirect, however, remains to be determined.
Metal Acquisition and Detoxification
Depriving pathogens of iron (Fe), manganese (Mn), and zinc (Zn) is a strategy employed by the host to resist microbial infections (402, 403). The vast majority of the Fe in mammalian tissues, for instance, is incorporated into cellular proteins or heme and is not directly available for use by bacterial pathogens. Neutrophils also release the metal binding proteins calprotectin and lactoferrin into the extracellular environment during the inflammatory response (404–406), and activated macrophages employ the divalent cation transporter Nramp1 to pump Fe2+, Mn2+, and Zn2+ out of phagosomes containing intracellular pathogens (407). In addition, the liver produces the hormone hepcidin during the inflammatory response, which inhibits the release of Fe from the liver and spleen into the bloodstream (408).
Brucella strains rely on the siderophore brucebactin (409), the Fe2+ transporter FtrABCD (410), the heme transporter BhuA (224), the Mn transporter MntH (411), and the Zn transporter ZnuA (412, 413) to overcome the Fe, Mn, and Zn deprivation they encounter in their mammalian hosts (Fig. 8). Interestingly, the need for brucebactin appears to be host dependent. This siderophore is not required for the virulence of B. abortus 2308 in mice (409, 414, 415) but is essential for the virulence of this strain in pregnant goats (416) and cattle (369). The basis for this differential requirement for brucebactin in these hosts is unknown, but experimental evidence suggests that it may be linked to erythritol catabolism (370).
FIG 8.
Fe, Mn, Zn, and Mg acquisition systems and defenses against metal toxicity that have been shown to play a role in the virulence of Brucella. The solid arrows represent direct regulatory links that have been documented experimentally, and the dashed arrows and lines denote suspected regulatory links. OM, outer membrane; CM, cytoplasmic membrane.
Because Fe, Mn, or Zn can be toxic to bacterial cells when accumulated in excess, the brucellae employ metal-responsive transcriptional regulators, storage proteins, and exporters to prevent metal toxicity. The transcriptional regulators Irr, RirA, Mur, and Zur ensure that the genes encoding high-affinity metal importers are selectively expressed only when bacterial levels of specific metals fall below certain thresholds (417–422). The Mn exporter EmfA (423) and Zn exporter ZntA also transport excess Mn and Zn out of Brucella cells, and the Zn-specific transcriptional regulator ZntR tightly regulates ZntA-mediated Zn export (422). The fact that Brucella irr (419), rirA (234, 424), emfA (423), and zntR (422) mutants exhibit attenuation in mice strongly suggests that in addition to overcoming the metal deprivation that they encounter with the host, the brucellae must also avoid metal toxicity to be effective pathogens.
Nickel (Ni) and magnesium (Mg) transport also play important roles in Brucella virulence. Ni is required for urease activity (see below), and Mg is the most abundant metal found in bacterial cells (425) and an essential micronutrient for Brucella (426). Two high-affinity Ni transporters, NikABCDE and NikKLMQO, play functionally redundant roles in supplying Brucella strains with the Ni required to support their urease activity (427, 428). Although the Mg transporters in Brucella have not been well characterized, a gene predicted to be involved in Mg transport (mgtB) was identified in a genetic screen for B. melitensis mutants displaying attenuation in cultured mammalian cells and mice (429). A B. suis mutant lacking a homolog of a Salmonella virulence determinant involved in maintaining cellular Mg/ATP balance (MgtC) (430) is also attenuated in cultured mammalian cells (431).
Urease
Most Brucella strains produce urease (432), and this enzyme is thought to protect the brucellae from the extremely acidic conditions they encounter during passage through the gastrointestinal tract following ingestion (63, 433, 434). Brucella ovis is an exception, and the absence of urease activity in this bacterium has been proposed to be one of the reasons for its limited host range and lack of transmission via the oral route (196). There are two different genetic loci, ure1 and ure2, in Brucella strains containing urease biosynthesis genes, but only one of these loci, ure1, encodes a functional urease (433, 434). The ure2 locus encodes urea and Ni transporters that are thought to be important for maintaining maximum urease activity at the low urea concentrations and acidic pH encountered in the mammalian gastrointestinal tract (428).
PrpA
Proline racemase protein A (PrpA) is a B cell mitogen secreted by Brucella into the cytoplasm of infected macrophages, where it is palmitoylated by the host cell and transported to the plasma membrane, where it interacts with the surface receptor NMM-IIA (435–438) (Fig. 3). This interaction stimulates the production of the anti-inflammatory cytokine IL-10 by these macrophages and represses their ability to produce proinflammatory cytokines. The B cell mitogen activity of PrpA also increases the production of Brucella-specific IgG2a, which is thought to increase the opsonic uptake of Brucella by host macrophages. The enzymatic activity of PrpA is essential for its immune modulatory functions, but the mechanism behind this link is unknown. It is also unknown how PrpA is secreted into the host cell cytoplasm since this protein has not been described as a T4SS substrate. The late-stage attenuation of a prpA mutant in mice suggests that the immunomodulatory functions of PrpA may play a role in the capacity of Brucella strains to sustain chronic infections in their mammalian hosts.
BacA
The plant symbiont Sinorhizobium meliloti is a close phylogenetic relative of Brucella. During its symbiotic interactions with its plant host, S. meliloti imports small cysteine-rich peptides known as NCRs (nodule-specific C-rich peptides) from the plant into its cytoplasm via an ABC transporter known as BacA (439). NCR import serves two beneficial functions for the rhizobia during symbiosis. It prevents the potentially bactericidal NCRs from damaging the bacterial cell envelope (440), and the NCRs serve as signaling molecules that drive the intracellular rhizobia to differentiate into N2-fixing bacteroids (441).
Brucella strains produce a BacA homolog, and a B. abortus bacA mutant is attenuated in cultured murine and human macrophages and mice (39, 442, 443). The basis for the attenuation of this mutant is presently unknown. The B. abortus bacA mutant has reduced levels of very-long-chain fatty acids in its lipid A (169) and induces stronger inflammatory responses in mice than its parent strain, which likely explains one aspect of its attenuation (443). But the plant NCRs are also considered to be homologs of mammalian defensins (444), and the Brucella bacA gene can restore NCR import and symbiotic capacity to an S. meliloti bacA mutant (445). This raises the possibility that BacA may also be able to protect Brucella strains from the antimicrobial peptides they encounter during their interactions with host phagocytes in a manner similar to that by which this transporter protects S. meliloti from NCRs in plants.
GadB, GadC, and GlsA
Many foodborne pathogens like E. coli and Salmonella rely on acid resistance (AR) systems to help them overcome the low pH they encounter during passage through the stomach (446). One of these is the AR2/AR2_Q system, which is comprised of a glutamate carboxylase (GadB), a glutaminase (GlsA), and a γ-aminobutyric acid (GABA)/glutamate-glutamine antiporter (GadC). GlsA converts glutamine to glutamate, and GadB converts glutamate into GABA. The latter reaction consumes a proton which deacidifies the cytoplasm. GadC exports GABA to the exterior of the bacterial cell in exchange for the import of glutamate or glutamine, which allows Gls and GadB to continue the deacidification cycle in the cytoplasm.
gadB, gadC, and glsA genes are present in all Brucella species, but they encode functional AR2/AR2_Q systems only in B. microti, B. ceti, B. pinnipedialis, B. inopinata, and the “atypical” Brucella strains isolated from amphibians (447–449). AR2/AR2_Q systems allow these strains to withstand exposure to very acidic pH, and a B. microti gadBC mutant is attenuated in mice infected by the oral route. It has been proposed that the genes encoding a functional AR2/AR2_Q system have been retained only in the so-called “ancestral” Brucella strains because these bacteria reside for prolonged periods in the external environment, unlike the classical Brucella strains, which are highly host adapted.
REGULATION OF VIRULENCE GENE EXPRESSION
BvrRS
The two-component regulator BvrRS (37) controls the expression of genes required at multiple stages of the infectious process, and Brucella bvrR and bvrS mutants are highly attenuated (37, 234, 335). BvrRS directly controls the expression of omp25, omp22, and genes involved in LPS lipid A modification (174, 227). The altered cell envelopes of Brucella bvrR and bvrS mutants make them extremely sensitive to killing by serum (450), less invasive for mammalian cells than their wild-type counterparts (451), and highly susceptible to the bactericidal activities of macrophages and dendritic cells (452, 453). BvrS recognizes the acidic pH and nutrient deprivation encountered by the brucellae in the endososomal BCVs and via BvrR directly activates the expression of the genes encoding the T4SS (454). BvrRS also indirectly activates the expression of these genes by activating the expression of the gene encoding the quorum-sensing regulator VjbR (112) (Fig. 9). Experimental evidence suggests that many other Brucella genes are regulated by BvrRS (228, 455–457), but deciphering the nature of these regulatory links is complicated by the fact that BvrR lies upstream of VjbR in a regulatory network that controls the expression of >200 Brucella genes (112, 119, 121). The bvrR and bvrS genes are also transcribed in an operon with genes that encode a regulatory network that coordinates C and N metabolism in these bacteria (385).
FIG 9.
Overlapping regulation of genes encoding major virulence determinants in Brucella by BvrRS, VjbR, RpoE, CtrA, and LovhK. BvrRS and LovhK are shown twice to reflect the fact that these regulators have been shown to have both direct and indirect effects on genes encoding these virulence determinants.
BvrRS is a member of a family of highly conserved two-component regulators that play critical roles in the interactions of alphaproteobacteria with their respective eukaryotic hosts (458). The BvrRS homologs ChvIG and ChvI-ExoS, for example, are essential for the pathogenic and symbiotic interactions of Agrobacterium tumefaciens and Sinorhizobium meliloti with their plant hosts (459, 460), and BatRS is required for the virulence of Bartonella henselae in cultured human endothelial cells (461) and Bartonella tribocorum in rats (462). Although the sensor components of these regulators appear to have evolved to recognize different host-relevant environmental stimuli, the genes under the control of these regulators have highly conserved functions directed at overcoming the innate immune responses of these hosts and establishing long-term pathogenic or symbiotic relationships. Together with a periplasmic protein known as ExoR, which modulates the regulatory function of the BvrRS homologs in Sinorhizobium and Agrobacterium, these proteins comprise a regulatory circuit known as the ExoR-ExoS-ChvI (RSI) invasion switch (458). This regulatory circuit is found only in the alphaproteobacteria that infect eukaryotic hosts and is thought to have played an important role in their evolution to their host-adapted lifestyles. Interestingly, Brucella strains possess an exoR gene, but whether the corresponding gene product plays a role in modulating the regulatory activity of BvrRS has not been reported.
N-Dodecanoyl Homoserine Lactone, VjbR, and BabR
Quorum sensing (QS) is a cell-to-cell signaling pathway that bacteria use to assess their population density and trigger the density-dependent expression of genes affecting a wide range of cellular behaviors (463, 464). A possible link between QS and Brucella virulence was uncovered when the QS signaling molecule N-dodecanoyl homoserine lactone (C12-HSL) was detected in the supernatant of B. melitensis cultures, and it was found that the addition of exogenous C12-HSL to this strain repressed the expression of its T4SS and flagellar biosynthesis genes (465). Subsequent studies identified the LuxR-type regulator VjbR as being responsible for this regulatory link (302), and >150 Brucella genes are now known to be regulated by VjbR (81, 119, 121, 302, 466, 467). Brucella vjbR mutants are highly attenuated (65, 188, 234, 302, 468–470), and one of the major reasons for this attenuation is that VjbR is required for the expression of the virB operon which encodes the T4SS (Fig. 6 and 9). But VjbR also directly controls the expression of genes encoding other important virulence determinants, including Omp25, the autotransporter adhesin BtaE, the T4SS effector VceC, the cbb3-type cytochrome oxidase, and FtcR, the master regulator of flagellar gene expression in Brucella (81, 272).
Interestingly, the impact that C12-HSL binding has on the regulatory activity of VjbR is the opposite of what is observed for canonical LuxR-type QS regulators in other bacteria. Specifically, the latter regulators generally turn on the expression of virulence genes when they bind the QS signal (463, 464). In contrast, VjbR serves as an activator of virB expression in Brucella, and binding of C12-HSL to VjbR causes it to disengage from the virB promoter (466). Moreover, global studies of gene expression in wild-type Brucella strains and isogenic vjbR mutants exposed to C12-HSL have also shown that this QS signaling molecule has a negative impact on the regulatory activity of VjbR on many other genes (119, 121, 234, 302). Based on these experimental findings, it has been postulated that C12-HSL and VjbR do not comprise a classical QS pathway but rather a regulatory circuit that allows the intracellular brucellae to sense the spatial confines of the Brucella-containing vacuole within host cells and turn off the expression of virB and other genes in a temporal fashion (119, 272, 302) (Fig. 10).
FIG 10.
Proposed role of C12-HSL signaling and VjbR in temporal regulation of virB expression during development of the Brucella-containing vacuoles in host cells. It is thought that accumulation of C12-HSL in the spatial confines of the BCVs prevents virB expression during the later stages of BCV development. The phagosome membrane is depicted in brown.
Another C12-HSL-responsive LuxR-type transcriptional regulator known as BabR (also known as BlxR) also controls the expression of a subset of the VjbR-regulated genes in Brucella, including the virB operon and flagellar biosythesis genes, and in some cases these two regulators have opposite effects on these coregulated genes (119–122, 471). BabR also regulates vjbR expression and vice versa. But in contrast to vjbR mutants, Brucella babR mutants display little or no attenuation in experimental models (119–121), leaving the importance of the regulatory overlap between VjbR and BabR presently unclear.
It is clear that we still have a lot to learn about the roles that C12-HSL, VjbR, and BabR play in the basic biology and virulence of Brucella. For instance, although a lactonase that degrades C12-HSL and modulates its regulatory activity on VjbR has been identified (472), the enzyme(s) responsible for the synthesis of the signaling molecule has not. In addition, the regulatory activity of VjbR at some promoters is dependent on the activities of other coregulators (272), but in only a few cases have these coregulators been identified (111, 115, 116, 118, 273). There are also many genes involved in basic physiologic processes such as metabolism and transport that are regulated by VjbR and/or BabR (119–121), but the importance of these particular regulatory links to virulence have not been determined. Finally, the fact that the vjbR and babR genes regulate each other (119–121) and are regulated by other global regulators (112, 123, 473) often makes it difficult to pinpoint precisely where VjbR and BabR lie in the regulatory pathways that control specific genes.
General Stress Response and LovhK
The general stress response (GSR) is a global change in gene expression that allows the alphaproteobacteria to withstand a wide variety of environmental stresses (474). Because some of these stresses, such as nutrient deprivation and exposure to reactive oxygen species and acidic pH, are those that the brucellae encounter during their intracellular life cycle in the host, the GSR has been proposed to play an important role in Brucella virulence (400). The alternative σ factor RpoE1 controls the GSR in Brucella, and the activity of RpoE1 is modulated by the anti-σ factor NepR, the anti-anti-σ factor PhyR, and the HWE-type sensor histidine kinase (HK) LovhK (305, 475, 476) (Fig. 11). Under nonstress conditions, NepR binds RpoE1 and prevents it from interacting with RNA polymerase (RNAP). In response to undefined environmental or physiologic stimuli (see below), LovhK phosphorylates PhyR and PhyR-P titrates NepR away from RpoE1. This allows RpoE1 to engage RNAP and regulate the >80 genes that comprise the Brucella GSR regulon (303, 305, 381). Regulated proteolysis of PhyR and the activity of another uncharacterized HWE-type sensor HK encoded by the gene immediately downstream of rpoE1 also play important roles in fine-tuning the GSR in Brucella (304, 475).
FIG 11.
Regulation of the general stress response (GSR) and other virulence determinants in Brucella by LovhK. The yellow and red lightning bolts in panel B denote the stimuli thought to activate the histidine kinase activity of Lovhk through its LOV and PAS domains. LovR has been proposed to function as a phosphate sink and to modulate LovhK signaling. HK, histidine kinase domain; SL, sigma factor-like domain; Rec, response regulator receiver domain.
Brucella rpoE1 and phyR mutants are more sensitive to oxidative stress and acidic pH than wild-type strains (305, 474), and these mutants exhibit limited attenuation in cultured mammalian cells and delayed clearance in the mouse model of chronic infection (305, 381, 475). These phenotypes are consistent with the proposed role of the GSR in supporting the long-term intracellular persistence of the brucellae in host macrophages. Specific genes in the Brucella GSR regulon that have individually been linked to virulence include those encoding the flagella, urease, the bd-type cytochrome oxidase, and the lectin-like protein BA14K (303, 305, 381) (Fig. 9).
Attempts to determine the environmental and/or physiologic stimuli that elicit the GSR in Brucella have been complicated by the fact that LovhK has two sensory domains that respond to different stimuli (475) (Fig. 11). One of these domains responds to blue light, and the other is thought to be responsive to an undefined redox stimulus. The light-sensing domain is required for the wild-type intracellular replication of Brucella strains in mammalian cells, but the redox-sensing domain is not (475, 477). But exposure to light does not evoke the GSR in Brucella (476). The biological relevance of light as a stimulus for LovhK is also unclear considering the intracellular nature of Brucella infections. One proposal that has been put forth is that recognition of light by LovhK may occur during transmission between natural hosts, where exposure to aborted fetuses in the external environment represents an important source of infection for naive animals (476, 477) (Fig. 2).
LovhK also plays an important role in the regulation of virulence genes independent of its role in inducing the GSR (123, 475–477) (Fig. 11). The virB, vjbR, and babR genes require LovhK for their wild-type expression, but these genes are not members of the RpoE1 regulon, and Brucella lovhK mutants are considerably more attenuated in mammalian cells and mice than rpoE1 and phyR mutants. The nature of the regulatory links between LovhK and the virB, vjbR, and babR genes is currently unknown.
CtrA and GcrA
Like the other alphaproteobacteria, Brucella strains display a distinctive cell cycle characterized by asymmetric cell division, cell polarity, and defined developmental changes in gene expression (268, 269, 478, 479) (Fig. 12). Disruption of the cell cycle has a negative impact on virulence (230, 480, 481), and as noted previously, Brucella cells in the G1 phase of the cell cycle appear to be the most infectious for mammalian cells (267, 482). The transcriptional regulator CtrA serves as the master regulator of the cell cycle in Brucella (230, 481, 483), and the histidine kinase PdhS (484), CckA-ChpT phosphorelay, and protease adaptor CpdR (481) modulate the regulatory activity of CtrA is response to endogenous cell cycle signals (Fig. 13). Consistent with its role in regulating the cell cycle, CtrA controls multiple genes involved in DNA replication, chromosome segregation, and cell division in Brucella (230), and proper coordination of the expression of these genes is undoubtedly important for sustaining the intracellular persistence of these bacteria in mammalian cells. But CtrA also controls the expression of omp25 and genes involved in LPS biosynthesis, so it is apparent that its contributions to virulence in Brucella go beyond its role as a cell cycle regulator.
FIG 12.
Unipolar cell division and coordination of cell division with the cell cycle in Brucella. The polar locations of the AT adhesins BtaE, BtaF, and BmaC are shown, and the red boxes indicate that Brucella cells in the G1 phase of the cell cycle are the most infectious for mammalian cells.
FIG 13.
Regulation of CtrA and CpdR activity by PdhS and the CckA-ChpT phosphorelay in Brucella. Arrows indicate the direction of phosphate transfer. The red X denotes CtrA degradation by ClpPX. The multiple dashed arrows between PdhS and CckA indicate that the exact number and nature of the regulatory steps between these two regulators have not been determined.
GcrA is another cell cycle regulator that allows σ70-bound RNA polymerase to recognize the promoters of genes that have been epigenetically “marked” by the DNA methyltransferase CcrM (485). Recent studies have identified a GcrA ortholog in Brucella and shown that this gene is essential for wild-type virulence in cultured mammalian cells (486). But the specific contributions of individual GcrA-regulated genes to virulence remains to be determined.
MucR
The Zn finger protein MucR is a global regulator that plays an important role in the virulence of Brucella strains (124, 270, 329, 375, 487). MucR serves predominantly as a transcriptional repressor and has been shown to regulate the expression of a multitude of Brucella genes required for virulence, including the virB operon, omp25, babR, and genes involved in LPS, CβG, and flagellar biosynthesis, iron acquisition, and c-di-GMP signaling. Experimental evidence suggests that one of the primary functions of MucR is to work in concert with antagonistic transcriptional activators to ensure the proper temporal expression of these genes during infection (271) (Fig. 14), and similar host-specific regulatory functions have been proposed for MucR homologs in Agrobacterium tumefaciens (488) and Sinorhizobium meliloti (489). MucR also works in concert with CtrA to regulate the cell cycle in Caulobacter (490), and given the conservation of the cell cycle genes across the alphaproteobacteria, it is likely that the Brucella MucR performs the same function. Thus, it will also be important to determine how misregulation of the cell cycle contributes to the attenuation of Brucella mucR mutants.
FIG 14.
Conserved roles that MucR/Ros-based transcriptional modules are proposed to play in controlling host-specific gene expression in Agrobacterium, Sinorhizobium, and Brucella.
GntR
The GntR family is one of the most common types of transcriptional regulators found in bacteria (491). Twenty-one GntR-type regulators have been described in Brucella (126), and remarkably, 7 of these have been linked to virulence (126, 492). The regulatory activities of GntR-type regulators are typically modulated by the allosteric binding of metabolites, and correspondingly, most of the genes controlled by these regulators are involved in metabolism (493). Notably, one of the GntR-type regulators in Brucella is HutC, which regulates both histidine catabolism and expression of the genes encoding the type IV secretion machinery (116). This relationship is intriguing, because three other GntRs (GntR4, GntR12, and GntR17) have also been linked to proper expression of the virB genes in Brucella (126, 473, 492, 494). GntR17 is also required for wild-type expression of omp25 and the genes encoding the quorum-sensing regulators VjbR and BabR in B. abortus (473, 494), and GntR12 is required for the capacity of B. suis to elicit the unfolded protein response in cultured caprine alveolar macrophages (492). Considering the clear role of the Brucella GntRs as virulence determinants, it will be important to better characterize the individual contributions of these regulators to virulence, define the specific genes they regulate, and identify the metabolites that control the regulatory activities of these GntRs.
OtpR, CpbB, NodVW, TceSR, and PrlSR
The histidine kinase CenK and response regulator CenR form a two-component regulator that plays an essential role in regulating cell growth and division in Caulobacter (495). The Brucella OtpR is a CenR homolog, and although otpR does not appear to be an essential gene in Brucella, a B. melitensis otpR mutant displays growth and morphologic defects and misregulation of peptidoglycan biosynthesis and cell division genes. This suggests that the Caulobacter CenR and Brucella OtpR have similar physiologic functions (496, 497). A B. melitensis otpR mutant is also extremely attenuated in both cultured mammalian cells and mice. OtpR has been proposed to play an important role in protecting Brucella from acidic pH, and indeed, over 500 genes display differential expression in B. melitensis 16M and an isogenic otpR mutant when these strains are exposed to acidic pH (127, 128). But how many of these genes are directly regulated by OtpR remains to be determined. It is also presently unclear if a CenK ortholog works in concert with OtpR to comprise a two-component regulator in Brucella. Interestingly, otpR resides upstream and in an operon with a gene encoding the putative cAMP-binding protein CbpB, which also plays a role in the virulence of B. melitensis 16M. Moreover, experimental evidence suggests that like OtpR, CbpB may also play an important role in regulating genes involved in peptidoglycan biosynthesis and cell division (498).
NodVW and TceSR are two-component regulators that are highly conserved in Brucella strains (499), but neither is found in their close phylogenetic relative, Ochrobactrum anthropi, a soil bacterium that only infrequently causes disease in humans. This observation led to the proposition that these regulators played an important role in the evolution of the brucellae as intracellular pathogens. This proposition is supported by the fact that Brucella nodVW and tceSR mutants are highly attenuated in cultured mammalian cells and mice (500–502). Although the environmental stimuli that the Brucella NodVW and TceSR respond to are unknown, it is interesting that NodVW allows the closely related bacterium Bradyrhizobium japonicum to recognize small molecules produced by its plant host and express genes required for symbiosis (503, 504).
PrlSR is a two-component regulator that allows B. melitensis 16M to form multicellular aggregates when exposed to environments of high ionic strength (505). Although B. melitensis prlS and prlR mutants are not attenuated in cultured mammalian cells, these mutants cannot sustain chronic spleen infections in BALB/c mice. The genes that are subject to PrlSR regulation have not been described, but the phenotypes reported for the prlS and prlR mutants suggest that they are likely involved in exopolysaccharide production or cell envelope modifications.
Stringent Response
When faced with intense nutrient deprivation, bacteria produce the alarmones guanosine 3′-diphosphate 5′-triphosphate (pppGpp) and guanosine 3′-diphosphate 5′-diphosphate (ppGpp), known collectively as (p)ppGpp. These signaling molecules bind to RNA polymerase and cause programmatic changes in gene expression that allow bacteria to undergo a physiologic transition known as the stringent response (506). This transition shifts their metabolism from one directed toward cell growth and division to a maintenance metabolism geared toward survival. Induction of the stringent response also provides bacteria with resistance to a variety of different environmental stresses other than nutrient deprivation. In addition, many bacterial pathogens rely on the stringent response to induce the virulence determinants they need for successful colonization of their mammalian hosts.
The (p)ppGpp synthetase/hydrolase Rsh controls the stringent response in Brucella (117). Microarray analysis indicates that approximately 12% of the genes in the B. suis 1330 genome are regulated by the stringent response (399). Consistent with its expected role in allowing the brucellae to adapt their physiology to nutrient deprivation, Rsh represses the expression of rRNA genes and induces the expression of methionine biosynthesis genes in B. suis 1330 when this strain is exposed to nutrient-deprived conditions. B. abortus, B. suis, and B. melitensis rsh mutants are also more sensitive to nutrient deprivation than their parent strains (117, 507, 508), and depriving a CO2-dependent B. ovis strain of CO2 elicits the stringent response (509).
B. abortus, B. melitensis, and B. suis rsh mutants are highly attenuated in mice and cultured mammalian cells (60, 117, 335, 507, 508), but evidence suggests that the contributions of Rsh to virulence go beyond its capacity to allow the brucellae to withstand the nutrient deprivation they encounter in their mammalian hosts. The genes encoding the type IV secretion system, cbb3-type high-affinity cytochrome oxidase, nitrate reductase, and Cu/Zn superoxide dismutase SodC, for instance, are regulated by Rsh (117, 399). Constitutive production of (p)ppGpp also arrests Brucella cells in G1 of the cell cycle (508), which as noted previously, is their most infectious form. It is obvious that we still have a lot to learn about precisely how the stringent response contributes to Brucella virulence.
c-di-GMP Signaling
The signaling molecule bis-(3′–5′)-cyclic diguanylic acid (c-di-GMP) regulates bacterial gene expression at multiple levels. c-di-GMP can bind transcriptional regulators and modulate their regulatory activity, bind to riboswitches in mRNAs and control the efficiency with which these transcripts are transcribed or translated, or bind to proteins and regulate their function (510, 511). c-di-GMP-regulated genes and gene products play critical roles in the virulence of many bacterial pathogens (512, 513), and pioneering studies from the Splitter and Smith laboratories have provided convincing evidence that the same holds true for Brucella (304, 327). Brucella mutants lacking the diguanylate cyclase CgsB or the c-di-GMP-specific phosphodiesterases BpdA or BpdB, for instance, display significant alterations in their virulence profiles in cultured macrophages and mice, and microarray and proteomic analyses of B. melitensis cgsB and bpdA mutants indicate that genes encoding important virulence determinants such as the flagella and the type IV secretion system are regulated by c-di-GMP. The mechanism(s) by which c-di-GMP regulates the expression of these genes, however, has not yet been determined, as no c-di-GMP-responsive transcriptional regulators, c-di-GMP-responsive riboswitches, or proteins with catalytic or structural functions responsive to this signaling molecule have been identified in Brucella. The phenotypic properties displayed by the B. melitensis bpdA mutant suggest that c-di-GMP signaling controls many aspects of the basic biology of Brucella strains, including their central metabolism and progression through the cell cycle (327). This is consistent with the function of c-di-GMP as a global regulator in bacteria in general (510, 511), and in the alphaproteobacteria in particular, where c-di-GMP plays a major role in regulating cell cycle progression and cellular differentiation in Caulobacter, Sinorhizobium, and Agrobacterium, as well as the symbiotic and pathogenic interactions of the last two bacteria with their respective eukaryotic hosts (514–517).
The innate immune sensor known as stimulator of interferon genes (STING) resides in the ER of mammalian cells (518). This pattern recognition receptor recognizes c-di-GMP produced by bacterial pathogens, and STING-induced inflammatory responses can have both positive and negative impacts on bacterial infections (519). Therefore, it is not surprising that recent studies indicate that one way that c-di-GMP production contributes to Brucella virulence is by modulating the host immune response (520, 521). Specifically, c-di-GMP binding to STING stimulates the unfolded protein response in the ER of infected cells, and the resulting inflammatory response facilitates granuloma formation, which is thought to be important for the persistence of chronic infections.
sRNAs and Hfq
Small regulatory RNAs (sRNAs) play important roles in regulating prokaryotic gene expression at the posttranscriptional level (522). sRNAs perform their regulatory functions by binding to the mRNA transcripts of genes and blocking their translation or causing folding changes in these transcripts that uncover ribosome binding sites and enhance their translation. sRNAs binding to their cognate mRNA transcripts can also enhance the degradation of these mRNAs or enhance their stability, and this feature of sRNAs also plays an important role in their regulatory function. Most sRNAs (i) range in size from 50 to 300 nucleotides in length, (ii) are rich in secondary structure, (iii) regulate genes that reside remotely from the gene encoding the sRNA, and (iv) have limited patches of nucleotides known as regulatory motifs that share imperfect complementarity with their mRNA targets. The limited complementarity of sRNAs with their target transcripts allows them to regulate multiple genes, but it also means that most sRNAs require the RNA chaperone Hfq to facilitate productive interactions with their target mRNAs (523).
Hfq is required for the wild-type expression of many Brucella genes (122, 388, 392, 400, 524, 525), and B. abortus and B. melitensis hfq mutants exhibit pleiotropic phenotypes and are highly attenuated in cultured mammalian cells and mice (400, 442, 443, 525–527). These experimental findings indirectly provide evidence for the importance of sRNAs in the basic biology and virulence of Brucella strains. But the first sRNAs to be identified and characterized in Brucella were the 110-nt sRNA AbcR1 and the 116-nt sRNA AbcR2, and studies of the interactions of these sRNAs with their target transcripts has provided us with important insight into how Brucella sRNAs function at the molecular level (528, 529). AbcR1 and AbcR2, for example, play redundant roles in controlling the expression of genes encoding ABC transporters involved in amino acid and polyamine transport, and a B. abortus mutant lacking both AbcR1 and AbcR2 is highly attenuated. AbcR1 and AbcR2 orthologs are also found in other members of the Rhizobiales order of the alphaproteobacteria along with a conserved LysR-type regulator known as VtlR in Brucella, which coordinates the expression of these sRNAs. Importantly, these sRNAs control multiple genes required for the successful interactions of these bacteria with their respective hosts (530–532).
Since the discovery of AbcR1 and AbcR2, bioinformatics-based approaches and RNA sequencing (RNA-seq) analysis have been used to identify other sRNA candidates in Brucella genomes, and the existence of over 100 potentially authentic Brucella sRNAs have been confirmed by reverse transcription PCR (RT-PCR) and/or Northern blot analysis (128, 533–540). Some of these Brucella sRNAs are required for virulence in cultured mammalian cells and/or mice, including BSR0602 (535), BSR0441 (537), BASI74 (538), Bmsr1 (539), and BSR1141 (540). Experimental evidence also suggests that an sRNA designated BsrH plays a role in Brucella iron metabolism (534). More extensive studies of these and other newly discovered sRNAs and the auxiliary proteins such as Hfq and RNase E (541) that modulate their regulatory functions will help us better understand how these genetic regulators contribute to the basic biology and virulence of Brucella.
CONCLUDING REMARKS
Over the past 2 decades, we have uncovered many of the “hidden credentials” of Brucella virulence. But there is obviously a lot more to learn about how these remarkable bacteria produce disease in their natural hosts. We do not know, for instance, how many of the T4SS effectors contribute to virulence. There are also unanswered questions about how the brucellae coordinate the expression of genes encoding virulence determinants in response to external and endogenous signals received in the host and how specific genetic regulators contribute to these patterns of gene expression. How the brucellae adjust their cellular metabolism to adapt to shifts in host cell metabolism is also an area that needs more investigation (109, 354, 355). More experimental work also needs to be done with natural hosts using routes of inoculation that mimic those that occur naturally. Mice have been indispensable for gaining a better understanding of the basic features of Brucella virulence (542), but studies suggest that virulence determinants required in natural hosts may not always be identified using the murine model (369). Specific virulence determinants required for Brucella strains in their natural hosts may differ, and it is likely that the requirement for individual virulence determinants may vary during different stages of the disease cycle in these hosts (e.g., chronic infection versus abortion and fetal pathology in ruminants). From an evolutionary standpoint, it will be interesting to determine what genetic changes allowed the brucellae to evolve from environmental bacteria with phenotypic characteristics resembling those of their close present-day phylogenetic relative Ochrobactrum to become the highly host-adapted and host-specific pathogens they are today (7). This review does not cover studies focused specifically on host immune responses to Brucella infection, but this topic is covered by other reviews (543–548). Moreover, it is obvious that a better understanding of these responses is needed before we can truly gain a clear picture of the hidden credentials of Brucella virulence.
From a translational perspective, gaining a better understanding of the hidden credentials of Brucella virulence provides us with molecular targets that can be exploited in our efforts to design better Brucella vaccines and novel antimicrobials that can be used to prevent and treat brucellosis. Vaccines have been integral components of programs that have been successfully used to control food animal brucellosis worldwide. But the currently available vaccines have their limitations and drawbacks, and widespread efforts are under way to develop better Brucella vaccines for use in both food animals and wildlife (549–552). There is also presently no safe and effective vaccine that can be used to prevent human brucellosis, and this disease is notoriously difficult to treat (553, 554). The development of new and better chemotherapeutic strategies for treating human brucellosis is an area that deserves greater attention because it has the potential to have a tremendous impact on the status of this disease as one of the world’s leading zoonoses and on the threat of Brucella strains as agents of bioterrorism.
ACKNOWLEDGMENTS
The Brucella research community is a highly interactive group, and we express our gratitude to the other members of this community for the free flow of information on a real-time basis that continually stimulates progress and makes this an exciting field to be a part of. We also thank Patrick Lane from ScEYEnce Studios for assisting us with the figures used in this review.
Work in the laboratory of R.M.R. and D.W.M. is funded by grants (AI1414138 and AI1418132) from the National Institute of Allergy and Infectious Diseases.
Biographies

R. Martin Roop II (Marty) obtained his Ph.D. in 1985 from Virginia Tech under the direction of Noel Krieg and was a postdoctoral fellow under the direction of Hugo Veit and Gerhardt Schurig from 1985 to 1988 at the Virginia-Maryland Regional College of Veterinary Medicine. In 1988, he joined the Department of Microbiology and Immunology at the University of Arkansas for Medical Sciences and relocated to the Department of Microbiology and Immunology at Louisiana State University Health Sciences Center in 1992. In 2001, he joined the faculty of the Department of Microbiology and Immunology at Brody School of Medicine at East Carolina University. Dr. Roop has spent the past 34 years studying the basic biology and virulence of Brucella.

Ian S. Barton is a postdoctoral fellow in the Department of Microbiology and Immunology at Brody School of Medicine at East Carolina University. He received his B.A. in Biology from Hiram College and then obtained his Ph.D. from Indiana University in 2019 while working with Clay Fuqua, where he studied genome instability and plasmid conjugation in the alphaproteobacterial plant pathogen Agrobacterium tumefaciens. Since joining the Roop laboratory, he has been investigating molecular mechanisms of virulence regulation in Brucella spp.

Dariel Hopersberger is currently a Ph.D. candidate under the mentorship of Dr. R. Martin Roop II in the Department of Microbiology and Immunology at Brody School of Medicine at East Carolina University. Her graduate project aims to characterize the role of an uncharacterized exopolysaccharide in Brucella virulence. She obtained her Bachelor of Science in Biochemistry from Old Dominion University in 2008.

Daniel W. Martin is a Research Associate Professor at Brody School of Medicine at East Carolina University. He earned a B.S. and an M.S. in Biology at The University of Texas at Tyler. He obtained his Ph.D. in Microbiology in 1994 from the University of Texas Health Science Center at San Antonio while working with Dr. Vojo Deretic. His postdoctoral training was performed at Stanford University with Drs. Lucy Tompkins and Stanley Falkow from 1994 to 1999. He has been studying Brucella biology and pathogenesis for the past 16 years in collaboration with Marty Roop.
REFERENCES
- 1.Moreno E. 2014. Retrospective and prospective perspectives on zoonotic brucellosis. Front Microbiol 5:213. doi: 10.3389/fmicb.2014.00213. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Olsen SC, Palmer MV. 2014. Advancement of knowledge of Brucella over the past 50 years. Vet Pathol 51:1076–1089. doi: 10.1177/0300985814540545. [DOI] [PubMed] [Google Scholar]
- 3.Eisenberg T, Hamann KP, Kaim U, Schelz K, Seeger H, Seeger N, Schauerte N, Melzer F, Tomaso H, Scholz HC, Koylass MS, Whatmore AM, Zschöck M. 2012. Isolation of potentially novel Brucella spp. from frogs. Appl Environ Microbiol 78:3753–3755. doi: 10.1128/AEM.07509-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Soler-Lloréns PF, Quance CR, Lawhon SD, Stuber TP, Edwards JF, Ficht TA, Robbe-Austerman S, O’Callaghan D, Keriel A. 2016. A Brucella spp. isolate from a Pac-Man frog (Ceratophrys ornata) reveals characteristics departing from classical brucellae. Front Cell Infect Microbiol 6:116. doi: 10.3389/fcimb.2016.00116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.El-Tras WF, Tayel AA, Eltholth MM, Guitian J. 2010. Brucella infection in freshwater fish: evidence for natural infection of Nile catfish, Clarias gariepinus, with Brucella melitensis. Vet Microbiol 141:321–325. doi: 10.1016/j.vetmic.2009.09.017. [DOI] [PubMed] [Google Scholar]
- 6.Eisenberg T, Riße K, Schauerte N, Geiger C, Blom J, Scholz HC. 2017. Isolation of a novel ‘atypical’ Brucella strain from a bluespotted ribbontail ray (Taeniura lymma). Antonie Van Leeuwenhoek 110:221–234. doi: 10.1007/s10482-016-0792-4. [DOI] [PubMed] [Google Scholar]
- 7.Wattam AR, Foster JT, Mane SP, Beckstrom-Sternberg SM, Beckstrom-Sternberg JM, Dickerman AW, Keim P, Pearson T, Shukla M, Ward DV, Williams KP, Sobral BW, Tsolis RM, Whatmore AM, O'Callaghan D. 2014. Comparative phylogenomics and evolution of the brucellae reveal a path to virulence. J Bacteriol 196:920–930. doi: 10.1128/JB.01091-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Boussau B, Karlberg EO, Frank AC, Legault BA, Andersson SGE. 2004. Computational inference of scenarios for α-proteobacterial genome evolution. Proc Natl Acad Sci U S A 101:9722–9727. doi: 10.1073/pnas.0400975101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Batut J, Andersson SGE, O'Callaghan D. 2004. The evolution of chronic infection strategies in the α-proteobacteria. Nat Rev Microbiol 2:933–945. doi: 10.1038/nrmicro1044. [DOI] [PubMed] [Google Scholar]
- 10.Ashford RT, Muchowski J, Koylass M, Scholz HC, Whatmore AM. 2020. Application of whole genome sequencing and pan-family multi-locus sequence analysis to characterize relationships within the family Brucellaceae. Front Microbiol 11:1329. doi: 10.3389/fmicb.2020.01329. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Suárez-Esquivel M, Chaves-Olarte E, Moreno E, Guzmán-Verri C. 2020. Brucella genomics: macro and micro evolution. Int J Mol Sci 21:7749. doi: 10.3390/ijms21207749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Young EJ. 2005. Brucella species, p 2669–2674. In Mandell GL, Bennett JE, Dolin R (ed), Mandell, Douglass and Bennett’s principles and practice of infectious disease, 6th ed. Elsevier Churchill Livingstone, Philadelphia, PA. [Google Scholar]
- 13.Pappas G, P Papadimitriou P, Akritidis N, Christou L, Tsianos EV. 2006. The new global map of human brucellosis. Lancet Infect Dis 6:91–99. doi: 10.1016/S1473-3099(06)70382-6. [DOI] [PubMed] [Google Scholar]
- 14.Dean AS, Crump L, Greter H, Schelling E, Zinsstag J. 2012. Global burden of human brucellosis: a systematic review of disease frequency. PLoS Negl Trop Dis 6:e1865. doi: 10.1371/journal.pntd.0001865. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Pappas G, Panagopoulou P, Christou L, Akritidis N. 2006. Brucella as a biological weapon. Cell Mol Life Sci 63:2229–2236. doi: 10.1007/s00018-006-6311-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Whatmore AM. 2009. Current understanding of the genetic diversity of Brucella, an expanding genus of zoonotic pathogens. Infect Genet Evol 9:1168–1184. doi: 10.1016/j.meegid.2009.07.001. [DOI] [PubMed] [Google Scholar]
- 17.Scholz HC, Vergnaud G. 2013. Molecular characterisation of Brucella species. Rev Sci Tech 32:149–162. doi: 10.20506/rst.32.1.2189. [DOI] [PubMed] [Google Scholar]
- 18.Roop RM, II, Gaines JM, Anderson ES, Caswell CC, Martin DW. 2009. Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host. Med Microbiol Immunol 198:221–238. doi: 10.1007/s00430-009-0123-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Tuon FF, Gondolfo RB, Cerchiari N. 2017. Human-to-human transmission of Brucella—a systematic review. Trop Med Int Health 22:539–546. doi: 10.1111/tmi.12856. [DOI] [PubMed] [Google Scholar]
- 20.Foster G, Osterman BS, Godfroid J, Jacques I, Cloeckaert A. 2007. Brucella ceti sp. nov. and Brucella pinnipedialis sp. nov. for Brucella strains with cetaceans and seals as their preferred hosts. Int J Syst Evol Microbiol 57:2688–2693. doi: 10.1099/ijs.0.65269-0. [DOI] [PubMed] [Google Scholar]
- 21.Scholz HC, Hubalek Z, Sedlácek I, Vergnaud G, Tomaso H, Al Dahouk S, Melzer F, Kämpfer P, Neubauer H, Cloeckaert A, Maquart M, Zygmunt MS, Whatmore AM, Falsen E, Bahn P, Göllner C, Pfeffer M, Huber B, Busse H-J, Nöckler K. 2008. Brucella microti sp. nov., isolated from the common vole Microtus arvalis. Int J Syst Evol Microbiol 58:375–382. doi: 10.1099/ijs.0.65356-0. [DOI] [PubMed] [Google Scholar]
- 22.Whatmore AM, Davison M, Cloeckaert A, Al Dahouk S, Zygmunt MS, Brew SD, Perrett LL, Koylass MS, Vergnaud G, Quance C, Scholz HC, Dick EJ, Jr, Hubbard G, Schlabritz-Loutsevitch NE. 2014. Brucella papionis sp nov., isolated from baboons (Papio spp.). Int J Syst Evol Microbiol 64:4120–4128. doi: 10.1099/ijs.0.065482-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Scholz HC, Mühldorfer K, Shilton C, Benedict S, Whatmore AM, Blom J, Eisenberg T. 2016. The change of a medically important genus: worldwide occurrence of genetically diverse novel Brucella species in exotic frogs. PLoS One 11:e0168872. doi: 10.1371/journal.pone.0168872. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Guzmán-Verri C, González-Barrientos R, Hernández-Mora G, Morales J-A, Baquero-Calvo E, Chaves-Olarte E, Moreno E. 2012. Brucella ceti and brucellosis in cetaceans. Front Cell Infect Microbiol 2:3. doi: 10.3389/fcimb.2012.00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Stoenner HG, Lackman DB. 1957. A new species of Brucella isolated from the desert wood rat, Neotoma lepida Thomas. Am J Vet Res 18:947–951. [PubMed] [Google Scholar]
- 26.Nymo IH, Tryland M, Godfroid J. 2011. A review of Brucella infection in marine mammals, with special emphasis on Brucella pinnipedialis in the hooded seal (Cystophora cristaca). Vet Res 42:93. doi: 10.1186/1297-9716-42-93. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Scholz HC, Revilla-Fernández S, Al Dahouk S, Hammerl JA, Zygmunt MS, Cloeckaert A, Koylass M, Whatmore AM, Blom J, Vergnaud G, Witte A, Aistleitner K, Hofer E. 2016. Brucella vulpis sp. nov., isolated from mandibular lymph nodes of red foxes (Vulpes vulpes). Int J Syst Evol Microbiol 66:2090–2098. doi: 10.1099/ijsem.0.000998. [DOI] [PubMed] [Google Scholar]
- 28.Brew SD, Perrett LL, Stack JA, MacMillan AP, Staunton NJ. 1999. Human exposure to Brucella recovered from a sea mammal. Vet Rec 144:483. [PubMed] [Google Scholar]
- 29.Sohn AH, Probert WS, Glaser CA, Gupta N, Bollen AW, Wong JD, Grace EM, McDonald WC. 2003. Human neurobrucellosis with intracerebral granuloma caused by a marine mammal Brucella spp. Emerg Infect Dis 9:485–488. doi: 10.3201/eid0904.020576. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.McDonald WL, Jamaludin R, Mackereth G, Hansen M, Humphrey S, Short P, Taylor T, Swingler J, Dawson CE, Whatmore AM, Stubberfield E, Perrett LL, Simmons G. 2006. Characterization of a Brucella sp. strain as a marine-mammal type despite isolation from a patient with spinal osteomyelitis in New Zealand. J Clin Microbiol 44:4363–4370. doi: 10.1128/JCM.00680-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Tiller RV, Gee JE, Lonsway DR, Gribble S, Bell SC, Jennison AV, Bates J, Coulter C, Hoffmaster AR, De BK. 2010. Identification of an unusual Brucella strain (BO2) from a lung biopsy in a 52 year-old patient with chronic destructive pneumonia. BMC Microbiol 10:23. doi: 10.1186/1471-2180-10-23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Scholz HC, Nöckler K, Göllner C, Bahn P, Vergnaud G, Tomaso H, Al Dahouk S, Kämpfer P, Cloeckaert A, Maquart M, Zygmunt MS, Whatmore AM, Pfeffer M, Huber B, Busse HJ, De BK. 2010. Brucella inopinata sp. nov., isolated from a breast implant infection. Int J Syst Evol Microbiol 60:801–808. doi: 10.1099/ijs.0.011148-0. [DOI] [PubMed] [Google Scholar]
- 33.Villalobos-Vindas JM, Amuy E, Barquero-Calvo E, Rojas N, Chacón-Díaz C, Chaves-Olarte E, Guzmán-Verri C, Moreno E. 2017. Brucellosis caused by the wood rat pathogen Brucella neotomae: two case reports. J Med Case Rep 11:352. doi: 10.1186/s13256-017-1496-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Suárez-Esquivel M, Ruiz-Villalobos N, Jiménez-Rojas C, Barquero-Calvo E, Chacón-Díaz C, Viquez-Ruiz E, Rojas-Campos N, Baker KS, Oviedo-Sánchez G, Amuy E, Chaves-Olarte E, Thomson NR, Moreno E, Guzmán-Verri C. 2017. Brucella neotomae infections in humans, Costa Rica. Emerg Infect Dis 23:997–1000. doi: 10.3201/eid2306.162018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Rouzic N, Desmier L, Cariou ME, Gay E, Foster JT, Williamson CHD, Schmitt F, Le Henaff M, Le Coz A, Lorléac’h A, Lavigne JP, O’Callaghan D, Keriel A. 2020. First case of brucellosis caused by an amphibian-type Brucella. Clin Infect Dis doi: 10.1093/cid/ciaa1082. [DOI] [PubMed] [Google Scholar]
- 36.Adams LG. 1990. Advances in brucellosis research. Texas A&M University Press, College Station, TX. [Google Scholar]
- 37.Sola-Landa A, Pizarro-Cerdá J, Grilló MJ, Moreno E, Moriyón I, Blasco JM, Gorvel JP, López-Goñi I. 1998. A two-component regulatory system playing a critical role in plant pathogens and endosymbionts is present in Brucella abortus and controls cell invasion and virulence. Mol Microbiol 29:125–138. doi: 10.1046/j.1365-2958.1998.00913.x. [DOI] [PubMed] [Google Scholar]
- 38.Ugalde RA. 1999. Intracellular lifestyle of Brucella spp. Common genes with other animal pathogens, plant pathogens and endosymbionts. Microbes Infect 1:1211–1219. doi: 10.1016/s1286-4579(99)00240-3. [DOI] [PubMed] [Google Scholar]
- 39.LeVier K, Phillips RW, Grippe VK, Roop RM, II, Walker GC. 2000. Similar requirements of a plant symbiont and mammalian pathogen for prolonged intracellular survival. Science 287:2492–2943. doi: 10.1126/science.287.5462.2492. [DOI] [PubMed] [Google Scholar]
- 40.Moreno E, Moriyón I. 2002. Brucella melitensis: a nasty bug with hidden credentials for virulence. Proc Natl Acad Sci U S A 99:1–3. doi: 10.1073/pnas.022622699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.DelVecchio VG, Kapatral V, Redkar RJ, Patra G, Mujer C, Los T, Ivanova N, Anderson I, Bhattacharyya A, Lykidis A, Reznik G, Jablonski L, Larsen N, D'Souza M, Bernal A, Mazur M, Goltsman E, Selkov E, Elzer PH, Hagius S, O'Callaghan D, Letesson J-J, Haselkorn R, Kyrpides N, Overbeek R. 2002. The genome sequence of the facultative intracellular pathogen Brucella melitensis. Proc Natl Acad Sci U S A 99:443–448. doi: 10.1073/pnas.221575398. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.O'Callaghan D, Cazevieille C, Allardet-Servent A, Boschiroli ML, Bourg G, Foulongne V, Frutos P, Kulakov Y, Ramuz M. 1999. A homologue of the Agrobacterium VirB and Bordetella pertussis Ptl type IV secretion systems is essential for intracellular survival of Brucella suis. Mol Microbiol 33:1210–1220. doi: 10.1046/j.1365-2958.1999.01569.x. [DOI] [PubMed] [Google Scholar]
- 43.Watarai M, Makino S-I, Shirahata T. 2002. An essential virulence protein of Brucella abortus, VirB4, requires an intact nucleoside-triphosphate-binding domain. Microbiology (Reading) 148:1439–1446. doi: 10.1099/00221287-148-5-1439. [DOI] [PubMed] [Google Scholar]
- 44.Höppner C, Liu Z, Domke N, Binns AN, Baron C. 2004. VirB1 orthologs from Brucella suis and pKM101 complement defects of the lytic transglycosylase required for efficient type IV secretion from Agrobacterium tumefaciens. J Bacteriol 186:1415–1422. doi: 10.1128/jb.186.5.1415-1422.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Höppner C, Carle A, Sivanesan D, Hoeppner S, Baron C. 2005. The putative lytic transglycosylase VirB1 from Brucella suis interacts with the type IV secretion system core components VirB8, VirB9 and VirB11. Microbiology (Reading) 151:3469–3482. doi: 10.1099/mic.0.28326-0. [DOI] [PubMed] [Google Scholar]
- 46.Terradot L, Bayliss R, Oomen C, Leonard GA, Baron C, Waksman G. 2005. Structures of two core subunits of the bacterial type IV secretion system, VirB8 from Brucella suis and ComB10 from Helicobacter pylori. Proc Natl Acad Sci U S A 102:4596–4601. doi: 10.1073/pnas.0408927102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Yuan Q, Carle A, Gao C, Sivanesan D, Aly KA, Höppner C, Krall L, Domke N, Baron C. 2005. Identification of the VirB4-VirB8-VirB5-VirB2 pilus assembly sequence of the type IV secretion systems. J Biol Chem 280:26349–26359. doi: 10.1074/jbc.M502347200. [DOI] [PubMed] [Google Scholar]
- 48.Carle A, Höppner C, Ahmed Aly K, Yuan Q, den Dulk-Ras A, Vergunst A, O'Callaghan D, Baron C. 2006. The Brucella suis type IV secretion system assembles in the cell envelope of the heterologous host Agrobacterium tumefaciens and increases IncQ plasmid recipient competence. Infect Immun 74:108–117. doi: 10.1128/IAI.74.1.108-117.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Paschos A, Patey G, Sivanesan D, Gao C, Bayliss R, Waksman G, O'Callaghan D, Baron C. 2006. Dimerization and interactions of Brucella suis VirB8 with VirB4 and VirB10 are required for its biological activity. Proc Natl Acad Sci U S A 103:7252–7257. doi: 10.1073/pnas.0600862103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Patey G, Qi Z, Bourg G, Baron C, O'Callaghan D. 2006. Swapping of periplasmic domains between Brucella suis VirB and a pSB102 VirB8 homologue allows heterologous complementation. Infect Immun 74:4945–4949. doi: 10.1128/IAI.00584-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Bourg G, Sube R, O'Callaghan D, Patey G. 2009. Interactions between Brucella suis VirB8 and its homolog TraJ from the plasmid pSB102 underline the dynamic nature of type IV secretion systems. J Bacteriol 191:2985–2992. doi: 10.1128/JB.01426-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Sivanesan D, Hancock MA, Giraldo AMV, Baron C. 2010. Quantitative analysis of VirB8-VirB9-VirB10 interactions provides a dynamic model of type IV secretion system core complex assembly. Biochemistry 49:4483–4493. doi: 10.1021/bi902201y. [DOI] [PubMed] [Google Scholar]
- 53.Sieira R, Comerci DJ, Sánchez DO, Ugalde RA. 2000. A homologue of an operon required for DNA transfer in Agrobacterium is required in Brucella abortus for virulence and intracellular multiplication. J Bacteriol 182:4849–4855. doi: 10.1128/jb.182.17.4849-4855.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Foulongne V, Bourg G, Cazevieille C, Michaux-Charachon S, O'Callaghan D. 2000. Identification of Brucella suis genes affecting intracellular survival in an in vitro human macrophage infection model by signature-tagged transposon mutagenesis. Infect Immun 68:1297–1303. doi: 10.1128/iai.68.3.1297-1303.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Hong PC, Tsolis RM, Ficht TA. 2000. Identification of genes required for chronic persistence of Brucella abortus in mice. Infect Immun 68:4102–4107. doi: 10.1128/iai.68.7.4102-4107.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Comerci DJ, Martinez-Lorenzo MJ, Sieira R, Gorvel JP, Ugalde RA. 2001. Essential role of the VirB machinery in the maturation of the Brucella abortus-containing vacuole. Cell Microbiol 3:159–168. doi: 10.1046/j.1462-5822.2001.00102.x. [DOI] [PubMed] [Google Scholar]
- 57.Delrue RM, Martinez-Lorenzo M, Lestrate P, Danese I, Bielarz V, Mertens P, De Bolle X, Tibor A, Gorvel JP, Letesson JJ. 2001. Identification of Brucella spp. genes involved in intracellular trafficking. Cell Microbiol 3:487–497. doi: 10.1046/j.1462-5822.2001.00131.x. [DOI] [PubMed] [Google Scholar]
- 58.Watarai M, Makino S, Fujii U, Okamoto K, Shirahata T. 2002. Modulation of Brucella-induced micropinocytosis by lipid rafts mediates intracellular replication. Cell Microbiol 4:341–355. doi: 10.1046/j.1462-5822.2002.00195.x. [DOI] [PubMed] [Google Scholar]
- 59.Celli J, de Chastellier C, Franchini DM, Pizarro-Cerda J, Moreno E, Gorvel JP. 2003. Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum. J Exp Med 198:545–556. doi: 10.1084/jem.20030088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Kim S, Watarai M, Kondo Y, Erdenebaatar J, Makino S, Shirahata T. 2003. Isolation and characterization of mini-Tn5Km2 insertion mutants of Brucella abortus deficient in internalization and intracellular growth in HeLa cells. Infect Immun 71:3020–3027. doi: 10.1128/iai.71.6.3020-3027.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Rajashekara G, Glover DA, Krepps M, Splitter GA. 2005. Temporal analysis of pathogenic events in virulent and avirulent Brucella melitensis infections. Cell Microbiol 7:1459–1473. doi: 10.1111/j.1462-5822.2005.00570.x. [DOI] [PubMed] [Google Scholar]
- 62.Zygmunt MS, Hagius SD, Walker JV, Elzer PH. 2006. Identification of Brucella melitensis 16M genes required for bacterial survival in the caprine host. Microbes Infect 8:2849–2854. doi: 10.1016/j.micinf.2006.09.002. [DOI] [PubMed] [Google Scholar]
- 63.Paixão TA, Roux CM, den Hartigh AB, Sankaran-Walters S, Dandekar S, Santos RL, Tsolis RM. 2009. Establishment of systemic Brucella melitensis infection through the digestive tract requires urease, the type IV secretion system, and lipopolysaccharide O antigen. Infect Immun 77:4197–4208. doi: 10.1128/IAI.00417-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Hanna N, Jiménez de Bagüés MP, Ouahrani-Bettache S, El Yakhlifi Z, Köhler S, Occhialini A. 2011. The virB operon is essential for lethality of Brucella microti in the Balb/c murine model of infection. J Infect Dis 203:1129–1135. doi: 10.1093/infdis/jiq163. [DOI] [PubMed] [Google Scholar]
- 65.Martín-Martín AI, Sancho P, de Miguel MJ, Fernández-Lago L, Vízcaino N. 2012. Quorum-sensing and BvrR/BvrS regulation, the type IV secretion system, cyclic glucans, and BacA in the virulence of Brucella ovis: similarities to and difference from smooth brucellae. Infect Immun 80:1783–1793. doi: 10.1128/IAI.06257-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Sá JC, Silva TMA, Costa EA, Silva APC, Tsolis RM, Paixão TA, Neta AVC, Santos RL. 2012. The virB-encoded type IV secretion system is critical for establishment of infection and persistence of Brucella ovis infection in mice. Vet Microbiol 159:130–140. doi: 10.1016/j.vetmic.2012.03.029. [DOI] [PubMed] [Google Scholar]
- 67.Palomares-Resendiz E, Arrelano-Reynoso B, Hernández-Castro R, Tenorio-Guttiérrez V, Salas-Téllez E, Suárez-Güemes F, Díaz-Aparicio E. 2012. Immunogenic response of Brucella canis virB10 and virB11 mutants in a murine model. Front Cell Infect Microbiol 2:35. doi: 10.3389/fcimb.2012.00035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Salcedo SP, Chevrier N, Lacerda TL, Ben Amara A, Gerart S, Gorvel VA, de Chastellier C, Blasco JM, Mege JL, Gorvel JP. 2013. Pathogenic brucellae replicate in human trophoblasts. J Infect Dis 207:1075–1083. doi: 10.1093/infdis/jit007. [DOI] [PubMed] [Google Scholar]
- 69.Mol JPS, Costa EA, Carvalho AF, Sun YH, Tsolis RM, Paixão TA, Santos RL. 2014. Early transcriptional responses of bovine chorioallantoic membrane explants to wild type, ΔvirB or ΔbtpB Brucella abortus infection. PLoS One 9:e108606. doi: 10.1371/journal.pone.0108606. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Silva TMA, Mol JPS, Winter MG, Atluri V, Xavier MN, Pires SF, Paixão TA, Andrade HM, Santos RL, Tsolis RM. 2014. The predicted ABC transporter AbcEDCBA is required for type IV secretion system expression and lysosomal evasion by Brucella ovis. PLoS One 9:e114532. doi: 10.1371/journal.pone.0114532. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Macedo AA, Silva APC, Mol JPS, Costa LF, Garcia LNN, Araujo MS, Filho OAM, Paixão TA, Santos RL. 2015. The abcEDCBA-encoded ABC transporter and the virB operon-encoded type IV secretion system of Brucella ovis are critical for intracellular trafficking and survival in ovine monocyte-derived macrophages. PLoS One 10:e0138131. doi: 10.1371/journal.pone.0138131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Chacón-Díaz C, Altamirano-Silva P, González-Espinoza G, Medina MC, Alfaro-Alarcón A, Bouza-Mora L, Jiménez-Rojas C, Wong M, Barquero-Calvo E, Rojas N, Guzmán-Verri C, Moreno E, Chaves-Olarte E. 2015. Brucella canis is an intracellular pathogen that induces a lower proinflammatory response than smooth zoonotic counterparts. Infect Immun 83:4861–4870. doi: 10.1128/IAI.00995-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Fernández AG, Ferrero MC, Hielpos MS, Fossati CA, Baldi PC. 2016. Proinflammatory response of human trophoblastic cells to Brucella abortus infection and upon interactions with infected phagocytes. Biol Reprod 94:48. doi: 10.1095/biolreprod.115.131706. [DOI] [PubMed] [Google Scholar]
- 74.Kang YS, Kirby JE. 2017. Promotion and rescue of intracellular Brucella neotomae replication during coinfection with Legionella pneumophila. Infect Immun 85:e00991-16. doi: 10.1128/IAI.00991-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Kang YS, Brown DA, Kirby JE. 2018. Brucella neotomae recapitulates attributes of zoonotic human disease in a murine infection model. Infect Immun 87:e00255-18. doi: 10.1128/IAI.00255-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Del Giudice MG, Ugalde JE, Czibener C. 2013. A lysozyme-like protein in Brucella abortus is involved in the early stages of intracellular replication. Infect Immun 81:956–964. doi: 10.1128/IAI.01158-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Del Giudice MG, Dohmer PH, Spera JM, Laporte FT, Marchesini MI, Czibener C, Ugalde JE. 2016. VirJ is a Brucella virulence factor involved in the secretion of type IV secreted substrates. J Biol Chem 291:12383–12393. doi: 10.1074/jbc.M116.730994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Starr T, Ng TW, Wehrly TD, Knodler LA, Celli J. 2008. Brucella intracellular replication requires trafficking through the late endosomal/lysosomal compartment. Traffic 9:678–694. doi: 10.1111/j.1600-0854.2008.00718.x. [DOI] [PubMed] [Google Scholar]
- 79.Starr T, Child R, Wehrly TD, Hansen B, Hwang S, Lopez-Otin C, Virgin HW, Celli J. 2012. Selective subversion of autophagy complexes facilitates completion of the Brucella intracellular life cycle. Cell Host Microbe 11:33–45. doi: 10.1016/j.chom.2011.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Boschiroli ML, Ouahrani-Bettache S, Foulongne V, Michaux-Charachon S, Bourg G, Allardet-Servent A, Cazevieille C, Liautard JP, Ramuz M, O'Callaghan D. 2002. The Brucella suis virB operon in induced intracellularly in macrophages. Proc Natl Acad Sci U S A 99:1544–1549. doi: 10.1073/pnas.032514299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.de Jong MF, Sun YH, den Hartigh AB, van Dijl JM, Tsolis RM. 2008. Identification of VceA and VceC, two members of the VjbR regulon that are translocated into macrophages by the Brucella type IV secretion system. Mol Microbiol 70:1378–1396. doi: 10.1111/j.1365-2958.2008.06487.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.de Barsy MA, Jamet A, Filopon D, Nicolas C, Laloux G, Rual JF, Muller A, Twizere JC, Nkengfac B, Vandenhaute J, Hill DE, Salcedo SP, Gorvel JP, Letesson JJ, De Bolle X. 2011. Identification of a Brucella spp. secreted effector specifically interacting with human small GTPase Rab2. Cell Microbiol 13:1044–1058. doi: 10.1111/j.1462-5822.2011.01601.x. [DOI] [PubMed] [Google Scholar]
- 83.Marchesini MI, Herrmann CK, Salcedo SP, Gorvel JP, Comerci DJ. 2011. In search of Brucella abortus type IV secretion substrates: screening and identification of four proteins translocated into host cells through VirB system. Cell Microbiol 13:1261–1274. doi: 10.1111/j.1462-5822.2011.01618.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Salcedo SP, Marchesini MI, Degos C, Terwagne CM, von Bargen K, Lepidi H, Herrmann CK, Lacerda TLS, Imbert PRC, Pierre P, Alexopoulou L, Letesson JJ, Comerci DJ, Gorvel JP. 2013. BtpB, a novel Brucella TIR-containing effector protein with immune modulatory functions. Front Cell Infect Microbiol 3:28. doi: 10.3389/fcimb.2013.00028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Myeni S, Child R, Ng TW, Kupko JJII, Wehrly TD, Porcella SF, Knodler LA, Celli J. 2013. Brucella modulates secretory trafficking via multiple type IV secretion effector proteins. PLoS Pathog 9:e1003556. doi: 10.1371/journal.ppat.1003556. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Döhmer PH, Valguarnera E, Czibener C, Ugalde JE. 2014. Identification of a type IV secretion substrate of Brucella abortus that participates in the early stages of intracellular survival. Cell Microbiol 16:396–410. doi: 10.1111/cmi.12224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Miller CN, Smith EP, Cundiff JA, Knodler LA, Blackburn JB, Lupashin V, Celli J. 2017. A Brucella type IV effector targets the COG tethering complex to remodel host secretory traffic and promote intracellular replication. Cell Host Microbe 22:317–329. doi: 10.1016/j.chom.2017.07.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Fugier E, Salcedo SP, de Chastellier C, Pophillat M, Muller A, Arce-Gorvel V, Fourquet P, Gorvel JP. 2009. The glyceraldehyde-3-phosphate dehydrogenase and the small GTPase Rab 2 are crucial for Brucella replication. PLoS Pathog 5:e1000487. doi: 10.1371/journal.ppat.1000487. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Smith EP, Cotto-Rosario A, Borghesan E, Held K, Miller CN, Celli J. 2020. Epistatic interplay between type IV secretion effectors engages the small GTPase Rab2 in the Brucella intracellular cycle. mBio 11:e03350-19. doi: 10.1128/mBio.03350-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Rolán HG, Tsolis RM. 2007. Mice lacking components of adaptive immunity show increased Brucella abortus virB mutant colonization. Infect Immun 75:2965–2973. doi: 10.1128/IAI.01896-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Roux CM, Rólan HG, Santos RL, Beremand PD, Thomas TL, Adams LG, Tsolis RM. 2007. Brucella requires a functional type IV secretion system to elicit innate immune responses in mice. Cell Microbiol 9:1851–1869. doi: 10.1111/j.1462-5822.2007.00922.x. [DOI] [PubMed] [Google Scholar]
- 92.Rolán HG, Tsolis RM. 2008. Inactivation of the type IV secretion system reduces the Th1 polarization of the immune response to Brucella abortus infection. Infect Immun 76:3207–3213. doi: 10.1128/IAI.00203-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Lapaque N, Muller A, Alexopoulou L, Howard JC, Gorvel JP. 2009. Brucella abortus induces Irgm3 and Irga6 expression via type-I IFN by a Myd88-dependent pathway, without the requirement of TLR2, TLR4 and TLR9. Microb Pathog 47:299–304. doi: 10.1016/j.micpath.2009.09.005. [DOI] [PubMed] [Google Scholar]
- 94.Gomes MTR, Campos PC, Oliveira FS, Corsetti PP, Bortoluci KR, Cunha LD, Zamboni DS, Oliveira SC. 2013. Critical role of ASC inflammasomes and bacterial type IV secretion system in caspase-1 activation and host innate resistance to Brucella abortus infection. J Immunol 190:3629–3638. doi: 10.4049/jimmunol.1202817. [DOI] [PubMed] [Google Scholar]
- 95.de Jong MF, Starr T, Winter MG, den Hartigh AB, Child R, Knodler LA, van Dijl JM, Celli J, Tsolis RM. 2013. Sensing of bacterial type IV secretion via the unfolded protein response. mBio 4:e00418-12. doi: 10.1128/mBio.00418-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Keestra-Gounder AM, Byndloss MX, Seyffert N, Young BM, Chávez-Arroyo A, Tsai AY, Cevallos SA, Winter MG, Pham OH, Tiffany CR, de Jong MF, Kerrinnes T, Ravindran R, Luciw PA, McSorley SJ, Bäumler AJ, Tsolis RM. 2016. NOD1 and NOD2 signalling links ER stress with inflammation. Nature 532:394–399. doi: 10.1038/nature17631. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Byndloss MX, Tsai AY, Walker GT, Miller CN, Young BM, English BC, Seyffert N, Kerrinnes T, de Jong MF, Atluri VL, Winter MG, Celli J, Tsolis RM. 2019. Brucella abortus infection of placental trophoblasts triggers endoplasmic reticulum stress-mediated cell death and fetal loss via type IV secretion system-dependent activation of CHOP. mBio 10:e01538-19. doi: 10.1128/mBio.01538-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Salcedo SP, Marchesini MI, Lelouard H, Fugier E, Jolly G, Balor S, Muller A, Lapaque N, Demaria O, Alexopoulou L, Comerci DJ, Ugalde RA, Pierre P, Gorvel J-P. 2008. Brucella control of dendritic cell maturation is dependent on the TIR-containing protein Btp1. PLoS Pathog 4:e21. doi: 10.1371/journal.ppat.0040021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Sengupta D, Koblansky A, Gaines J, Brown T, West AP, Zhang D, Nishikawa T, Park SG, Roop RM, II, Ghosh S. 2010. Subversion of innate immune responses by Brucella through targeted degradation of the TLR signaling adapter, MAL. J Immunol 184:956–964. doi: 10.4049/jimmunol.0902008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Alaidarous M, Ve T, Casey LW, Valkov E, Ericsson DJ, Ullah MO, Schembri MA, Mansell A, Sweet MJ, Kobe B. 2014. Mechanism of bacterial interference with TLR4 signaling by Brucella Toll/interleukin-1 receptor domain-containing protein TcpB. J Biol Chem 289:654–668. doi: 10.1074/jbc.M113.523274. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.de Jong MF, Rolán HG, Tsolis RM. 2010. Innate immune encounters of the (type) 4th kind: Brucella. Cell Microbiol 12:1195–1202. doi: 10.1111/j.1462-5822.2010.01498.x. [DOI] [PubMed] [Google Scholar]
- 102.Radhakrishnan GK, Harms JS, Splitter GA. 2011. Modulation of microtubule dynamics by a TIR domain protein from the intracellular pathogen Brucella melitensis. Biochem J 439:79–83. . doi: 10.1042/BJ20110577. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Felix C, Türköz BK, Ranaldi S, Koelblen T, Terradot L, O’Callaghan D, Vergunst AC. 2014. The Brucella TIR domain containing proteins BtpA and BtpB have a structural WxxxE motif important for protection against microtubule depolymerisation. Cell Commun Sign 12:53. doi: 10.1186/s12964-014-0053-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Smith JA, Khan M, Magnani DD, Harms JS, Durward M, Radhakrishnan GK, Liu YP, Splitter GA. 2013. Brucella induces an unfolded response via TcpB that supports intracellular replication in macrophages. PLoS Pathog 9:e1003785. doi: 10.1371/journal.ppat.1003785. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Coronas-Serna JM, Louche A, Rodríguez-Escudero M, Roussin M, Imbert PRC, Rodríguez-Escudero I, Terradot L, Molina M, Gorvel JP, Cid VJ, Salcedo SP. 2020. The TIR-domain containing effectors BtpA and BtpB from Brucella abortus impact NAD metabolism. PLoS Pathog 16:e10007979. doi: 10.1371/journal.ppat.1007979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Benitez PCA, Serantes DR, Herrmann CK, Viglietti AIP, Vanzulli S, Giambartolomei GH, Comerci DJ, Delpino MV. 2016. The effector protein BPE005 from Brucella abortus induces collagen deposition and matrix metalloproteinase 9 downmodulation via transforming growth factor 1 in hepatic stellate cells. Infect Immun 84:598–606. doi: 10.1128/IAI.01227-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Benitez PCA, Viglietti AIP, Herrmann CK, Dennis VA, Comerci DJ, Giambarolomei GH, Delpino MV. 2018. Brucella abortus promotes a fibrotic phenotype in hepatic stellate cells, with concomitant activation of the autophagy pathway. Infect Immun 86:e00522-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Marchesini MI, Seijo SM, Guaimas FF, Comerci DJ. 2016. A T4SS effector targets host cell alpha-enolase contributing to Brucella abortus intracellular lifestyle. Front Cell Infect Microbiol 6:e153. doi: 10.3389/fcimb.2016.00153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Xavier MN, Winter MG, Spees AM, den Hartigh AB, Nguyen K, Roux CM, Silva TMA, Atluri VL, Kerrinnes T, Keestra AM, Monack DM, Luciw PA, Eigenheer RA, Bäumler AJ, Santos RL, Tsolis RM. 2013. PPARγ-mediated increase in glucose availability sustains chronic Brucella abortus infection in alternatively activated macrophages. Cell Host Microbe 14:159–170. doi: 10.1016/j.chom.2013.07.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Ma Z, Li R, Hu R, Deng X, Xu Y, Zheng W, Yi J, Wang Y, Chen C. 2020. Brucella abortus BspJ is a nucleomodulin that inhibits macrophage apoptosis and promotes intracellular survival of Brucella. Front Microbiol 11:599205. doi: 10.3389/fmicb.2020.599205. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Sieira R, Comerci DJ, Pietrasanta LI, Ugalde RA. 2004. Integration host factor is involved in transcriptional regulation of the Brucella abortus virB operon. Mol Microbiol 54:808–822. doi: 10.1111/j.1365-2958.2004.04316.x. [DOI] [PubMed] [Google Scholar]
- 112.Altamirano-Silva P, Meza-Torres J, Castillo-Zeledón A, Ruiz-Villalobos N, Zuñiga-Pereira AM, Chacón-Díaz C, Moreno E, Guzmán-Verri C, Chaves-Olarte E. 2018. Brucella abortus senses the intracellular environment through the BvrR/BvrS two-component system, which allows B. abortus to adapt to its replicative niche. Infect Immun 86:e00713-17. doi: 10.1128/IAI.00713-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.Sprynski N, Felix C, O'Callaghan D, Vergunst AC. 2012. Restoring virulence to mutants lacking subunits of multiprotein machines: functional complementation of a Brucella virB5 mutant. FEBS Open Bio 2:71–75. doi: 10.1016/j.fob.2012.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Smith EP, Miller CN, Child R, Cundiff JA, Celli J. 2016. Postreplication roles of the Brucella VirB type IV secretion system uncovered via conditional expression of the virB11 ATPase. mBio 7:e0170-16. doi: 10.1128/mBio.01730-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Sieira R. 2013. Regulation of virulence in Brucella: an eclectic repertoire of transcription factors defines the complex architecture of the virB promoter. Future Microbiol 8:1193–1208. doi: 10.2217/fmb.13.83. [DOI] [PubMed] [Google Scholar]
- 116.Sieira R, Arocena GM, Bukata L, Comerci DJ, Ugalde RA. 2010. Metabolic control of virulence genes in Brucella abortus: HutC coordinates virB expression and the histidine utilization pathway by direct binding to both promoters. J Bacteriol 192:217–224. doi: 10.1128/JB.01124-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117.Dozot M, Boigegrain RA, Delrue RM, Hallez R, Ouahrani-Bettache S, Danese I, Letesson JJ, De Bolle X, Köhler S. 2006. The stringent response mediator Rsh is required for Brucella melitensis and Brucella suis virulence, and for expression of the type IV secretion system virB. Cell Microbiol 8:1791–1802. doi: 10.1111/j.1462-5822.2006.00749.x. [DOI] [PubMed] [Google Scholar]
- 118.Sieira R, Arocena GM, Zorreguieta A, Comerci DJ, Ugalde RA. 2012. A MarR-type regulator directly activates transcription from the Brucella abortus virB promoter by sharing a redundant role with HutC. J Bacteriol 194:6431–6440. doi: 10.1128/JB.01007-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Uzureau S, Lemaire J, Delaive E, Dieu M, Gaigneaux A, Raes M, De Bolle X, Letesson JJ. 2010. Global analysis of quorum sensing targets in the intracellular pathogen Brucella melitensis 16M. J Proteome Res 9:3200–3217. doi: 10.1021/pr100068p. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120.Rambow-Larsen AA, Rajashekara G, Petersen E, Splitter G. 2008. Putative quorum-sensing regulator BlxR of Brucella melitensis regulates virulence factors including the type IV secretion system and flagella. J Bacteriol 190:3274–3282. doi: 10.1128/JB.01915-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Weeks JN, Galindo CL, Drake KL, Adams LG, Garner HR, Ficht TA. 2010. Brucella melitensis VjbR and C12-HSL regulons: contributions of the N-dodecanoyl homoserine lactone signaling molecule and LuxR homologue VjbR to gene expression. BMC Microbiol 10:167. doi: 10.1186/1471-2180-10-167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Caswell CC, Gaines JM, Roop RM, II. 2012. The RNA chaperone Hfq independently coordinates expression of the VirB type IV secretion system and the LuxR-type regulator BabR in Brucella abortus 2308. J Bacteriol 194:3–14. doi: 10.1128/JB.05623-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123.Gourley CR, Petersen E, Harms J, Splitter G. 2014. Decrease in vivo virulence and altered gene expression by a Brucella melitensis light-sensing histidine kinase mutant. Pathog Dis 73:1–8. doi: 10.1111/2049-632X.12209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Dong H, Liu W, Peng X, Jing Z, Wu Q. 2013. The effects of MucR on expression of type IV secretion system and stress responses in Brucella melitensis. Vet Microbiol 166:535–542. doi: 10.1016/j.vetmic.2013.06.023. [DOI] [PubMed] [Google Scholar]
- 125.Borriello G, Russo V, Paradiso R, Riccardi MG, Criscuolo D, Verde G, Marasco R, Pedone PV, Galiero G, Baglivo I. 2020. Different impacts of MucR binding to the babR and virB promoters on gene expression in Brucella abortus 2308. Biomolecules 10:788. doi: 10.3390/biom10050788. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 126.Haine V, Sinon A, Van Steen F, Rousseau S, Dozot M, Lestrate P, Lambert C, Letesson JJ, De Bolle X. 2005. Systematic targeted mutagenesis of Brucella melitensis 16M reveals a major role for GntR regulators in the control of virulence. Infect Immun 73:5578–5586. doi: 10.1128/IAI.73.9.5578-5586.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 127.Liu W, Dong H, Li J, Ou Q, Lv Y, Wang X, Xiang Z, He Y, Wu Q. 2015. RNA-seq reveals the critical role of OtpR in regulating Brucella melitensis metabolism and virulence under acidic stress. Sci Rep 5:10864. doi: 10.1038/srep10864. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128.Vishnu US, Sankarasubramanian J, Gunasekaran P, Rajendhran J. 2017. Identification of OtpR regulated sRNAs in Brucella melitensis expressed under acid stress and their roles in pathogenesis and metabolism. Comp Immunol Microbiol Infect Dis 50:40–47. doi: 10.1016/j.cimid.2016.11.007. [DOI] [PubMed] [Google Scholar]
- 129.Rouot B, Alvarez-Martinez M-T, Marius C, Menanteau P, Guilloteau L, Boigegrain R-A, Zumbihl R, O'Callaghan D, Domke N, Baron C. 2003. Production of the type IV secretion system differs among Brucella species as revealed with VirB5- and Vir8-specific antisera. Infect Immun 71:1075–1082. doi: 10.1128/iai.71.3.1075-1082.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130.Iriarte M, González D, Delrue RM, Monreal D, Conde R, López-Goñi I, Letesson JJ, Moriyón I. 2004. Brucella lipopolysaccharide: structure, biosynthesis and genetics, p 159–191. In López-Goñi I, Moriyón I (ed), Brucella: molecular and cellular biology. Horizon Bioscience, Norfolk, United Kingdom. [Google Scholar]
- 131.Vizcaíno N, Cloeckaert A. 2012. Biology and genetics of the Brucella outer membrane, p 133–161. In López-Goñi I, O’Callaghan D (ed), Brucella: molecular microbiology and genomics. Caister Academic Press, Norfolk, United Kingdom. [Google Scholar]
- 132.Kreutzer DL, Robertson DC. 1979. Surface macromolecules and virulence in intracellular parasitism: comparison of cell envelope components of smooth and rough strains of Brucella abortus. Infect Immun 23:819–828. doi: 10.1128/IAI.23.3.819-828.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133.Riley LK, Robertson DC. 1984. Ingestion and intracellular survival of Brucella abortus in human and bovine polymorphonuclear leukocytes. Infect Immun 46:224–230. doi: 10.1128/IAI.46.1.224-230.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134.Price RE, Templeton JW, Adams LG. 1990. Survival of smooth, rough and transposon mutant strains of Brucella abortus in bovine mammary macrophages. Vet Immunol Immunopathol 26:353–365. doi: 10.1016/0165-2427(90)90119-d. [DOI] [PubMed] [Google Scholar]
- 135.Roop RM, II, Jeffers G, Bagchi T, Walker J, Enright FM, Schurig GG. 1991. Experimental infection of goat fetuses in utero with a stable, rough mutant of Brucella abortus. Res Vet Sci 51:123–127. doi: 10.1016/0034-5288(91)90001-5. [DOI] [PubMed] [Google Scholar]
- 136.Schurig GG, Roop RM, II, Bagchi T, Boyle S, Buhrman D, Sriranganathan N. 1991. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet Microbiol 28:171–188. doi: 10.1016/0378-1135(91)90091-S. [DOI] [PubMed] [Google Scholar]
- 137.Cheville NF, Jensen AE, Halling SM, Tatum FM, Morfitt DC, Hennager SG, Frerichs WM, Schurig G. 1992. Bacterial survival, lymph node changes, and immunologic responses of cattle vaccinated with standard and mutant strains of Brucella abortus. Am J Vet Res 53:1881–1888. [PubMed] [Google Scholar]
- 138.Winter AJ, Schurig GG, Boyle SM, Sriranganathan N, Bevins JS, Enright FM, Elzer PH, Kopec JD. 1996. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitenis and Brucella suis biovar 4. Am J Vet Res 57:677–683. [PubMed] [Google Scholar]
- 139.Allen CA, Adams LG, Ficht TA. 1998. Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival. Infect Immun 66:1008–1016. doi: 10.1128/IAI.66.3.1008-1016.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 140.Elzer PH, Enright FM, McQuiston JR, Boyle SM, Schurig GG. 1998. Evaluation of a rough mutant of Brucella melitensis in pregnant goats. Res Vet Sci 64:259–260. doi: 10.1016/s0034-5288(98)90135-7. [DOI] [PubMed] [Google Scholar]
- 141.Godfroid F, Taminiau B, Danese I, Denoel P, Tibor A, Weynants V, Cloeckaert A, Godfroid J, Letesson JJ. 1998. Identification of the perosamine synthetase gene of Brucella melitensis 16M and involvement of lipopolysaccharide O side chain in Brucella survival in mice and in macrophages. Infect Immun 66:5485–5493. doi: 10.1128/IAI.66.11.5485-5493.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142.Monreal D, Grilló MJ, González D, Marín CM, De Miguel MJ, López-Goñi I, Blasco JM, Cloeckaert A, Moriyón I. 2003. Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model. Infect Immun 71:3261–3271. doi: 10.1128/iai.71.6.3261-3271.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 143.González D, Grilló MJ, De Miguel MJ, Ali T, Arce-Gorvel V, Delrue RM, Conde-Alvarez R, Muñoz P, López-Goñi I, Iriarte M, Marín CM, Weintraub A, Widmalm G, Zygmunt M, Letesson JJ, Gorvel JP, Blasco JM, Moriyón I. 2008. Brucellosis vaccines: assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export. PLoS One 3:e2760. doi: 10.1371/journal.pone.0002760. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 144.Stoffregen WC, Johnson CS, Olsen SC. 2013. Immunogenicity and safety of a natural rough mutant of Brucella suis as a vaccine for swine. Res Vet Sci 95:451–458. doi: 10.1016/j.rvsc.2013.04.014. [DOI] [PubMed] [Google Scholar]
- 145.Ouahrani-Bettache S, Jiménez de Bagüés MP, De La Garza J, Freddi L, Bueso JP, Lyonnais S, Al Dahouk S, De Biase D, Köhler S, Occhialini A. 2019. Lethality of Brucella microti in a murine model of infection depends on the wbkE gene involved in O-polysaccharide synthesis. Virulence 10:868–878. doi: 10.1080/21505594.2019.1682762. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 146.Eisenschenk FC, Houle JJ, Hoffmann EM. 1999. Mechanism of serum resistance among Brucella abortus isolates. Vet Microbiol 68:235–244. doi: 10.1016/s0378-1135(99)00075-9. [DOI] [PubMed] [Google Scholar]
- 147.Riley LK, Robertson DC. 1984. Brucellacidal activity of human and bovine polymorphonuclear leukocyte granule extracts against smooth and rough strains of Brucella abortus. Infect Immun 46:231–236. doi: 10.1128/IAI.46.1.231-236.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 148.Martínez de Tejada G, Pizarro-Cerdá J, Moreno E, Moriyón I. 1995. The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides. Infect Immun 63:3054–3061. doi: 10.1128/IAI.63.8.3054-3061.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 149.Porte F, Naroeni A, Ouahrani-Bettache S, Liautard JP. 2003. Role of the Brucella suis lipopolysaccharide O antigen in phagosomal genesis and in inhibition of phagosome-lysosome fusion in murine macrophages. Infect Immun 71:1481–1490. doi: 10.1128/iai.71.3.1481-1490.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 150.Naroeni A, Porte F. 2002. Role of cholesterol and the ganglioside GM1 in entry and short-term survival of Brucella suis in murine macrophages. Infect Immun 70:1640–1644. doi: 10.1128/iai.70.3.1640-1644.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 151.Watarai M, Makino S, Michikawa M, Yanagisawa K, Murakami S, Shirahata T. 2002. Macrophage plasma membrane cholesterol contributes to Brucella abortus infection in mice. Infect Immun 70:4818–4825. doi: 10.1128/iai.70.9.4818-4825.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 152.Jiménez de Bagüés MP, Terraza A, Gross A, Dornand J. 2004. Different responses of macrophages to smooth and rough Brucella strains: relationship to virulence. Infect Immun 72:2429–2433. doi: 10.1128/iai.72.4.2429-2433.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 153.Billard E, Dornand J, Gross A. 2007. Interaction of Brucella suis and Brucella abortus rough strains with human dendritic cells. Infect Immun 75:5916–5923. doi: 10.1128/IAI.00931-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 154.Forestier C, Moreno E, Pizarro-Cerda J, Gorvel JP. 1999. Lysosomal accumulation and recycling of lipopolysaccharide to the cell surface of murine macrophages, an in vitro and in vivo study. J Immunol 162:6784–6791. [PubMed] [Google Scholar]
- 155.Forestier C, Deleuil F, Lapaque L, Moreno E, Gorvel JP. 2000. Brucella abortus lipopolysaccharide in murine peritoneal macrophages acts as a down-regulator of T cell activation. J Immunol 165:5202–5210. doi: 10.4049/jimmunol.165.9.5202. [DOI] [PubMed] [Google Scholar]
- 156.Lapaque N, Forquet F, de Chastellier C, Mishal Z, Jolly G, Moreno E, Moriyón I, Heuser JE, He HT, Gorvel JP. 2006. Characterization of Brucella abortus lipopolysaccharide macrodomains as mega rafts. Cell Microbiol 8:197–206. doi: 10.1111/j.1462-5822.2005.00609.x. [DOI] [PubMed] [Google Scholar]
- 157.Gross A, Terraza A, Ouahrani-Bettache S, Liautard JP, Dornand J. 2000. In vitro Brucella suis infection prevents the programmed cell death of human monocytic cells. Infect Immun 68:342–451. doi: 10.1128/iai.68.1.342-351.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 158.Fernandez-Prada CM, Zelazowska EB, Nikolich M, Hadfield TL, Roop RM, II, Robertson GT, Hoover DL. 2003. Interactions between Brucella melitensis and human phagocytes: bacterial surface O-polysaccharide inhibits phagocytosis, bacterial killing, and subsequent host cell apoptosis. Infect Immun 71:2110–2119. doi: 10.1128/iai.71.4.2110-2119.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 159.He Y, Reichow S, Ramamoorthy S, Ding X, Lathigra R, Craig JC, Sobral BWS, Schurig GG, Sriranganathan N, Boyle SM. 2006. Brucella melitensis triggers time-dependent modulation of apoptosis and down-regulation of mitochondrion-associated gene expression in mouse macrophages. Infect Immun 74:5035–5046. doi: 10.1128/IAI.01998-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 160.Pei J, Turse JE, Wu Q, Ficht TA. 2006. Brucella abortus rough mutants induce macrophage oncosis that requires bacterial protein synthesis and direct interaction with the macrophage. Infect Immun 74:2667–2675. doi: 10.1128/IAI.74.5.2667-2675.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 161.Chen F, He Y. 2009. Caspase-2 mediated apoptotic and necrotic murine macrophage cell death induced by rough Brucella abortus. PLoS One 4:e6830. doi: 10.1371/journal.pone.0006830. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 162.Bryant CE, Spring DR, Gangloff M, Gay NJ. 2010. The molecular basis of the host response to lipopolysaccharide. Nat Rev Microbiol 8:8–14. doi: 10.1038/nrmicro2266. [DOI] [PubMed] [Google Scholar]
- 163.Baker PJ, Wilson JB. 1965. Chemical composition and biological properties of the endotoxin of Brucella abortus. J Bacteriol 90:895–902. doi: 10.1128/JB.90.4.895-902.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 164.Leong D, Diaz R, Milner K, Rudbach J, Wilson JB. 1970. Some structural and biological properties of Brucella endotoxin. Infect Immun 1:174–182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 165.Dueñas AI, Orduña A, Sánchez Crespo M, García-Rodríguez C. 2004. Interaction of endotoxins with Toll-like receptor 4 correlates with their endotoxic potential and may explain the proinflammatory effect of Brucella spp. Int Immunol 16:1467–1475. doi: 10.1093/intimm/dxh148. [DOI] [PubMed] [Google Scholar]
- 166.Tumurkhuu G, Koide N, Takahashi K, Hassan F, Islam S, Ito H, Mori I, Yoshida T, Yokochi T. 2006. Characterization of biological properties of Brucella melitensis lipopolysaccharide. Microbiol Immunol 50:421–427. doi: 10.1111/j.1348-0421.2006.tb03810.x. [DOI] [PubMed] [Google Scholar]
- 167.Barquero-Calvo E, Chaves-Olarte E, Weiss DS, Guzmán-Verri C, Chacón-Díaz C, Rucavado A, Moriyón I, Moreno E. 2007. Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection. PLoS One 2:e631. doi: 10.1371/journal.pone.0000631. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 168.Velasco J, Bengoechea JA, Brandenburg K, Lindner B, Seydel U, González D, Zähringer U, Moreno E, Moriyón I. 2000. Brucella abortus and its closest phylogenetic relative, Ochrobactrum spp., differ in outer membrane permeability and cationic peptide resistance. Infect Immun 68:3210–3218. doi: 10.1128/iai.68.6.3210-3218.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 169.Ferguson GP, Datta A, Baumgartner J, Roop RM, II, Carlson RW, Walker GC. 2004. Similarity to peroxisomal-membrane protein family reveals that Sinorhizobium and Brucella BacA affect lipid-A fatty acids. Proc Natl Acad Sci U S A 101:5012–5017. doi: 10.1073/pnas.0307137101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 170.Lapaque N, Takeuchi O, Corrales F, Akira S, Moriyón I, Howard JC, Gorvel JP. 2006. Differential inductions of TNF-α and IGTP, IIGP by structurally diverse classic and non-classic lipopolysaccharides. Cell Microbiol 8:401–413. doi: 10.1111/j.1462-5822.2005.00629.x. [DOI] [PubMed] [Google Scholar]
- 171.Barquero-Calvo E, Mora-Cartín R, Arce-Gorvel V, de Diego JL, Chacón-Díaz C, Chaves-Olarte E, Guzmán-Verri C, Buret AG, Gorvel JP, Moreno E. 2015. Brucella abortus induces the premature death of human neutrophils through the action of its lipopolysaccharide. PLoS Pathog 11:e1004853. doi: 10.1371/journal.ppat.1004853. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 172.Conde-Álvarez R, Arce-Gorvel V, Iriarte M, Manček-Keber M, Barquero-Calvo E, Palacios-Chaves L, Chacón-Díaz C, Chaves-Olarte E, Martirosyan A, von Bargen K, Grilló M-J, Jerala R, Brandenburg K, Llobet E, Bengoechea JA, Moreno E, Moriyón I, Gorvel J-P. 2012. The lipopolysaccharide core of Brucella abortus acts as a shield against innate immunity recognition. PLoS Pathog 8:e1002675. doi: 10.1371/journal.ppat.1002675. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 173.Gil-Ramírez Y, Conde-Álvarez R, Palacio-Chaves L, Zúñiga-Ripa A, Grilló MJ, Arce-Gorvel V, Hanniffy S, Moriyón I, Iriarte M. 2014. The identification of wadB, a new glycosyltransferase gene, confirms the branched structure and the role in virulence of the lipopolysaccharide core of Brucella abortus. Microb Pathog 73:53–59. doi: 10.1016/j.micpath.2014.06.002. [DOI] [PubMed] [Google Scholar]
- 174.Fontana C, Conde-Álvarez R, Ståhle J, Holst O, Iriarte M, Zhao Y, Arce-Gorvel V, Hanniffy S, Gorvel JP, Moriyón I, Widmalm G. 2016. Structural studies of lipopolysaccharide-defective mutants from Brucella melitensis identify a core oligosaccharide critical in virulence. J Biol Chem 291:7727–7741. doi: 10.1074/jbc.M115.701540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 175.Salvador-Bescós M, Gil-Ramírez Y, Zúñiga-Ripa A, Martínez-Gómez E, de Miguel MJ, Muñoz PM, Cloeckaert A, Zygmunt MS, Moriyón I, Iriarte M, Conde-Álvarez R. 2018. WadD, a new Brucella lipopolysaccharide glycosyltransferase identified by genomic search and phenotypic characterization. Front Microbiol 9:2293. doi: 10.3389/fmicb.2018.02293. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 176.Soler-Lloréns P, Gil-Ramírez Y, Zabalza-Baranguá A, Iriarte M, Conde-Álvarez R, Zúñiga-Ripa A, San Román B, Zygmunt MS, Vizcaíno N, Cloeckaert A, Grilló MJ, Moriyón I, López-Goñi I. 2014. Mutants in the lipopolysaccharide of Brucella ovis are attenuated and protect against B. ovis infection in mice. Vet Res 45:72. doi: 10.1186/s13567-014-0072-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 177.Blasco JM. 1990. Brucella ovis, p 351–378. In Nielsen K, Duncan JR (ed), Animal brucellosis. CRC Press, Boca Raton, FL. [Google Scholar]
- 178.Ridler AL, West DM. 2011. Control of Brucella ovis infection in sheep. Vet Clin North Am Food Anim Pract 27:61–66. doi: 10.1016/j.cvfa.2010.10.013. [DOI] [PubMed] [Google Scholar]
- 179.Kauffman LK, Petersen CA. 2019. Canine brucellosis—old foe and reemerging scourge. Vet Clin North Am Small Anim Pract 49:763–779. doi: 10.1016/j.cvsm.2019.02.013. [DOI] [PubMed] [Google Scholar]
- 180.Hensel ME, Negron M, Arenas-Gamboa AM. 2018. Brucellosis in dogs and public health risk. Emerg Infect Dis 24:1401–1406. doi: 10.3201/eid2408.171171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 181.Martín-Martín AI, Sancho P, Tejedor C, Fernández-Lago L, Vizcaíno N. 2011. Differences in the outer membrane-related properties of the six classical Brucella species. Vet J 189:103–105. doi: 10.1016/j.tvjl.2010.05.021. [DOI] [PubMed] [Google Scholar]
- 182.Martín-Martín AI, Caro-Hernández P, Sancho P, Tejedor C, Cloeckaert A, Fernández-Lago L, Vizcaíno N. 2009. Analysis of the occurrence and distribution of the Omp25/Omp31 family of surface proteins in the six classical Brucella species. Vet Microbiol 137:74–82. doi: 10.1016/j.vetmic.2008.12.003. [DOI] [PubMed] [Google Scholar]
- 183.Caro-Hernández P, Fernández-Lago L, de Miguel MJ, Martín-Martín AI, Cloeckaert A, Grilló MJ, Vizcaíno N. 2007. Role of the Omp25/Omp31 family in outer membrane properties and virulence of Brucella ovis. Infect Immun 75:4050–4061. doi: 10.1128/IAI.00486-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 184.Eskra L, Covert J, Glasner J, Splitter G. 2012. Differential expression of iron acquisition genes by Brucella melitensis and Brucella canis during macrophage infection. PLoS One 7:e31747. doi: 10.1371/journal.pone.0031747. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 185.Domingues de Souza T, de Carvalho TL, Mol JPS, Lopes JVM, Silva MF, Paixão TA, Santos RL. 2018. Tissue distribution and cell tropism of Brucella canis in naturally infected canine foetuses and neonates. Sci Rep 8:7203. doi: 10.1038/s41598-018-25651-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 186.Elzer PH, Kovach ME, Phillips RW, Robertson GT, Peterson KM, Roop RM, II. 1995. In vivo and in vitro stability of the broad-host-range cloning vector pBBR1MC in six Brucella species. Plasmid 33:51–57. doi: 10.1006/plas.1995.1006. [DOI] [PubMed] [Google Scholar]
- 187.Stranahan LW, Khalaf OH, Garcia-Gonzalez DG, Arenas-Gamboa AM. 2019. Characterization of Brucella canis infection in mice. PLoS One 14:e0218809. doi: 10.1371/journal.pone.0218809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 188.Liu Y, Sun J, Peng X, Dong H, Qin Y, Shen Q, Jiang J, Xu G, Feng Y, Sun S, Ding J, Chen R. 2020. Deletion of the LuxR-type regulator VjbR in Brucella canis affects expression of type IV secretion system and bacterial virulence, and the mutant strain confers protection against Brucella canis challenge in mice. Microb Pathog 139:103865. doi: 10.1016/j.micpath.2019.103865. [DOI] [PubMed] [Google Scholar]
- 189.Martín-Martín AI, Vizcaíno N, Fernández-Lago L. 2010. Cholesterol, ganglioside GM1 and class A scavenger receptor contribute to infection by Brucella ovis and Brucella canis in murine macrophages. Microbes Infect 12:246–250. doi: 10.1016/j.micinf.2009.12.008. [DOI] [PubMed] [Google Scholar]
- 190.Rittig MG, Kaufmann A, Robins A, Shaw B, Sprenger H, Gemsa D, Foulongne V, Rouot B, Dornand J. 2003. Smooth and rough lipopolysaccharide phenotypes of Brucella induce different intracellular trafficking and cytokine/chemokine release in human monocytes. J Leukoc Biol 74:1045–1055. doi: 10.1189/jlb.0103015. [DOI] [PubMed] [Google Scholar]
- 191.Galindo RC, Munoz PM, de Miguel MJ, Marin CM, Blasco JM, Gortazar C, Kocan KM, de la Fuente J. 2009. Differential expression of inflammatory and immune responses in rams experimentally infected with a rough virulent strain of Brucella ovis. Vet Immunol Immunopathol 127:339–343. [DOI] [PubMed] [Google Scholar]
- 192.de Paula Antunes JMA, Allendorf SD, Appolinário CM, Cagnini DQ, Figueiredo PR, Júnior JB, Baños JV, Kocan KM, de la Fuente J, Megid J. 2013. Rough virulent strain of Brucella ovis induces pro- and anti-inflammatory cytokines in reproductive tissues in experimentally infected rams. Vet Microbiol 161:339–343. doi: 10.1016/j.vetmic.2012.07.024. [DOI] [PubMed] [Google Scholar]
- 193.Pujol M, Castillo F, Alvarez C, Rojas C, Borie C, Ferreira A, Vernal R. 2017. Variability in the response of canine and human dendritic cells stimulated with Brucella canis. Vet Res 48:72. doi: 10.1186/s13567-017-0476-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 194.Vizcaíno N, Caro-Hernández P, Cloeckaert A, Fernández-Lago L. 2004. DNA polymorphism in the omp25/omp31 family of Brucella spp.: identification of a 1.7-kb inversion in Brucella cetaceae and of a 15.1-kb genomic island, absent from Brucella ovis, related to the synthesis of smooth lipopolysaccharide. Microbes Infect 6:821–834. doi: 10.1016/j.micinf.2004.04.009. [DOI] [PubMed] [Google Scholar]
- 195.Rajashekara G, Glasner JD, Glover DA, Splitter GA. 2004. Comparative whole-genome hybridization reveals genomic islands in Brucella species. J Bacteriol 186:5040–5051. doi: 10.1128/JB.186.15.5040-5051.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 196.Tsolis RM, Seshadri R, Santos RL, Sangari FJ, Garcia Lobo JM, de Jong MF, Ren Q, Myers G, Brinkac LM, Nelson WC, DeBoy RT, Angiuoli S, Khouri H, Dimitrov G, Robinson JR, Mulligan S, Walker RL, Elzer PH, Hassan KA, Paulsen IT. 2009. Genome degradation in Brucella ovis corresponds with narrowing of its host range and tissue tropism. PLoS One 4:e5519. doi: 10.1371/journal.pone.0005519. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 197.Zygmunt M, Blasco JM, Letesson JJ, Cloeckaert A, Moriyón I. 2009. DNA polymorphism analysis of Brucella lipopolysaccharide genes reveals marked differences in O-polysaccharide biosynthetic genes between smooth and rough Brucella species and novel species-specific markers. BMC Microbiol 9:92. doi: 10.1186/1471-2180-9-92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 198.Wattam AR, Inzana TJ, Williams KP, Mane SP, Shukla M, Almeida NF, Dickerman AW, Mason S, Moriyón I, O'Callaghan D, Whatmore AM, Sobral BW, Tiller RV, Hoffmaster AR, Frace MA, De Castro C, Molinaro A, Boyle SM, De BK, Setubal JC. 2012. Comparative genomics of early-diverging Brucella strains reveals a novel lipopolysaccharide biosynthesis pathway. mBio 3:e00246-12. doi: 10.1128/mBio.00388-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 199.Wattam AR, Williams KP, Snyder EE, Almeida NR, Jr, Shukla M, Dickerman AW, Crasta OR, Kenyon R, Lu J, Shallom JM, Yoo H, Ficht TA, Tsolis RM, Munk C, Tapia R, Han CS, Detter JC, Bruce D, Brettin TS, Sobral BW, Boyle SM, Setubal JC. 2009. Analysis of ten Brucella genomes reveals evidence for horizontal gene transfer despite a preferred intracellular lifestyle. J Bacteriol 191:3569–3579. doi: 10.1128/JB.01767-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 200.Zygmunt MS, Jacques I, Bernardet N, Cloeckaert A. 2012. Lipopolysaccharide heterogeneity in the atypical group of novel emerging Brucella species. Clin Vaccine Immunol 19:1370–1373. doi: 10.1128/CVI.00300-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 201.Vemulapalli TH, Vemulapalli R, Schurig GG, Boyle SM, Sriranganathan N. 2006. Role in virulence of a Brucella abortus protein exhibiting lectin-like activity. Infect Immun 74:183–191. doi: 10.1128/IAI.74.1.183-191.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 202.Valguarnera E, Spera JM, Czibener C, Fulgenzi FR, Casabuono AC, Altabe SG, Pasquevich KA, Guaimas F, Cassataro J, Couto AS, Ugalde JE. 2018. RomA, a periplasmic protein involved in the synthesis of the lipopolysaccharide, tunes down the inflammatory response triggered by Brucella. J Infect Dis 217:1257–1266. doi: 10.1093/infdis/jiy002. [DOI] [PubMed] [Google Scholar]
- 203.Cloeckaert A, Vizcaíno N, Paquet YV, Bowden RA, Elzer PH. 2002. Major outer membrane proteins of Brucella spp: past, present and future. Vet Microbiol 90:229–247. doi: 10.1016/S0378-1135(02)00211-0. [DOI] [PubMed] [Google Scholar]
- 204.Salhi I, Boigegrain RA, Machold J, Weise C, Cloeckaert A, Rouot B. 2003. Characterization of new members of the group 3 outer membrane protein family of Brucella spp. Infect Immun 71:4326–4332. doi: 10.1128/iai.71.8.4326-4332.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 205.Edmonds MD, Cloeckaert A, Elzer PH. 2002. Brucella species lacking the major outer membrane protein Omp25 are attenuated in mice and protect against Brucella melitensis and Brucella ovis. Vet Microbiol 23:1–17. [DOI] [PubMed] [Google Scholar]
- 206.Manterola L, Guzmán-Verri C, Chaves-Olarte E, Barquero-Calvo E, de Miguel MJ, Moriyón I, Grilló MJ, López-Goñi I, Moreno E. 2007. BvrR/BvrS-controlled outer membrane proteins Omp3a and Omp3b are not essential for Brucella virulence. Infect Immun 75:4867–4874. doi: 10.1128/IAI.00439-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 207.Martín-Martín AI, Caro-Hernández IP, Orduña A, Vizcaíno N, Fernández-Lago L. 2008. Importance of the Omp25/Omp31 family in the internalization and intracellular replication of virulent B. ovis in murine macrophages and HeLa cells. Microbes Infect 10:706–710. doi: 10.1016/j.micinf.2008.02.013. [DOI] [PubMed] [Google Scholar]
- 208.Edmonds MD, Cloeckaert A, Booth N, Fulton WT, Hagius S, Walker JV, Elzer PH. 2001. Attenuation of a Brucella abortus mutant lacking a major 25 kDa outer membrane protein in cattle. Am J Vet Res 62:1461–1466. doi: 10.2460/ajvr.2001.62.1461. [DOI] [PubMed] [Google Scholar]
- 209.Edmonds MD, Cloeckaert A, Hagius SD, Samartino LE, Fulton WT, Walker JV, Enright FM, Booth NJ, Elzer PH. 2002. Pathogenicity and protective activity in pregnant goats of a Brucella melitensis omp25 deletion mutant. Res Vet Sci 72:235–239. doi: 10.1053/rvsc.2002.0555. [DOI] [PubMed] [Google Scholar]
- 210.Verdiguel-Fernández L, Oropeza-Navarro R, Basurto-Alcántara FJ, Castañeda-Ramírez A, Verdugo-Rodríguez A. 2017. Omp31 plays an important role on outer membrane properties and intracellular survival of Brucella melitensis in murine macrophages and HeLa cells. Arch Microbiol 199:971–978. doi: 10.1007/s00203-017-1360-7. [DOI] [PubMed] [Google Scholar]
- 211.Verdiguel-Fernández L, Oropeza-Navarro R, Ortiz-Rico RA, Robles-Pesina G, Ramirez-Lezama J, Castañeda-Ramírez A, Verdugo-Rodriguez A. 2020. Brucella melitensis omp31 mutant is attenuated and confers protection against virulent Brucella melitensis challenge in BALB/c mice. J Microbiol Biotechnol 30:497–504. doi: 10.4014/jmb.1908.08056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 212.Degos C, Hysenaj L, Gonzalez-Espinoza G, Arce-Gorvel V, Gagnaire A, Papadopoulos A, Pasquevich KA, Meresse S, Cassataro J, Memet S, Gorvel JP. 2020. Omp25-dependent engagement of SLAMF1 by Brucella abortus in dendritic cells limits acute inflammation and favours bacterial persistence in vivo. Cell Microbiol 22:e13164. doi: 10.1111/cmi.13164. [DOI] [PubMed] [Google Scholar]
- 213.Jubier-Maurin V, Boigegrain RA, Cloeckaert A, Gross A, Alvarez-Martinez MT, Terraza A, Liautard J, Köhler S, Rouot B, Dornand J, Liautard JP. 2001. Major outer membrane protein Omp25 of Brucella suis is involved in inhibition of tumor necrosis factor alpha production during infection of human macrophages. Infect Immun 69:4823–4830. doi: 10.1128/IAI.69.8.4823-4830.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 214.Ma QL, Liu AC, Ma XJ, Yang YB, Hou YT, Wang ZH. 2015. Brucella outer membrane protein Omp25 induces microglial cells in vitro to secrete inflammatory cytokines and inhibit apoptosis. Int J Clin Exp Med 8:17530–17535. [PMC free article] [PubMed] [Google Scholar]
- 215.Zhang K, Wang H, Guo F, Yuan L, Zhang W, Wang Y, Chen C. 2016. Omp31 of Brucella melitensis 16M impairs the apoptosis of macrophages triggered by TNF-α. Exp Ther Med 12:2783–2789. doi: 10.3892/etm.2016.3655. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 216.Cui B, Liu W, Wang X, Chen Y, Du Q, Zhao X, Zhang H, Liu S, Tong D, Huang Y. 2017. Brucella Omp25 upregulates miR-155, miR-21-5p, and miR-23b to inhibit interleukin-12 production via modulation of programmed death-1 signaling in human monocyte/macrophages. Front Immunol 8:708. doi: 10.3389/fimmu.2017.00708. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 217.Zhang J, Zhang Y, Liu Z, Shao Z, Wu C, Want Y, Wang K, Li T, Liu L, Chen C, Zhang H. 2017. Outer membrane protein 25 of Brucella activates mitogen-activated protein kinase signal pathway in human trophoblast cells. Front Vet Sci 4:197. doi: 10.3389/fvets.2017.00197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 218.Luo X, Zhang X, Wu X, Yang X, Han C, Wang Z, Du Q, Zhao X, Liu SL, Tong D, Huang Y. 2018. Brucella downregulates tumor necrosis factor-α to promote intracellular survival via Omp25 regulation of different microRNAs in porcine and murine macrophages. Front Immunol 8:2013. doi: 10.3389/fimmu.2017.02013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 219.Jiao H, Luo Y, Zhou Z, Gu G, Li B, Li W, Liu Y, Wang Y, Wang X, Zhao Y, Wu L, Chen J, Shuai X, Huang Q. 2020. Integrative bioinformatics identification of the autophagic pathway-associated miRNA-mRNA networks in RAW264.7 macrophage cells infected with ΔOmp25 Brucella melitensis. Inflammation 43:532–539. doi: 10.1007/s10753-019-01135-6. [DOI] [PubMed] [Google Scholar]
- 220.Jia YH, Li LP, Hou QM, Pan SQ. 2002. Agrobacterium gene involved in tumorigenesis encodes an outer membrane protein exposed on the bacterial cell surface. Gene 284:113–124. doi: 10.1016/s0378-1119(02)00385-2. [DOI] [PubMed] [Google Scholar]
- 221.Minnick MF, Sappington KN, Smitherman LS, Andersson SGE, Karlberg O, Carroll JA. 2003. Five-member gene family of Bartonella quintana. Infect Immun 71:814–821. doi: 10.1128/iai.71.2.814-821.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 222.Liu M, Ferrandez Y, Bouhsira E, Monteil M, Franc M, Boulouis HJ, Biville F. 2012. Heme binding proteins of Bartonella henselae are required when undergoing oxidative stress during cell and flea invasion. PLoS One 7:e48408. doi: 10.1371/journal.pone.0048408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 223.Delpino MV, Cassataro J, Fossati CA, Goldbaum FA, Baldi PC. 2006. Brucella outer membrane protein Omp31 is a haemin-binding protein. Microbes Infect 8:1203–1208. doi: 10.1016/j.micinf.2005.11.008. [DOI] [PubMed] [Google Scholar]
- 224.Paulley JT, Anderson ES, Roop RM, II. 2007. Brucella abortus requires the heme transporter BhuA for maintenance of chronic infection in BALB/c mice. Infect Immun 75:5248–5254. doi: 10.1128/IAI.00460-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 225.Roop RM, II, Anderson E, Ojeda J, Martinson D, Menscher E, Martin DW. 2012. Metal acquisition by Brucella strains, p 179–199. In López-Goñi I, O’Callaghan D (ed), Brucella—molecular microbiology and genomics. Caister Academic Press, Norfolk, United Kingdom. [Google Scholar]
- 226.Vizcaíno N, Verger JM, Grayon M, Zygmunt MS, Cloeckaert A. 1997. DNA polymorphism at the omp-31 locus of Brucella spp.: evidence for a large deletion in Brucella abortus, and other species-specific markers. Microbiology (Reading) 143:2913–2921. doi: 10.1099/00221287-143-9-2913. [DOI] [PubMed] [Google Scholar]
- 227.Guzmán-Verri C, Manterola L, Sola-Landa A, Parra A, Cloeckaert A, Garin J, Gorvel JP, Moriyón I, Moreno E, López-Goñi I. 2002. The two-component system BvrR/BvrS essential for Brucella abortus virulence regulates the expression of outer membrane proteins with counterparts in members of the Rhizobiaceae. Proc Natl Acad Sci U S A 99:12375–12380. doi: 10.1073/pnas.192439399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 228.Viadas C, Rodríguez MC, Sangari FJ, Gorvel J-P, García-Lobo JM, López-Goñi I. 2010. Transcriptome analysis of the Brucella abortus BvrR/BvrS two-component regulatory system. PLoS One 5:e10216. doi: 10.1371/journal.pone.0010216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 229.Uzureau S, Godefroid M, Deschamps C, Lemaire J, De Bolle X, Letesson JJ. 2007. Mutations of the quorum sensing-dependent regulator VjbR lead to drastic surface modifications in Brucella melitensis. J Bacteriol 189:6035–6047. doi: 10.1128/JB.00265-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 230.Francis N, Poncin K, Fioravanti A, Vassen V, Willemart K, Ong TAP, Rappez L, Letesson JJ, Biondi EG, De Bolle X. 2017. CtrA controls cell division and outer membrane composition of the pathogen Brucella abortus. Mol Microbiol 103:780–797. doi: 10.1111/mmi.13589. [DOI] [PubMed] [Google Scholar]
- 231.Tibor A, Decelle B, Letesson JJ. 1999. Outer membrane proteins Omp10, Omp16, and Omp19 of Brucella spp. are lipoproteins. Infect Immun 67:4960–4962. doi: 10.1128/IAI.67.9.4960-4962.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 232.Godlewska R, Wiśniewska K, Pietras Z, Jagusztyn-Krynicka EK. 2009. Peptidoglycan-associated lipoprotein (Pal) of Gram-negative bacteria: function, structure, role in pathogenesis and potential application in immunoprophylaxis. FEMS Microbiol Lett 298:1–11. doi: 10.1111/j.1574-6968.2009.01659.x. [DOI] [PubMed] [Google Scholar]
- 233.Sidhu-Muñoz RS, Sancho P, Vizcaíno N. 2016. Brucella ovis PA mutants for outer membrane proteins Omp10, Omp19, SP41, and BepC are not altered in their virulence and outer membrane properties. Vet Microbiol 186:59–66. doi: 10.1016/j.vetmic.2016.02.010. [DOI] [PubMed] [Google Scholar]
- 234.Sternon J-F, Godessart P, Gonçalves de Freitas R, Van der Henst M, Poncin K, Francis N, Willemart K, Christen M, Christen B, Letesson J-J, De Bolle X. 2018. Transposon sequencing of Brucella abortus uncovers essential genes for growth in vitro and inside macrophages. Infect Immun 86:e00312-18. doi: 10.1128/IAI.00312-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 235.Zhi F, Zhou D, Li J, Tian L, Zhang G, Jin Y, Wang A. 2020. Omp16, a conserved peptidoglycan-associated lipoprotein, is involved in Brucella virulence in vitro. J Microbiol 58:793–804. doi: 10.1007/s12275-020-0144-y. [DOI] [PubMed] [Google Scholar]
- 236.Giambartolomei GH, Zwerdling A, Cassataro J, Bruno J, Fossati CA, Philipp MT. 2004. Lipoproteins, not lipopolysaccharide, are the key mediators of the proinflammatory response elicited by heat-killed Brucella abortus. J Immunol 173:4635–4642. doi: 10.4049/jimmunol.173.7.4635. [DOI] [PubMed] [Google Scholar]
- 237.Barrionuevo P, Cassataro J, Delpino MV, Zwerdling A, Pasquevich KA, Samartino CG, Wallach JC, Fossati CA, Giambartolomei GH. 2008. Brucella abortus inhibits major histocompatibility complex II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2. Infect Immun 76:250–262. doi: 10.1128/IAI.00949-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 238.Zwerdling A, Delpino MV, Barrionuevo P, Cassataro J, Pasquevich KA, Samartino CG, Fossati CA, Giambartolomei GH. 2008. Brucella lipoproteins mimic dendritic cell maturation induced by Brucella abortus. Microbes Infect 10:1346–1354. doi: 10.1016/j.micinf.2008.07.035. [DOI] [PubMed] [Google Scholar]
- 239.Zwerdling A, Delpino MV, Pasquevich KA, Barrionuevo P, Cassataro J, Samartino CG, Giambartolomei GH. 2009. Brucella abortus activates human neutrophils. Microbes Infect 11:689–697. doi: 10.1016/j.micinf.2009.04.010. [DOI] [PubMed] [Google Scholar]
- 240.Samartino CG, Delpino MV, Pott Godoy C, Di Genaro MS, Pasquevich KA, Zwerdling A, Barrionuevo P, Mathieu P, Cassataro J, Pitossi F, Giambartolomei GH. 2010. Brucella abortus induces the secretion of proinflammatory mediators from glial cells leading to astrocyte apoptosis. Am J Pathol 176:1323–1338. doi: 10.2353/ajpath.2010.090503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 241.Scian R, Barrionuevo P, Giambartolomei GH, Fossati CA, Baldi PC, Delpino MV. 2011. Granulocyte-macrophage colony-stimulating factor- and tumor necrosis factor alpha-mediated matrix metalloproteinase production by human osteoclasts and monocytes after infection with Brucella abortus. Infect Immun 79:192–202. doi: 10.1128/IAI.00934-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 242.Barrionuevo P, Delpino MV, Velásquez LN, García Samartino C, Coria LM, Ibañez AE, Rodríguez ME, Cassataro J, Giambartolomei GH. 2011. Brucella abortus inhibits IFN-γ-induced FcγRI expression and FcγRI-restricted phagocytosis via toll-like receptor 2 on human monocytes/macrophages. Microbes Infect 13:239–250. doi: 10.1016/j.micinf.2010.10.020. [DOI] [PubMed] [Google Scholar]
- 243.Ferrero MC, Bregante J, Delpino MV, Barrionuevo P, Fossati CA, Giambartolomei GH, Baldi PC. 2011. Proinflammatory response of human endothelial cells to Brucella infection. Microbes Infect 13:852–861. doi: 10.1016/j.micinf.2011.04.010. [DOI] [PubMed] [Google Scholar]
- 244.Scian R, Barrionuevo P, Giambartolomei GH, De Simone EA, Vanzulli SI, Fossati CA, Baldi PC, Delpino MV. 2011. Potential role of fibroblast-like synoviocytes in joint damage induced by Brucella abortus infection through production and induction of matrix metalloproteinases. Infect Immun 79:3619–3632. doi: 10.1128/IAI.05408-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 245.Delpino MV, Barrionuevo P, Macedo GC, Oliveira SC, Genaro SD, Scian R, Miraglia MC, Fossati CA, Baldi PC, Giambartolomei GH. 2012. Macrophage-elicited osteoclastogenesis in response to Brucella abortus infection requires TLR2/MyD88-dependent TNF-α production. J Leukoc Biol 91:285–298. doi: 10.1189/jlb.04111185. [DOI] [PubMed] [Google Scholar]
- 246.Velásquez LN, Delpino MV, Ibañez AE, Coria LM, Miraglia MC, Scian R, Cassataro J, Giambartolomei GH, Barrionuevo P. 2012. Brucella abortus induces apoptosis of human T lymphocytes. Microbes Infect 14:639–650. doi: 10.1016/j.micinf.2012.02.004. [DOI] [PubMed] [Google Scholar]
- 247.Miraglia MC, Scian R, Samartino CG, Barrionuevo P, Rodriguez AM, Ibañez AE, Coria LM, Velásquez LN, Baldi PC, Cassataro J, Delpino MV, Giambartolomei GH. 2013. Brucella abortus induces TNF-α-dependent astroglial MMP-9 secretion through mitogen-activated protein kinases. J Neuroinflammation 10:47. doi: 10.1186/1742-2094-10-47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 248.Ferrero MC, Hielpos MS, Carvalho NB, Barrionuevo P, Corsetti PP, Giambartolomei GH, Oliveira SC, Baldi PC. 2014. Key role of Toll-like receptor 2 in the inflammatory response and major histocompatibility complex II downregulation in Brucella abortus-infected alveolar macrophages. Infect Immun 82:626–639. doi: 10.1128/IAI.01237-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 249.Hielpos MS, Ferrero MC, Fernandez AG, Bonetto J, Giambartolomei CH, Fossati CA, Baldi PC. 2015. CCL20 and β-defensin 2 production by human lung epithelial cells and macrophages in response to Brucella abortus infection. PLoS One 10:e0140408. doi: 10.1371/journal.pone.0140408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 250.Coria LM, Ibañez AE, Tkach M, Sabbione F, Bruno L, Carabajal MV, Berguer PM, Barrionuevo P, Schillaci R, Trevani AS, Giambartolomei GH, Pasquevich KA, Cassataro J. 2016. A Brucella spp. protease inhibitor limits antigen lysosomal proteolysis, increases cross-presentation, and enhances CD8+ T cell responses. J Immunol 196:4014–4029. doi: 10.4049/jimmunol.1501188. [DOI] [PubMed] [Google Scholar]
- 251.Velásquez LN, Milillo MA, Delpino MV, Trotta A, Fernandez P, Pozner RG, Lang R, Balboa L, Giambartolomei GH, Barrionuevo P. 2017. Brucella abortus down-regulates MHC class II by the IL-6-dependent inhibition of CIITA through the downmodulation of INF regulatory factor-1 (IRF-1). J Leukoc Biol 101:759–773. doi: 10.1189/jlb.4A0416-196R. [DOI] [PubMed] [Google Scholar]
- 252.Rodriguez AM, Delpino MV, Miraglia MC, Costa Franco MM, Barrionuevo P, Dennis VA, Oliveira SC, Giambartolomei GH. 2017. Brucella abortus-activated microglia induce neuronal death through primary phagocytosis. Glia 65:1137–1151. doi: 10.1002/glia.23149. [DOI] [PubMed] [Google Scholar]
- 253.Ibañez AE, Coria LM, Carabajal MV, Delpino MV, Risso GS, Cobiello PG, Rinaldi J, Barrionuevo P, Bruno L, Frank F, Klinke S, Goldbaum FA, Briones G, Giambartolomei GH, Pasquevich KA, Cassataro JA. 2015. A bacterial protease inhibitor protects antigens delivered in oral vaccines from digestion while triggering specific mucosal immune responses. J Control Release 220:18–28. doi: 10.1016/j.jconrel.2015.10.011. [DOI] [PubMed] [Google Scholar]
- 254.Pasquevich KA, Carabajal MV, Guaimas FF, Bruno L, Roset MS, Coria LM, Rey Serrantes DA, Comerci DJ, Cassataro JA. 2019. Omp19 enables Brucella abortus to evade the antimicrobial activity from host’s proteolytic defense system. Front Immunol 10:1436. doi: 10.3389/fimmu.2019.01436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 255.Cloeckaert A, Tibor A, Zygmunt M. 1999. Brucella outer membrane lipoproteins share antigenic determinants with bacteria of the family Rhizobiaceae. Clin Diagn Lab Immunol 6:627–629. doi: 10.1128/CDLI.6.4.627-629.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 256.Tibor A, Wansard V, Bielartz V, Delrue RM, Danese I, Michel P, Walravens K, Godfroid J, Letesson JJ. 2002. Effect of omp10 and omp19 deletion on Brucella abortus outer membrane properties and virulence in mice. Infect Immun 70:5540–5546. doi: 10.1128/iai.70.10.5540-5546.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 257.de Souza Filho JV, de Paulo Martins V, Campos PC, Alves-Silva J, Santos NV, Souza de Oliveira F, Menezes GB, Azevedo V, Cravero SL, Costa SC. 2015. Mutant Brucella abortus membrane fusogenic protein induces protection against challenge infection in mice. Infect Immun 83:1458–1464. doi: 10.1128/IAI.02790-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 258.Henderson IR, Navarro-Garcia F, Desvaux M, Fernandez RC, Ala'Aldeen D. 2004. Type V protein secretion pathway: the autotransporter story. Microbiol Mol Biol Rev 68:692–744. doi: 10.1128/MMBR.68.4.692-744.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 259.Bandara AB, Sriranganathan N, Schurig GG, Boyle SM. 2005. Putative outer membrane autotransporter protein influences survival of Brucella suis in BALB/c mice. Vet Microbiol 109:95–104. doi: 10.1016/j.vetmic.2005.05.012. [DOI] [PubMed] [Google Scholar]
- 260.Posadas DM, Ruiz-Ranwez V, Bonomi HR, Martín FA, Zorreguieta A. 2012. BmaC, a novel autotransporter of Brucella suis, is involved in bacterial adhesion to host cells. Cell Microbiol 14:965–982. doi: 10.1111/j.1462-5822.2012.01771.x. [DOI] [PubMed] [Google Scholar]
- 261.Ruiz-Ranwez V, Posadas DM, van der Henst C, Estein SM, Arocena GM, Abdian PL, Martín FA, Sieira R, De Bolle X, Zorreguieta A. 2013. BtaE, an adhesin that belongs to the trimeric autotransporter family, is required for full virulence and defines a specific adhesive pole of Brucella suis. Infect Immun 81:996–1007. doi: 10.1128/IAI.01241-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 262.Ruiz-Ranwez V, Posadas DM, Estein SM, Abdian PL, Martín FA, Zorreguieta A. 2013. The BtaF trimeric autotransporter of Brucella suis is involved in attachment of various surfaces, resistance to serum and virulence. PLoS One 8:e79770. doi: 10.1371/journal.pone.0079770. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 263.González FM, Sycz G, Paiva IMA, Linke D, Zorreguieta A, Baldi PC, Ferrero MC. 2019. The BtaF adhesin is necessary for full virulence during respiratory infection by Brucella suis and is a novel immunogen for nasal vaccination against Brucella infection. Front Immunol 10:1775. doi: 10.3389/fimmu.2019.01775. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 264.Czibener C, Merwaiss F, Guaimas F, del Giudice MG, Serantes DAR, Spera JM, Ugalde JE. 2016. BigA is a novel adhesin of Brucella that mediates adhesion to epithelial cells. Cell Microbiol 18:500–513. doi: 10.1111/cmi.12526. [DOI] [PubMed] [Google Scholar]
- 265.Leo JC, Oberhettinger P, Schütz M, Linke D. 2015. The inverse autotransporter family: intimin, invasin and related proteins. Int J Med Microbiol 305:276–282. doi: 10.1016/j.ijmm.2014.12.011. [DOI] [PubMed] [Google Scholar]
- 266.Ruch TR, Engel JN. 2017. Targeting the mucosal barrier: how pathogens modulate the cellular polarity network. Cold Spring Harb Perspect Biol 9:a027953. doi: 10.1101/cshperspect.a027953. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 267.Deghelt M, Mullier C, Sternon JF, Francis N, Laloux G, Dotreppe G, Van der Henst C, Jacobs-Wagner C, Letesson JJ, De Bolle X. 2014. G1-arrested newborn cells are the predominant infectious form of the pathogen Brucella abortus. Nat Commun 5:4366. doi: 10.1038/ncomms5366. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 268.Van der Henst C, de Barsy M, Zorreguieta A, Letesson JJ, De Bolle X. 2013. The Brucella pathogens are polarized bacteria. Microbes Infect 15:998–1004. doi: 10.1016/j.micinf.2013.10.008. [DOI] [PubMed] [Google Scholar]
- 269.De Bolle X, Crosson S, Matroule JY, Letesson JJ. 2015. Brucella abortus cell cycle and infection are coordinated. Trends Microbiol 23:812–821. doi: 10.1016/j.tim.2015.09.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 270.Caswell CC, Elhassanny AEM, Planchin EE, Roux CM, Weeks-Gorospe JN, Ficht TA, Dunman PM, Roop RM, II. 2013. Diverse genetic regulon of the virulence-associated transcriptional regulator MucR in Brucella abortus 2308. Infect Immun 81:1040–1051. doi: 10.1128/IAI.01097-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 271.Pirone L, Pitzer JE, D'Abrosca G, Fattorusso R, Malgieri G, Pedone EM, Pedone PV, Roop RM, Baglivo I. 2018. Identifying the region responsible for Brucella abortus MucR higher-order oligomer formation and examining its role in gene regulation. Sci Rep 8:17238. doi: 10.1038/s41598-018-35432-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 272.Kleinman CL, Sycz G, Bonomi HR, Rodríguez RM, Zorreguieta A, Sieira R. 2017. ChIP-seq analysis of the LuxR-type regulator VjbR reveals novel insights into the Brucella virulence gene expression network. Nucleic Acids Res 45:5757–5769. doi: 10.1093/nar/gkx165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 273.Sieira R, Bialer MG, Roset MS, Ruiz-Ranwez V, Langer T, Arocena GM, Mancini E, Zorreguieta A. 2017. Combinatorial control of adhesion of Brucella abortus 2308 to host cells by transcriptional rewiring of the trimeric autotransporter btaE gene. Mol Microbiol 103:553–565. doi: 10.1111/mmi.13576. [DOI] [PubMed] [Google Scholar]
- 274.Bontemps-Gallo S, Lacroix JM. 2015. New insights into the biological role of the osmoregulated periplasmic glucans in pathogenic and symbiotic bacteria. Environ Microbiol Rep 7:690–697. doi: 10.1111/1758-2229.12325. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 275.Iñón de Iannino N, Briones G, Tolmasky M, Ugalde RA. 1998. Molecular cloning and characterization of cgs, the Brucella abortus cyclic β(1–2) glucan synthetase gene: genetic complementation of Rhizobium meliloti ndvB and Agrobacterium chvB mutants. J Bacteriol 180:4392–4400. doi: 10.1128/JB.180.17.4392-4400.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 276.Breedveld MW, Miller KJ. 1994. Cyclic β-glucans of members of the family Rhizobiaceae. Microbiol Rev 58:145–161. doi: 10.1128/MR.58.2.145-161.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 277.Briones G, Iñón de lannino N, Steinberg M, Ugalde RA. 1997. Periplasmic cyclic 1,2-β-glucan in Brucella spp. is not osmoregulated. Microbiology (Reading) 143:1115–1124. doi: 10.1099/00221287-143-4-1115. [DOI] [PubMed] [Google Scholar]
- 278.Iñón de Iannino N, Briones G, Iannino F, Ugalde RA. 2000. Osmotic regulation of cyclic 1,2-β-glucan synthesis. Microbiology (Reading) 146:1735–1742. doi: 10.1099/00221287-146-7-1735. [DOI] [PubMed] [Google Scholar]
- 279.Roset MS, Ibañez AI, de Souza Filho JA, Spera JM, Minatel L, Oliveira SC, Giambartolomei GH, Cassataro J, Briones G. 2014. Brucella cyclic β-1,2-glucan plays a critical role in the induction of splenomegaly in mice. PLoS One 9:e101279. doi: 10.1371/journal.pone.0101279. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 280.Briones G, Iñón de Iannino N, Roset M, Vigliocco A, Paulo PS, Ugalde RA. 2001. Brucella abortus cyclic β-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells. Infect Immun 69:4528–4535. doi: 10.1128/IAI.69.7.4528-4535.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 281.Arellano-Reynoso B, Lapaque N, Salcedo S, Briones G, Ciocchini AE, Ugalde R, Moreno E, Moriyón I, Gorvel JP. 2005. Cyclic β-1,2-glucan is a Brucella virulence factor required for intracellular survival. Nat Immunol 6:618–625. doi: 10.1038/ni1202. [DOI] [PubMed] [Google Scholar]
- 282.Martirosyan A, Pérez-Gutierrez C, Banchereau R, Dutartre H, Lecine P, Dullaers M, Mello M, Salcedo SP, Muller A, Leserman L, Levy Y, Zurawski G, Zurawski S, Moreno E, Moriyón I, Klechevsky E, Banchereau J, Oh S, Gorvel J-P. 2012. Brucella β 1,2 cyclic glucan is an activator of human and mouse dendritic cells. PLoS Pathog 8:e1002983. doi: 10.1371/journal.ppat.1002983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 283.Degos C, Gagnaire A, Banchereau R, Moriyón I, Gorvel JP. 2015. Brucella CβG induces a dual pro- and anti-inflammatory response leading to a transient neutrophil recruitment. Virulence 6:19–28. doi: 10.4161/21505594.2014.979692. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 284.Guidolin LS, Arce-Gorvel V, Ciocchini AE, Comerci DJ, Gorvel JP. 2018. Cyclic β-glucans at the bacteria-host cell interphase: one sugar ring to rule them all. Cell Microbiol 20:e12850. doi: 10.1111/cmi.12850. [DOI] [PubMed] [Google Scholar]
- 285.Guidolin LS, Morrone Seijo SM, Guaimas FF, Comerci DJ, Ciocchini AE. 2015. Interaction network and localization of Brucella abortus membrane proteins involved in the synthesis, transport, and succinylation of cyclic β-1,2-glucans. J Bacteriol 197:1640–1648. doi: 10.1128/JB.00068-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 286.Halling SM. 1998. On the presence and organization of open reading frames of the nonmotile pathogen Brucella abortus similar to class II, III, and IV flagellar genes and to LcrD virulence superfamily. Microb Comp Genomics 3:21–29. doi: 10.1089/omi.1.1998.3.21. [DOI] [PubMed] [Google Scholar]
- 287.Letesson JJ, Lestrate P, Delrue RM, Danese I, Bellefontaine F, Fretin D, Taminiau B, Tibor A, Dricot A, Deschamps C, Haine V, Leonard S, Laurent T, Mertens P, Vandenhaute J, De Bolle X. 2002. Fun stories about Brucella: the “furtive nasty bug.” Vet Microbiol 90:317–328. doi: 10.1016/s0378-1135(02)00208-0. [DOI] [PubMed] [Google Scholar]
- 288.Paulsen IT, Seshadri R, Nelson KE, Eisen JA, Heidelberg JF, Read TD, Dodson RJ, Umayam L, Brinkac LM, Beanan MJ, Daugherty SC, Deboy RT, Durkin AS, Kolonay JF, Madupu R, Nelson WC, Ayodeji B, Kraul M, Shetty J, Malek J, Van Aken SE, Riedmuller S, Tettelin H, Gill SR, White O, Salzberg SL, Hoover DL, Lindler LE, Halling SM, Boyle SM, Fraser CM. 2002. The Brucella suis genome reveals fundamental similarities between animal and plant pathogens and symbionts. Proc Natl Acad Sci U S A 99:13148–13153. doi: 10.1073/pnas.192319099. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 289.Fretin D, Fauconnier A, Köhler S, Halling S, Léonard S, Nijskens C, Ferooz J, Lestrate P, Delrue RM, Danese I, Vandenhaute J, Tibor A, De Bolle X, Letesson JJ. 2005. The sheathed flagellum of Brucella melitensis is involved in persistence in a murine model of infection. Cell Microbiol 7:687–698. doi: 10.1111/j.1462-5822.2005.00502.x. [DOI] [PubMed] [Google Scholar]
- 290.Al Dahouk S, Köhler S, Occhialini A, Jiménez de Bagüés MP, Hammerl JA, Eisenberg T, Vergnaud G, Cloeckaert A, Zygmunt MS, Whatmore AM, Melzer F, Drees KP, Foster JT, Wattam AR, Scholz HC. 2017. Brucella spp. of amphibians comprise genomically diverse motile strains competent for replication in macrophages and survival in mammalian hosts. Sci Rep 7:44420. doi: 10.1038/srep44420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 291.Lestrate P, Dricot A, Delrue RM, Lambert C, Martinelli V, De Bolle X, Letesson JJ, Tibor A. 2003. Attenuated signature-tagged mutagenesis mutants of Brucella melitensis identified during the acute phase of infection in mice. Infect Immun 71:7053–7060. doi: 10.1128/iai.71.12.7053-7060.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 292.Ferooz JJ, Letesson JJ. 2010. Morphological analysis of the sheathed flagellum of Brucella melitensis. BMC Res Notes 3:333. doi: 10.1186/1756-0500-3-333. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 293.Coloma-Rivero RF, Gómez L, Alvarez F, Saitz W, Del Canto F, Céspedes S, Vidal R, Oñate AA. 2020. The role of the flagellar protein FlgJ in the virulence of Brucella abortus. Front Cell Infect Microbiol 10:178. doi: 10.3389/fcimb.2020.00178. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 294.Sidhu-Muñoz RS, Tejedor C, Vizcaíno N. 2020. The three flagellar loci of Brucella ovis PA are dispensable for virulence in cellular models and mice. Front Vet Sci 7:441. doi: 10.3389/fvets.2020.00441. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 295.Terwagne M, Ferooz J, Rolán HG, Sun YH, Atluri V, Xavier MN, Franchi L, Núñez G, Legrand T, Flavell RA, De Bolle X, Letesson JJ, Tsolis RM. 2013. Innate immune recognition of flagellin limits systemic persistence of Brucella. Cell Microbiol 15:942–960. doi: 10.1111/cmi.12088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 296.Hug I, Deshpande S, Sprecher KS, Pfohl T, Jenal U. 2017. Second messenger-mediated tactile response by a bacterial rotary motor. Science 358:531–534. doi: 10.1126/science.aan5353. [DOI] [PubMed] [Google Scholar]
- 297.Ellison CK, Kan J, Dillard RS, Kysela DT, Ducret A, Berne C, Hampton CM, Ke Z, Wright WR, Biais N, Dalia AB, Brun YV. 2017. Obstruction of pilus retraction simulates bacterial surface sensing. Science 358:535–538. doi: 10.1126/science.aan5706. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 298.Aschtgen MS, Lynch JB, Koch E, Schwartzman J, McFall-Ngai M, Ruby E. 2016. Rotation of Vibrio fischeri flagella produces outer membrane vesicles that induce host development. J Bacteriol 198:2156–2165. doi: 10.1128/JB.00101-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 299.Pollak CN, Delpino MV, Fossati CA, Baldi PC. 2012. Outer membrane vesicles from Brucella abortus promote bacterial internalization by human monocytes and modulate their innate immune response. PLoS One 7:e50214. doi: 10.1371/journal.pone.0050214. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 300.Léonard S, Ferooz J, Haine V, Danese I, Fretin D, Tibor A, de Walque S, De Bolle X, Letesson JJ. 2007. FtcR is a new master regulator of the flagellar system of Brucella melitensis 16M with homologs in Rhizobiaceae. J Bacteriol 189:131–141. doi: 10.1128/JB.00712-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 301.Ferooz J, Lemaire JJ, Letesson JJ. 2011. Role of FlbT in flagellin production in Brucella melitensis. Microbiology (Reading) 157:1253–1262. doi: 10.1099/mic.0.044867-0. [DOI] [PubMed] [Google Scholar]
- 302.Delrue RM, Deschamps C, Léonard S, Nijskens C, Danese I, Schaus JM, Bonnot S, Ferooz J, Tibor A, De Bolle X, Letesson JJ. 2005. A quorum-sensing regulator controls expression of both the type IV secretion system and the flagellar apparatus of Brucella melitensis. Cell Microbiol 7:1151–1161. doi: 10.1111/j.1462-5822.2005.00543.x. [DOI] [PubMed] [Google Scholar]
- 303.Ferooz J, Lemaire J, Delory M, De Bolle X, Letesson JJ. 2011. RpoE1, an extracytoplasmic function sigma factor, is a repressor of the flagellar system in Brucella melitensis. Microbiology (Reading) 157:1263–1268. doi: 10.1099/mic.0.044875-0. [DOI] [PubMed] [Google Scholar]
- 304.Petersen E, Chaudhuri P, Gourley C, Harms J, Splitter G. 2011. Brucella melitensis cyclic di-GMP phosphodiesterase BpdA controls expression of flagellar genes. J Bacteriol 193:5683–5691. doi: 10.1128/JB.00428-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 305.Kim HS, Caswell CC, Foreman R, Roop RM, II, Crosson S. 2013. The Brucella abortus general stress response system regulates chronic mammalian infection and is controlled by phosphorylation and proteolysis. J Biol Chem 288:13906–13916. doi: 10.1074/jbc.M113.459305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 306.Wuichet K, Zhulin IB. 2010. Origins and diversification of a complex signal transduction system in prokaryotes. Sci Signal 3:ra50. doi: 10.1126/scisignal.2000724. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 307.Sohlenkamp C, Lopez-Lara IM, Geiger O. 2003. Biosynthesis of phosphatidylcholine in bacteria. Prog Lipid Res 42:115–162. doi: 10.1016/s0163-7827(02)00050-4. [DOI] [PubMed] [Google Scholar]
- 308.Thiele OW, Schwinn G. 1973. The free lipids of Brucella melitensis and Bordetella pertussis. Eur J Biochem 34:333–344. doi: 10.1111/j.1432-1033.1973.tb02764.x. [DOI] [PubMed] [Google Scholar]
- 309.Comerci DJ, Altabe S, de Mendoza D, Ugalde RA. 2006. Brucella abortus synthesizes phosphatidylcholine from choline provided by the host. J Bacteriol 188:1929–1934. doi: 10.1128/JB.188.5.1929-1934.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 310.Conde-Álvarez R, Grilló MJ, Salcedo SP, de Miguel MJ, Fugier E, Gorvel JP, Moriyón I, Iriarte M. 2006. Synthesis of phosphatidylycholine, a typical eukaryotic phospholipid, is necessary for full virulence of the intracellular bacterial parasite Brucella abortus. Cell Microbiol 8:1322–1335. doi: 10.1111/j.1462-5822.2006.00712.x. [DOI] [PubMed] [Google Scholar]
- 311.Herrmann CK, Bukata L, Melli L, Marchesini MI, Caramelo JJ, Comerci DJ. 2013. Identification and characterization of a high-affinity choline uptake system of Brucella abortus. J Bacteriol 195:493–501. doi: 10.1128/JB.01929-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 312.Bukata L, Altabe S, de Mendoza D, Ugalde RA, Comerci D. 2008. Phosphatidylethanolamine synthesis is required for optimal virulence of Brucella abortus. J Bacteriol 190:8197–8203. doi: 10.1128/JB.01069-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 313.Aktas M, Wessel M, Hacker S, Klusener S, Gleichenhagen J, Narberhaus F. 2010. Phosphatidylcholine biosynthesis and its significance in bacteria interacting with eukaryotic cells. Eur J Cell Biol 89:888–894. doi: 10.1016/j.ejcb.2010.06.013. [DOI] [PubMed] [Google Scholar]
- 314.Cuthbertson L, Mainprize IL, Naismith JH, Whitfield C. 2009. Pivotal roles of the outer membrane polysaccharide export and polysaccharide copolymerase protein families in export of extracellular polysaccharides in Gram-negative bacteria. Microbiol Mol Biol Rev 73:155–177. doi: 10.1128/MMBR.00024-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 315.Tomlinson AD, Fuqua C. 2009. Mechanisms and regulation of polar surface attachment in Agrobacterium tumefaciens. Curr Opin Microbiol 12:708–714. doi: 10.1016/j.mib.2009.09.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 316.Leid JG, Willson CJ, Shirtliff ME, Hassett DJ, Parsek MR, Jeffers AK. 2005. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-γ-mediated macrophage killing. J Immunol 175:7512–7518. doi: 10.4049/jimmunol.175.11.7512. [DOI] [PubMed] [Google Scholar]
- 317.Mishra M, Byrd MS, Sergeant S, Azad AK, Parsek MR, McPhail L, Schlesinger LS, Wozniak DJ. 2012. Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and oxidative response by limiting complement-mediated opsonization. Cell Microbiol 14:95–106. doi: 10.1111/j.1462-5822.2011.01704.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 318.Muñoz VL, Porsch EA, St Geme JW, III. 2018. Kingella kingae surface polysaccharides promote resistance to human serum and virulence in a juvenile rat model. Infect Immun 86:e00100-18. doi: 10.1128/IAI.00100-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 319.Vuong C, Voyich JM, Fischer ER, Braughton KR, Whitney AR, DeLeo RF, Otto M. 2004. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol 6:269–275. doi: 10.1046/j.1462-5822.2004.00367.x. [DOI] [PubMed] [Google Scholar]
- 320.Danhorn T, Fuqua C. 2007. Biofilm formation by plant-associated bacteria. Annu Rev Microbiol 61:401–422. doi: 10.1146/annurev.micro.61.080706.093316. [DOI] [PubMed] [Google Scholar]
- 321.Rinaudi LV, Giordano W. 2010. An integrated view of biofilm formation in rhizobia. FEMS Microbiol Lett 304:1–11. doi: 10.1111/j.1574-6968.2009.01840.x. [DOI] [PubMed] [Google Scholar]
- 322.Jones CJ, Wozniak DJ. 2017. Psl produced by mucoid Pseudomonas aeruginosa contributes to the establishment of biofilms and immune evasion. mBio 8:e00864-17. doi: 10.1128/mBio.00864-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 323.Vizcaíno N, Cloeckaert A, Zygmunt MS, Fernández-Lago L, 2001. Characterization of a Brucella species 23-kilobase DNA fragment deleted from Brucella abortus reveals a large gene cluster related to the synthesis of a polysaccharide. Infect Immun 69:6738–6748. doi: 10.1128/IAI.69.11.6738-6748.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 324.Wang Y, Chen Z, Qiao F, Zhong Z, Xu J, Wang Z, Du X, Qu Q, Yuan J, Jia L, Song H, Sun Y, Huang L. 2010. The type IV secretion affects the expression of Omp25/31 and the outer membrane properties of Brucella melitensis. FEMS Microbiol Lett 303:92–100. doi: 10.1111/j.1574-6968.2009.01866.x. [DOI] [PubMed] [Google Scholar]
- 325.Dabral N, Jain-Gupta N, Seleem MN, Sriranganathan N, Vemulapalli R. 2015. Overexpression of Brucella putative glycosyltransferase WkbA in B. abortus RB51 leads to production of exopolysaccharide. Front Cell Infect Microbiol 5:54. doi: 10.3389/fcimb.2015.00054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 326.Almirón MA, Roset MS, Sanjuan N. 2013. The aggregation of Brucella abortus occurs under microaerobic conditions and promotes desiccation tolerance and biofilm formation. Open Microbiol J 7:87–91. doi: 10.2174/1874285801307010087. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 327.Khan M, Harms JS, Marim FM, Armon L, Hall CL, Liu YP, Banai M, Oliveira SC, Splitter GA, Smith JA. 2016. The bacterial second messenger cyclic di-GMP regulates Brucella pathogenesis and leads to altered host immune response. Infect Immun 84:3458–3470. doi: 10.1128/IAI.00531-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 328.Tang T, Chen G, Guo A, Xu Y, Zhao L, Wang M, Lu C, Jiang Y, Zhang C. 2020. Comparative proteomic and genomic analyses of Brucella abortus biofilm and planktonic cells. Mol Med Rep 21:731–743. doi: 10.3892/mmr.2019.10888. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 329.Mirabella A, Terwagne M, Zygmunt MS, Cloeckaert A, De Bolle X, Letesson JJ. 2013. Brucella melitensis MucR, an orthologue of Sinorhizobium meliloti MucR, is involved in resistance to oxidative, detergent, and saline stresses and cell envelope modifications. J Bacteriol 195:453–465. doi: 10.1128/JB.01336-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 330.Marczak M, Mazur A, Koper P, Żebracki K, Skorupska A. 2017. Synthesis of rhizobial exopolysaccharides and their importance for symbiosis with legume plants. Genes 8:360. doi: 10.3390/genes8120360. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 331.Thompson MA, Onyeziri MC, Fuqua C. 2018. Function and regulation of Agrobacterium tumefaciens cell surface structures that promote attachment. Curr Top Microbiol Immunol 418:143–184. doi: 10.1007/82_2018_96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 332.Gerhardt P. 1958. The nutrition of brucellae. Bacteriol Rev 22:81–98. doi: 10.1128/BR.22.2.81-98.1958. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 333.Ko J, Splitter GA. 2000. Residual virulence of Brucella abortus in the absence of the cytochrome bc1 complex in a murine model in vitro and in vivo. Microb Pathog 29:191–200. doi: 10.1006/mpat.2000.0373. [DOI] [PubMed] [Google Scholar]
- 334.Endley S, McMurray D, Ficht TA. 2001. Interruption of the cydB locus in Brucella abortus attenuates intracellular survival and virulence in the mouse model of infection. J Bacteriol 183:2454–2462. doi: 10.1128/JB.183.8.2454-2462.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 335.Köhler S, Foulongne V, Ouahrani-Bettache S, Bourg G, Teyssier J, Ramuz M, Liautard JP. 2002. The analysis of the intramacrophagic virulome of Brucella suis deciphers the environment encountered by the pathogen inside the macrophage host cell. Proc Natl Acad Sci U S A 99:15711–15716. doi: 10.1073/pnas.232454299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 336.Loisel-Meyer S, Jiménez de Bagüés MP, Köhler S, Liautard JP, Jubier-Maurin V. 2005. Differential use of the two high-oxygen-affinity terminal oxidases of Brucella suis for in vitro and intramacrophagic multiplication. Infect Immun 73:7768–7771. doi: 10.1128/IAI.73.11.7768-7771.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 337.Jiménez de Bagüés MP, Loisel-Meyer S, Liautard JP, Jubier-Maurin V. 2007. Different roles for the two high-oxygen-affinity terminal oxidases of Brucella suis: cytochrome c oxidase, but not ubiquinol oxidase, is required for persistence in mice. Infect Immun 75:531–535. doi: 10.1128/IAI.01185-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 338.Sun YH, de Jong MF, den Hartigh AB, Roux CM, Rolán HG, Tsolis RM. 2012. The small protein CydX is required for function of cytochrome bd oxidase in Brucella abortus. Front Cell Infect Microbiol 2:47. doi: 10.3389/fcimb.2012.00047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 339.Bueno E, Mesa S, Bedmar EJ, Richardson DJ, Delgado MJ. 2012. Bacterial adaptation of respiration from oxic to microoxic and anoxic conditions: redox control. Antioxid Redox Signal 16:819–852. doi: 10.1089/ars.2011.4051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 340.Haine V, Dozot M, Dornand J, Letesson JJ, De Bolle X. 2006. NnrA is required for full virulence and regulates several Brucella melitensis denitrification genes. J Bacteriol 188:1615–1619. doi: 10.1128/JB.188.4.1615-1619.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 341.Loisel-Meyer S, Jiménez de Bagüés MP, Basseres E, Dornand J, Köhler S, Liautard JP, Jubier-Maurin V. 2006. Requirement of norD for Brucella suis virulence in a murine model of in vitro and in vivo infection. Infect Immun 74:1973–1976. doi: 10.1128/IAI.74.3.1973-1976.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 342.Kim DH, Lim JJ, Lee JJ, Kim DJ, Lee HJ, Min W, Kim KD, Chang HH, Rhee MH, Watarai M, Kim S. 2012. Identification of genes contributing to the intracellular replication of Brucella abortus within HeLa and RAW 264.7 cells. Vet Microbiol 158:322–328. doi: 10.1016/j.vetmic.2012.02.019. [DOI] [PubMed] [Google Scholar]
- 343.Wang M, Qureshi N, Soeurt N, Splitter G. 2001. High levels of nitric oxide production decrease early but increase late survival of Brucella abortus in macrophages. Microb Pathog 31:221–230. doi: 10.1006/mpat.2001.0463. [DOI] [PubMed] [Google Scholar]
- 344.Baek SH, Rajashekara G, Splitter GA, Shapleigh JP. 2004. Denitrification genes regulate Brucella virulence in mice. J Bacteriol 186:6025–6031. doi: 10.1128/JB.186.18.6025-6031.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 345.Carrica MDC, Fernandez I, Marti MA, Paris G, Goldbaum FA. 2012. The NtrY/NtrX two-component system of Brucella spp. acts as a redox sensor and regulates the expression of nitrogen respiration genes. Mol Microbiol 85:39–50. doi: 10.1111/j.1365-2958.2012.08095.x. [DOI] [PubMed] [Google Scholar]
- 346.Abdou E, Deredjian A, Jiménez de Bagüés MP, Köhler S, Jubier-Maurin V. 2013. RegA, the regulator of the two-component system RegB/RegA of Brucella suis, is a controller of both oxidative respiration and denitrification required for chronic infection of mice. Infect Immun 81:2053–2061. doi: 10.1128/IAI.00063-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 347.Carrica MDC, Fernandez I, Sieira R, Paris G, Goldbaum FA. 2013. The two-component systems PrrBA and NtrYX co-ordinately regulate the adaptation of Brucella abortus to an oxygen-limited environment. Mol Microbiol 88:222–233. doi: 10.1111/mmi.12181. [DOI] [PubMed] [Google Scholar]
- 348.Abdou E, Jiménez de Bagüés MP, Martínez-Abadia I, Ouahrani-Bettache S, Pantesco V, Occhialini A, Al Dahouk S, Köhler S, Jubier-Maurin V. 2017. RegA plays a key role in oxygen-dependent establishment of persistence and in isocitrate lyase activity, a critical determinant of in vivo Brucella suis pathogenicity. Front Cell Infect Microbiol 7:186. doi: 10.3389/fcimb.2017.00186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 349.Eisenreich W, Dandekar T, Heesemann J, Goebel W. 2010. Carbon metabolism of intracellular bacterial pathogens and possible links to virulence. Nat Rev Microbiol 8:401–412. doi: 10.1038/nrmicro2351. [DOI] [PubMed] [Google Scholar]
- 350.O'Neill LAJ, Kishton RJ, Rathmell J. 2016. A guide to immunometabolism for immunologists. Nat Rev Immunol 16:553–565. doi: 10.1038/nri.2016.70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 351.Eisenreich W, Rudel T, Heesemann J, Goebel W. 2017. To eat or be eaten: mutual metabolic adaptations of immune cells and intracellular bacterial pathogens upon infection. Front Cell Infect Microbiol 7:316. doi: 10.3389/fcimb.2017.00316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 352.Escoll P, Buchrieser C. 2018. Metabolic reprogramming of host cells upon bacterial infection: why shift to a Warburg-like metabolism? FEBS J 285:2146–2160. doi: 10.1111/febs.14446. [DOI] [PubMed] [Google Scholar]
- 353.Russell DG, Huang L, VanderVen BC. 2019. Immunometabolism at the interface between macrophages and pathogens. Nat Rev Immunol 19:291–304. doi: 10.1038/s41577-019-0124-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 354.Czyż DM, Willett JW, Crosson S. 2017. Brucella abortus induces a Warburg shift in host metabolism that is linked to enhanced intracellular survival of the pathogen. J Bacteriol 199:e00227-17. doi: 10.1128/JB.00227-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 355.Kerrinnes T, Winter MG, Young BM, Diaz-Ochoa VE, Winter SE, Tsolis RM. 2017. Utilization of host polyamines in alternatively activated macrophages promotes chronic infection by Brucella abortus. Infect Immun 86:e00458-17. doi: 10.1128/IAI.00458-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 356.Gao J, Tian M, Bao Y, Li P, Liu J, Ding C, Wang S, Li T, Yu S. 2016. Pyruvate kinase is necessary for Brucella abortus virulence in BALB/c mouse. Vet Res 47:87. doi: 10.1186/s13567-016-0372-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 357.Pitzer JE, Zeczycki TN, Baumgartner JE, Martin DW, Roop RM, II. 2018. The manganese-dependent pyruvate kinase PykM is required for wild-type glucose utilization by Brucella abortus 2308 and its virulence in C57BL/6 mice. J Bacteriol 200:e00471-18. doi: 10.1128/JB.00471-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 358.Zúñiga-Ripa A, Barbier T, Conde-Álvarez R, Martínez-Gómez E, Palacios-Chaves L, Gil-Ramírez Y, Grilló MJ, Letesson JJ, Iriarte M, Moriyón I. 2014. Brucella abortus depends on pyruvate phosphate dikinase and malic enzyme but not Fbp and GlpX fructose-1,6-bisphosphatases for full virulence in laboratory models. J Bacteriol 196:3045–3057. doi: 10.1128/JB.01663-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 359.Machelart A, Willemart K, Zúñiga-Ripa A, Godard T, Plovier H, Wittmann C, Moriyón I, De Bolle X, Van Schaftingen A, Letesson JJ, Barbier T. 2020. Convergent evolution of zoonotic Brucella species toward selective use of the pentose phosphate pathway. Proc Natl Acad Sci U S A 117:26374–26381. doi: 10.1073/pnas.2008939117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 360.Zúñiga-Ripa A, Barbier T, Lázaro-Antón L, de Miguel MJ, Conde-Álvarez R, Muñoz PM, Letesson JJ, Iriarte M, Moriyón I. 2018. The fast-growing Brucella suis biovar 5 depends on phosphoenolpyruvate carboxykinase and pyruvate phosphate dikinase but not on Fbp and GlpX fructose-1,6-bisphosphatases or isocitrate lyase for full virulence in laboratory models. Front Microbiol 9:641. doi: 10.3389/fmicb.2018.00641. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 361.McCullough NB, Beal GA. 1951. Growth and manometric studies on carbohydrate utilization of Brucella. J Infect Dis 89:266–271. doi: 10.1093/infdis/89.3.266. [DOI] [PubMed] [Google Scholar]
- 362.Anderson JD, Smith H. 1965. The metabolism of erythritol by Brucella abortus. J Gen Microbiol 38:109–124. doi: 10.1099/00221287-38-1-109. [DOI] [PubMed] [Google Scholar]
- 363.Meyer M. 1966. Metabolic characterization of the genus Brucella. V. Relationship of strain oxidation rate of i-erythritol to strain virulence for guinea pigs. J Bacteriol 92:584–588. doi: 10.1128/JB.92.3.584-588.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 364.Smith H, Williams AE, Pearce JH, Keppie J, Harris-Smith PW, Fitz-George RB, Witt K. 1962. Foetal erythritol: a cause of the localization of Brucella abortus in bovine contagious abortus. Nature 193:47–49. doi: 10.1038/193047a0. [DOI] [PubMed] [Google Scholar]
- 365.Barbier T, Collard F, Zúñiga-Ripa A, Moriyón I, Godard T, Becker J, Wittmann C, Van Schaftingen E, Letesson JJ. 2014. Erythritol feeds the pentose phosphate pathway via three new isomerases leading to d-erythrose-4-phosphate in Brucella. Proc Natl Acad Sci U S A 111:17815–17820. doi: 10.1073/pnas.1414622111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 366.Sangari FJ, Agüero J, García-Lobo JM. 2000. The genes for erythritol catabolism are organized as an inducible operon in Brucella abortus. Microbiology (Reading) 146:487–495. doi: 10.1099/00221287-146-2-487. [DOI] [PubMed] [Google Scholar]
- 367.Rodríguez MC, Viadas C, Seoane A, Sangari FJ, López-Goñi I, García-Lobo JM. 2012. Evaluation of the effects of erythritol on gene expression in Brucella abortus. PLoS One 7:e50876. doi: 10.1371/journal.pone.0050876. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 368.Petersen E, Rajashekara G, Sanakkayala N, Eskra L, Harms J, Splitter G. 2013. Erythritol triggers the expression of virulence traits in Brucella melitensis. Microbes Infect 15:440–449. doi: 10.1016/j.micinf.2013.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 369.Bellaire BH, Elzer PH, Hagius S, Walker J, Baldwin CL, Roop RM, II. 2003. Genetic organization and iron-responsive regulation of the Brucella abortus 2,3-dihydroxybenzoic acid biosynthesis operon, a cluster of genes required for wild-type virulence in pregnant cattle. Infect Immun 71:1794–1803. doi: 10.1128/iai.71.4.1794-1803.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 370.Bellaire BH, Elzer PH, Baldwin CL, Roop RM, II. 2003. Production of the siderophore 2,3-dihydroxybenzoic acid is required for wild-type growth of Brucella abortus in the presence of erythritol under low-iron conditions in vitro. Infect Immun 71:2927–2932. doi: 10.1128/iai.71.5.2927-2932.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 371.Burkhardt S, Jiménez de Bagüés MP, Liautard JP, Köhler S. 2005. Analysis of the behavior of eryC mutants of Brucella suis attenuated in macrophages. Infect Immun 73:6782–6790. doi: 10.1128/IAI.73.10.6782-6790.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 372.Barbier T, Machelart A, Zúñiga-Ripa A, Plovier H, Hougardy C, Lobet E, Willemart K, Muraille E, De Bolle X, Van Schaftingen E, Moriyón I, Letesson JJ. 2017. Erythritol availability in bovine, murine and human models highlights a potential role for the host aldose reductase during Brucella infection. Front Microbiol 8:1088. doi: 10.3389/fmicb.2017.01088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 373.Ronneau S, Moussa S, Barbier T, Conde-Álvarez R, Zuñíga-Ripa A, Moriyón I, Letesson JJ. 2016. Brucella, nitrogen and virulence. Crit Rev Microbiol 42:507–525. doi: 10.3109/1040841X.2014.962480. [DOI] [PubMed] [Google Scholar]
- 374.Gerhardt P, Tucker LA, Wilson JB. 1950. The nutrition of brucellae: utilization of single amino acids for growth. J Bacteriol 59:777–782. doi: 10.1128/JB.59.6.777-782.1950. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 375.Wu Q, Pei J, Turse C, Ficht TA. 2006. Mariner mutagenesis of Brucella melitensis reveals genes with previously uncharacterized roles in virulence and survival. BMC Microbiol 6:102. doi: 10.1186/1471-2180-6-102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 376.Zimmer DP, Soupene E, Lee HL, Wendisch VF, Khodursky AB, Peter BJ, Bender RA, Kustu S. 2000. Nitrogen regulatory protein C-controlled genes of Escherichia coli: scavenging as a defense against nitrogen limitation. Proc Natl Acad Sci U S A 97:14674–14679. doi: 10.1073/pnas.97.26.14674. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 377.Leigh JA, Dodsworth JA. 2007. Nitrogen regulation in bacteria and archaea. Annu Rev Microbiol 61:349–377. doi: 10.1146/annurev.micro.61.080706.093409. [DOI] [PubMed] [Google Scholar]
- 378.Franck WL, Qiu J, Lee HI, Chang WS, Stacey G. 2015. DNA microarray-based identification of genes regulated by NtrC in Bradyrhizobium japonicum. Appl Environ Microbiol 81:5299–5308. doi: 10.1128/AEM.00609-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 379.López MF, Cabrera JJ, Salas A, Delgado MJ, López-García SL. 2017. Dissecting the role of NtrC and RpoN in the expression of assimilatory nitrate and nitrite reductases in Bradyrhizobium diazoefficiens. Antonie Van Leeuwenhoek 110:531–542. doi: 10.1007/s10482-016-0821-3. [DOI] [PubMed] [Google Scholar]
- 380.Dorrell N, Guigue-Talet P, Spencer S, Foulonge V, O'Callaghan D, Wren BW. 1999. Investigation into the role of the response regulator NtrC in the metabolism and virulence of Brucella suis. Microb Pathog 27:1–11. doi: 10.1006/mpat.1999.0278. [DOI] [PubMed] [Google Scholar]
- 381.Delory RM, Hallez R, Letesson JJ, De Bolle X. 2006. An RpoH-like heat shock factor is involved in stress response and virulence in Brucella melitensis 16M. J Bacteriol 188:7707–7710. doi: 10.1128/JB.00644-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 382.Iannino F, Ugalde RA, Iñón de Iannino N. 2008. Characterization of Brucella abortus sigma factor σ54 (rpoN): genetic complementation of Sinorhizobium meliloti ntrA mutant. Microb Pathog 45:394–402. doi: 10.1016/j.micpath.2008.09.002. [DOI] [PubMed] [Google Scholar]
- 383.Deutscher J, Aké FMD, Derkaoui M, Zébré AC, Cao TN, Bouraoui H, Kentache T, Mokhtari A, Milohanic E, Joyet P. 2014. The bacterial phosphoenolpyruvate:carbohydrate phosphotransferase system: regulation by protein phosphorylation and phosphorylation-dependent protein-protein interactions. Microbiol Mol Biol Rev 78:231–256. doi: 10.1128/MMBR.00001-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 384.Pflüger-Grau K, Görke B. 2010. Regulatory roles of the bacterial nitrogen-related phosphotransferase system. Trends Microbiol 18:205–214. doi: 10.1016/j.tim.2010.02.003. [DOI] [PubMed] [Google Scholar]
- 385.Dozot M, Poncet S, Nicolas C, Copin R, Bouraoui H, Mazé A, Deutscher J, De Bolle X, Letesson JJ. 2010. Functional characterization of the incomplete phosphotransferase system (PTS) of the intracellular pathogen Brucella melitensis. PLoS One 5:e12679. doi: 10.1371/journal.pone.0012679. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 386.Jiang X, Leonard B, Benson R, Baldwin CL. 1993. Macrophage control of Brucella abortus: role of reactive oxygen intermediates and nitric oxide. Cell Immunol 151:309–319. doi: 10.1006/cimm.1993.1241. [DOI] [PubMed] [Google Scholar]
- 387.Keleher LL, Skyberg JA. 2016. Activation of bovine neutrophils by Brucella spp. Vet Immunol Immunopathol 177:1–6. doi: 10.1016/j.vetimm.2016.05.011. [DOI] [PubMed] [Google Scholar]
- 388.Steele KH, Baumgartner JE, Valderas MW, Roop RM, II. 2010. Comparative studies of the roles of AhpC and KatE as respiratory antioxidants in Brucella abortus 2308. J Bacteriol 192:4912–4922. doi: 10.1128/JB.00231-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 389.Martin DW, Baumgartner JE, Gee JM, Anderson ES, Roop RM, II. 2012. SodA is a major metabolic antioxidant in Brucella abortus 2308 that plays a significant, but limited, role in the virulence of this strain in the mouse model. Microbiology (Reading) 158:1767–1774. doi: 10.1099/mic.0.059584-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 390.Imlay J. 2008. Cellular defenses against superoxide and hydrogen peroxide. Annu Rev Biochem 77:755–776. doi: 10.1146/annurev.biochem.77.061606.161055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 391.Beck BL, Tabatabai LB, Mayfield JE. 1990. A protein isolated from Brucella abortus is a Cu-Zn superoxide dismutase. Biochemistry 29:372–376. doi: 10.1021/bi00454a010. [DOI] [PubMed] [Google Scholar]
- 392.Gee JM, Valderas MV, Kovach ME, Grippe VK, Robertson GT, Ng WL, Richardson JM, Winkler ME, Roop RM, II. 2005. The Brucella abortus Cu,Zn superoxide dismutase is required for optimal resistance to oxidative killing by murine macrophages and wild-type virulence in experimentally infected mice. Infect Immun 73:2873–2880. doi: 10.1128/IAI.73.5.2873-2880.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 393.Tatum FM, Detilleux PG, Sacks JM, Halling SM. 1992. Construction of Cu-Zn superoxide dismutase deletion mutants of Brucella abortus: analysis of survival in vitro in epithelial and phagocytic cells and in vivo in mice. Infect Immun 60:2863–2899. doi: 10.1128/IAI.60.7.2863-2869.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 394.Sha Z, Stabel TJ, Mayfield JE. 1994. Brucella abortus catalase is a periplasmic protein lacking a standard signal sequence. J Bacteriol 176:7375–7377. doi: 10.1128/jb.176.23.7375-7377.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 395.Sangari FJ, Agüero J. 1996. Molecular basis of Brucella pathogenicity: an update. Microbiologia 12:207–218. [PubMed] [Google Scholar]
- 396.Gee JM, Kovach ME, Grippe VK, Hagius S, Walker JV, Elzer PH, Roop RM, II. 2004. Role of catalase in the virulence of Brucella melitensis in pregnant goats. Vet Microbiol 102:111–115. doi: 10.1016/j.vetmic.2004.05.009. [DOI] [PubMed] [Google Scholar]
- 397.Kim JA, Sha Z, Mayfield JE. 2000. Regulation of Brucella abortus catalase. Infect Immun 68:3861–3866. doi: 10.1128/iai.68.7.3861-3866.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 398.Kim JA, Mayfield J. 2000. Identification of Brucella abortus OxyR and its role in control of catalase expression. J Bacteriol 182:5631–5633. doi: 10.1128/jb.182.19.5631-5633.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 399.Hanna N, Ouahrani-Bettache S, Drake KL, Adams LG, Köhler S, Occhialini A. 2013. Global Rsh-dependent transcription profile of Brucella suis during stringent response unravels adaptation to nutrient starvation and cross-talk with other stress responses. BMC Genomics 14:459. doi: 10.1186/1471-2164-14-459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 400.Roop RM, II, Gee JM, Robertson GT, Richardson JM, Ng WL, Winkler ME. 2003. Brucella stationary-phase gene expression and virulence. Annu Rev Microbiol 57:57–76. doi: 10.1146/annurev.micro.57.030502.090803. [DOI] [PubMed] [Google Scholar]
- 401.Cui M, Wang T, Xu J, Ke Y, Du X, Yuan X, Wang Z, Gong C, Zhuang Y, Lei S, Su X, Wang X, Huang L, Zhong Z, Peng G, Yuan J, Chen Z, Wang Y. 2013. Impact of Hfq on global gene expression and intracellular survival in Brucella melitensis. PLoS One 8:e71933. doi: 10.1371/journal.pone.0071933. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 402.Hood MI, Skaar EP. 2012. Nutritional immunity: transition metals at the pathogen-host interface. Nat Rev Microbiol 10:525–537. doi: 10.1038/nrmicro2836. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 403.Nairz M, Schroll A, Sonnweber T, Weiss G. 2010. The struggle for iron—a metal at the host-pathogen interface. Cell Microbiol 12:1691–1702. doi: 10.1111/j.1462-5822.2010.01529.x. [DOI] [PubMed] [Google Scholar]
- 404.Corbin BD, Seeley EH, Raab A, Feldmann J, Miller MR, Torres VJ, Anderson KL, Dattilo BM, Dunman PM, Gerads R, Caprioli RM, Nacken W, Chazin WJ, Skaar EP. 2008. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 319:962–965. doi: 10.1126/science.1152449. [DOI] [PubMed] [Google Scholar]
- 405.Vogel HJ. 2012. Lactoferrin, a bird’s eye view. Biochem Cell Biol 90:233–244. doi: 10.1139/o2012-016. [DOI] [PubMed] [Google Scholar]
- 406.Nakashige TG, Zhang B, Krebs C, Nolan EM. 2015. Human calprotectin is an iron-sequestering host-defense protein. Nat Chem Biol 11:765–771. doi: 10.1038/nchembio.1891. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 407.Cellier MF, Courville P, Campion C. 2007. Nramp1 phagocyte intracellular metal withdrawal defense. Microbes Infect 9:1662–1670. doi: 10.1016/j.micinf.2007.09.006. [DOI] [PubMed] [Google Scholar]
- 408.Michels K, Nemeth E, Ganz T, Mehrad B. 2015. Hepcidin and host defense against infectious diseases. PLoS Pathog 11:e1004998. doi: 10.1371/journal.ppat.1004998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 409.González-Carreró MI, Sangari FJ, Agüero J, García Lobo JM. 2002. Brucella abortus strain 2308 produces brucebactin, a highly efficient catecholic siderophore. Microbiology (Reading) 148:353–360. doi: 10.1099/00221287-148-2-353. [DOI] [PubMed] [Google Scholar]
- 410.Elhassanny AEM, Anderson ES, Menscher EA, Roop RM, II. 2013. The ferrous iron transporter FtrABCD is required for the virulence of Brucella abortus 2308 in mice. Mol Microbiol 88:1070–1082. doi: 10.1111/mmi.12242. [DOI] [PubMed] [Google Scholar]
- 411.Anderson ES, Paulley JT, Gaines JM, Valderas MW, Martin DW, Menscher E, Brown TD, Burns CS, Roop RM, II. 2009. The manganese transporter MntH is a critical virulence determinant for Brucella abortus 2308 in experimentally infected mice. Infect Immun 77:3466–3474. doi: 10.1128/IAI.00444-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 412.Kim S, Watanabe K, Shirahata T, Watarai M. 2004. Zinc uptake system (znuA locus) of Brucella abortus is essential for intracellular survival and virulence in mice. J Vet Med Sci 66:1059–1063. doi: 10.1292/jvms.66.1059. [DOI] [PubMed] [Google Scholar]
- 413.Yang X, Becker T, Walters N, Pascual DW. 2006. Deletion of znuA virulence factor attenuates Brucella abortus and confers protection against wild-type challenge. Infect Immun 74:3874–3879. doi: 10.1128/IAI.01957-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 414.Bellaire BH, Elzer PH, Baldwin CL, Roop RM, II. 1999. The siderophore 2,3-dihydroxybenzoic acid is not required for virulence of Brucella abortus in BALB/c mice. Infect Immun 67:2615–2618. doi: 10.1128/IAI.67.5.2615-2618.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 415.Parent MS, Bellaire BH, Murphy EA, Roop RM, II, Elzer PH, Baldwin CL. 2002. Brucella abortus siderophore 2,3-dihydroxybenzoic acid (DHBA) facilitates intracellular survival of the bacteria. Microb Pathog 32:239–248. doi: 10.1006/mpat.2002.0500. [DOI] [PubMed] [Google Scholar]
- 416.Bellaire BH, Baldwin CL, Elzer PH, Roop RM, II. 2000. The siderophore 2,3-dihydroxybenzoic acid contributes to the virulence of Brucella abortus in ruminants, abstr B-17, p 44. Abstr 100th Gen Meet Amer Soc Microbiol. American Society for Microbiology, Washington, DC. [Google Scholar]
- 417.Martínez M, Ugalde RA, Almirón M. 2005. Dimeric Brucella abortus Irr protein controls its own expression and binds haem. Microbiology (Reading) 151:3427–3433. doi: 10.1099/mic.0.28213-0. [DOI] [PubMed] [Google Scholar]
- 418.Martínez M, Ugalde RA, Almirón M. 2006. Irr regulates brucebactin and 2,3-dihydroxybenzoic acid biosynthesis, and is implicated in the oxidative stress resistance and intracellular survival of Brucella abortus. Microbiology (Reading) 152:2591–2598. doi: 10.1099/mic.0.28782-0. [DOI] [PubMed] [Google Scholar]
- 419.Anderson ES, Paulley JT, Martinson DA, Gaines JM, Steele KH, Roop RM, II. 2011. The iron-responsive regulator Irr is required for wild-type expression of the gene encoding the heme transporter BhuA in Brucella abortus 2308. J Bacteriol 193:5359–5364. doi: 10.1128/JB.00372-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 420.Ojeda JF, Martinson DA, Menscher EA, Roop RM, II. 2012. The bhuQ gene encodes a heme oxygenase that contributes to the ability of Brucella abortus 2308 to use heme as an iron source and is regulated by Irr. J Bacteriol 194:4052–4058. doi: 10.1128/JB.00367-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 421.Menscher EA, Caswell CC, Anderson ES, Roop RM, II. 2012. Mur regulates the gene encoding the manganese transporter MntH in Brucella abortus 2308. J Bacteriol 194:561–566. doi: 10.1128/JB.05296-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 422.Sheehan LM, Budnick JA, Roop RM, II, Caswell CC. 2015. Coordinated zinc homeostasis is essential for the wild-type virulence of Brucella abortus. J Bacteriol 197:1582–1591. doi: 10.1128/JB.02543-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 423.Johnsrude MJ, Pitzer JE, Martin DW, Roop RM, II. 2019. The cation diffusion facilitator family protein EmfA confers resistance to manganese toxicity in Brucella abortus 2308 and is an essential virulence determinant in mice. J Bacteriol 202:e00357-19. doi: 10.1128/JB.00357-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 424.Zhang H, Wang B, Wu W, Deng X, Shao Z, Yi J, Wang Z, Yang N, Wang Y, Wang Y, Chen C. 2020. Insights into irr and rirA gene regulation on the virulence of Brucella melitensis M5-90. Can J Microbiol 66:351–358. doi: 10.1139/cjm-2019-0393. [DOI] [PubMed] [Google Scholar]
- 425.Groisman EA, Hollands K, Kriner MA, Lee EJ, Park SY, Pontes MH. 2013. Bacterial Mg2+ homeostasis, transport and virulence. Annu Rev Genet 47:625–646. doi: 10.1146/annurev-genet-051313-051025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 426.Evenson MA, Gerhardt P. 1955. Nutrition of brucellae: utilization of iron, magnesium and manganese for growth. Proc Soc Exp Biol Med 89:678–680. doi: 10.3181/00379727-89-21914. [DOI] [PubMed] [Google Scholar]
- 427.Jubier-Maurin V, Rodrigue A, Ouahrani-Bettache S, Layssac M, Mandrand-Berthelot MA, Köhler S, Liautard JP. 2001. Identification of the nik gene cluster of Brucella suis: regulation and contribution to urease activity. J Bacteriol 183:426–434. doi: 10.1128/JB.183.2.426-434.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 428.Sangari FJ, Cayón AM, Seoane A, García-Lobo JM. 2010. Brucella abortus ure2 region contains an acid-activated urea transporter and a nickel transport system. BMC Microbiol 10:107. doi: 10.1186/1471-2180-10-107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 429.Lestrate P, Delrue RM, Danese I, Didembourg C, Taminiau B, Mertens P, De Bolle X, Tibor A, Tang CM, Letesson JJ. 2000. Identification and characterization of in vivo attenuated mutants of Brucella melitensis. Mol Microbiol 38:543–551. doi: 10.1046/j.1365-2958.2000.02150.x. [DOI] [PubMed] [Google Scholar]
- 430.Lee EJ, Pontes MH, Groisman EA. 2013. A bacterial virulence protein promotes pathogenicity by inhibiting the bacterium’s own F1F0 ATP synthase. Cell 154:146–156. doi: 10.1016/j.cell.2013.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 431.Lavigne J-P, O'callaghan D, Blanc-Potard A-B. 2005. Requirement of MgtC for Brucella suis intramacrophage growth: a potential mechanism shared by Salmonella enterica and Mycobacterium tuberculosis for adaptation to a low-Mg2+ environment. Infect Immun 73:3160–3163. doi: 10.1128/IAI.73.5.3160-3163.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 432.Corbel MJ, Hendry DM. 1985. Urease activity of Brucella species. Res Vet Sci 38:252–253. doi: 10.1016/S0034-5288(18)31838-1. [DOI] [PubMed] [Google Scholar]
- 433.Bandara AB, Contreras A, Contreras-Rodriguez A, Martins AM, Dobrean V, Poff-Reichow S, Rajasekaran P, Sriranganathan N, Schurig GG, Boyle SM. 2007. Brucella suis urease encoded by ure1 but not ure2 is necessary for intestinal infection of BALB/c mice. BMC Microbiol 7:57. doi: 10.1186/1471-2180-7-57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 434.Sangari FJ, Seoane A, Rodríguez MC, Agüero J, García-Lobo JM. 2007. Characterization of the urease operon of Brucella abortus and assessment of its role in virulence of the bacterium. Infect Immun 75:774–780. doi: 10.1128/IAI.01244-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 435.Spera JM, Ugalde JE, Mucci M, Comerci DJ, Ugalde RA. 2006. A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection. Proc Natl Acad Sci U S A 103:16514–16519. doi: 10.1073/pnas.0603362103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 436.Spera JM, Herrmann CK, Roset MS, Comerci DJ, Ugalde JE. 2013. A Brucella virulence factor targets macrophages to trigger B-cell proliferation. J Biol Chem 288:20208–20216. doi: 10.1074/jbc.M113.453282. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 437.Spera JM, Comerci DJ, Ugalde JE. 2014. Brucella alters the immune response in a prpA-dependent manner. Microb Pathog 67–68:8–13. doi: 10.1016/j.micpath.2014.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 438.Spera JM, Guaimas F, Corvi MM, Ugalde JE. 2018. Brucella hijacks host-mediated palmitoylation to stabilize and localize PrpA to the plasma membrane. Infect Immun 86:e00402-18. doi: 10.1128/IAI.00402-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 439.Haag AF, Baloban M, Sani M, Kerscher B, Pierre O, Farkas A, Longhi R, Boncompagni E, Hérouart D, Dall'angelo S, Kondorosi E, Zanda M, Mergaert P, Ferguson GP. 2011. Protection of Sinorhizobium against host cysteine-rich antimicrobial peptides is critical for symbiosis. PLoS Biol 9:e1001169. doi: 10.1371/journal.pbio.1001169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 440.Arnold MFF, Shabab M, Penterman J, Boehme KL, Griffitts JS, Walker GC. 2017. Genome-wide sensitivity analysis of the microsymbiont Sinorhizobium meliloti to symbiotically important, defensin-like host peptides. mBio 8:e01060-17. doi: 10.1128/mBio.01060-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 441.Penterman J, Abo RP, De Nisco NJ, Arnold MFF, Longhi R, Zanda M, Walker GC. 2014. Host plant peptides elicit a transcriptional response to control the Sinorhizobium meliloti cell cycle during symbiosis. Proc Natl Acad Sci U S A 111:3561–3566. doi: 10.1073/pnas.1400450111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 442.Bellaire BH, Roop RM, II, Cardelli JA. 2005. Opsonized virulent Brucella abortus replicates within nonacidic, endoplasmic reticulum-negative, LAMP-1-positive phagosomes in human monocytes. Infect Immun 73:3702–3713. doi: 10.1128/IAI.73.6.3702-3713.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 443.Parent MA, Goenka R, Murphy E, LeVier K, Carreiro N, Golding B, Ferguson G, Roop RM, II, Walker GC, Baldwin CL. 2007. Brucella abortus bacA mutant induces greater pro-inflammatory cytokines than the wild-type parent strain. Microbes Infect 9:55–62. doi: 10.1016/j.micinf.2006.10.008. [DOI] [PubMed] [Google Scholar]
- 444.Van de Velde W, Zehirov G, Szatmari A, Debreczeny M, Ishihara H, Kevei Z, Farkas A, Mikulass K, Nagy A, Tiricz H, Satiat-Jeunemaître B, Alunni B, Bourge M, Kucho K-i, Abe M, Kereszt A, Maroti G, Uchiumi T, Kondorosi E, Mergaert P. 2010. Plant peptides govern terminal differentiation of bacteria in symbiosis. Science 327:1122–1126. doi: 10.1126/science.1184057. [DOI] [PubMed] [Google Scholar]
- 445.Wehmeier S, Arnold MFF, Marlow VL, Aouida M, Myka KK, Fletcher V, Benincasa M, Scocchi M, Ramotar D, Ferguson GP. 2010. Internalization of a thiazole-modified peptide in Sinorhizobium meliloti occurs by BacA-dependent and -independent mechanisms. Microbiology (Reading) 156:2702–2713. doi: 10.1099/mic.0.039909-0. [DOI] [PubMed] [Google Scholar]
- 446.Lund P, Tramonti A, De Biase D. 2014. Coping with low pH: molecular strategies in neutralophilic bacteria. FEMS Microbiol Rev 38:1091–1125. doi: 10.1111/1574-6976.12076. [DOI] [PubMed] [Google Scholar]
- 447.Occhialini A, Jimenez de Bagüés MP, Saadeh B, Bastianelli D, Hanna H, De Biase D, Köhler S. 2012. The glutamic acid decarboxylase system of the new species Brucella microti contributes to its acid resistance and to oral infection in mice. J Infect Dis 206:1424–1432. doi: 10.1093/infdis/jis522. [DOI] [PubMed] [Google Scholar]
- 448.Damiano MA, Bastianelli D, Al Dahouk S, Köhler S, Cloeckaert A, De Biase D, Occhialini A. 2015. Glutamate decarboxylase-dependent acid resistance in Brucella spp.: distribution and contribution to fitness under extremely acidic conditions. Appl Environ Microbiol 81:578–586. doi: 10.1128/AEM.02928-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 449.Freddi L, Damiano MA, Chaloin L, Pennacchietti P, Al Dahouk S, Köhler S, De Biase D, Occhialini A. 2017. The glutaminase-dependent system confers extreme acid resistance to new species and atypical strains of Brucella. Front Microbiol 8:2236. doi: 10.3389/fmicb.2017.02236. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 450.Manterola L, Moriyón I, Moreno E, Sola-Landa A, Weiss DS, Koch MHJ, Howe J, Brandenburg K, López-Goñi I. 2005. The lipopolysaccharide of Brucella abortus BvrR/BvrS mutants contains lipid A modifications and has higher affinity for bactericidal cationic peptides. J Bacteriol 187:5631–5639. doi: 10.1128/JB.187.16.5631-5639.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 451.Guzmán-Verrí C, Chaves-Olarte E, von Eichel-Streiber C, López-Goñi I, Thelestam M, Arvidson S, Gorvel JP, Moreno E. 2001. GTPases of the Rho subfamily are required for Brucella abortus internalization in nonprofessional phagocytes. J Biol Chem 276:44435–44443. doi: 10.1074/jbc.M105606200. [DOI] [PubMed] [Google Scholar]
- 452.Billard E, Cazevieille C, Dornand J, Gross A. 2005. High susceptibility of human dendritic cells to invasion by the intracellular pathogens Brucella suis, B. abortus, and B. melitensis. Infect Immun 73:8418–8424. doi: 10.1128/IAI.73.12.8418-8424.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 453.Billard E, Dornand J, Gross A. 2007. Brucella suis prevents human dendritic cell maturation and antigen presentation through regulation of tumor necrosis factor alpha secretion. Infect Immun 75:4980–4989. doi: 10.1128/IAI.00637-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 454.Martínez-Nuñez C, Altamirano-Silva P, Alvarado-Guillén F, Moreno E, Guzmán-Verri C, Chaves-Olarte E. 2010. The two-component system BvrR/BvrS regulates the expression of the type IV secretion system VirB in Brucella abortus. J Bacteriol 192:5603–5608. doi: 10.1128/JB.00567-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 455.Lamontagne J, Butler H, Chaves-Olarte E, Hunter J, Schirm M, Paquet C, Tian M, Kearney P, Hamaidi L, Chelsky D, Moriyón I, Moreno E, Paramithiotis E. 2007. Extensive cell envelope modulation is associated with virulence in Brucella abortus. J Proteome Res 6:1519–1529. doi: 10.1021/pr060636a. [DOI] [PubMed] [Google Scholar]
- 456.Barbier T, Nicolas C, Letesson JJ. 2011. Brucella adaptation and survival at the crossroad of metabolism and virulence. FEBS Lett 585:2929–2934. doi: 10.1016/j.febslet.2011.08.011. [DOI] [PubMed] [Google Scholar]
- 457.Barbier T, Zúñiga-Ripa A, Moussa S, Plovier H, Sternon JF, Lázaro-Antón L, Conde-Álvarez R, De Bolle X, Iriarte M, Moriyón I, Letesson JJ. 2018. Brucella central carbon metabolism: an update. Crit Rev Microbiol 44:182–211. doi: 10.1080/1040841X.2017.1332002. [DOI] [PubMed] [Google Scholar]
- 458.Heavner ME, Qiu WG, Cheng HP. 2015. Phylogenetic co-occurrence of ExoR, ExoS, and ChvI, components of the RSI bacterial invasion switch, suggests a key adaptive mechanism regulating the transition between free-living and host-invading phases in Rhizobiales. PLoS One 10:e0135655. doi: 10.1371/journal.pone.0135655. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 459.Li L, Jia Y, Hou Q, Charles TC, Nester EW, Pan SQ. 2002. A global pH sensor: Agrobacterium sensor protein ChvG regulates acid-inducible genes on its two chromosomes and Ti plasmid. Proc Natl Acad Sci U S A 99:12369–12374. doi: 10.1073/pnas.192439499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 460.Cheng HP, Walker GC. 1998. Succinoglycan production by Rhizobium meliloti is regulated through the ExoS-ChvI two-component regulatory system. J Bacteriol 180:20–26. doi: 10.1128/JB.180.1.20-26.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 461.Quebatte M, Dehio M, Tropel D, Basler A, Toller I, Raddatz G, Engel P, Huser S, Schein H, Lindroos HL, Andersson SG, Dehio C. 2010. The BatR/BatS two-component regulatory system controls the adaptive response of Bartonella henselae during human endothelial cell infection. J Bacteriol 192:3352–3367. doi: 10.1128/JB.01676-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 462.Saenz HL, Engel P, Stoeckli MC, Lanz C, Raddatz G, Vayssier-Taussat M, Birtles R, Schuster SC, Dehio C. 2007. Genomic analysis of Bartonella identifies type IV secretion systems as host adaptability factors. Nat Genet 39:1469–1476. doi: 10.1038/ng.2007.38. [DOI] [PubMed] [Google Scholar]
- 463.Fuqua C, Greenberg EP. 2002. Listening in on bacteria: acyl-homoserine lactone signalling. Nat Rev Mol Cell Biol 3:685–695. doi: 10.1038/nrm907. [DOI] [PubMed] [Google Scholar]
- 464.Papenfort K, Bassler BL. 2016. Quorum sensing signal-response systems in Gram-negative bacteria. Nat Rev Microbiol 14:576–588. doi: 10.1038/nrmicro.2016.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 465.Taminiau B, Daykin M, Swift S, Boschiroli M-L, Tibor A, Lestrate P, De Bolle X, O'Callaghan D, Williams P, Letesson J-J. 2002. Identification of a quorum-sensing signal molecule in the facultative intracellular pathogen Brucella melitensis. Infect Immun 70:3004–3011. doi: 10.1128/iai.70.6.3004-3011.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 466.Arocena GM, Sieira R, Comerci DJ, Ugalde RA. 2010. Identification of the quorum-sensing target DNA sequence and N-acyl homoserine lactone responsiveness of the Brucella abortus virB promoter. J Bacteriol 192:3434–3440. doi: 10.1128/JB.00232-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 467.Ke Y, Wang Y, Yuan Z, Zhong Z, Qu Q, Zhou D, Zeng X, Xu J, Wang Z, Du X, Wang T, Yang R, Zhen Q, Yu Y, Huang L, Chen Z. 2012. Altered transcriptome of the B. melitensis vaccine candidate 16MΔvjbR, implications for development of genetically marked live vaccine. Indian J Microbiol 52:575–580. doi: 10.1007/s12088-012-0293-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 468.Arenas-Gamboa AM, Ficht TA, Kahl-McDonagh MM, Rice-Ficht AC. 2008. Immunization with a single dose of a microencapsulated Brucella melitensis mutant enhances protection against wild-type challenge. Infect Immun 76:2448–2455. doi: 10.1128/IAI.00767-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 469.Hensel ME, Garcia-Gonzalez DG, Chaki SP, Hartwig A, Gordy PW, Bowen R, Ficht TA, Arenas-Gamboa AM. 2020. Vaccine candidate Brucella melitensis 16MΔvjbR is safe in a pregnant sheep model and confers protection. mSphere 5:e00120-20. doi: 10.1128/mSphere.00120-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 470.Stranahan LW, Chaki SP, Garcia-Gonzalez DG, Khalaf OH, Arenas-Gamboa AM. 2020. Evaluation of the efficacy of the Brucella canis RM6/66 ΔvjbR vaccine candidate for protection against B. canis infection in mice. mSphere 5:e00172-20. doi: 10.1128/mSphere.00172-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 471.Brambila-Tapia AJL, Perez-Rueda E. 2014. A functional and phylogenetic comparison of quorum sensing related genes in Brucella melitensis 16M. J Microbiol 52:709–715. doi: 10.1007/s12275-014-3570-x. [DOI] [PubMed] [Google Scholar]
- 472.Terwagne M, Mirabella A, Lemaire J, Deschamps C, De Bolle X, Letesson JJ. 2013. Quorum sensing and self-quorum quenching in the intracellular pathogen Brucella melitensis. PLoS One 8:e82514. doi: 10.1371/journal.pone.0082514. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 473.Li ZQ, Zhang JL, Xi L, Yang GL, Wang SL, Zhang ZG, Zhang JB, Zhang H. 2017. Deletion of the transcriptional regulator GntR down regulated the expression of genes related to virulence and conferred protection against wild-type Brucella challenge in BALB/c mice. Mol Immunol 92:99–105. doi: 10.1016/j.molimm.2017.10.011. [DOI] [PubMed] [Google Scholar]
- 474.Fiebig A, Herrou J, Willett J, Crosson S. 2015. General stress signaling in the alphaproteobacteria. Annu Rev Genet 49:603–625. doi: 10.1146/annurev-genet-112414-054813. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 475.Kim HS, Willett JW, Jain-Gupta N, Fiebig A, Crosson S. 2014. The Brucella abortus virulence regulator, LovhK, is a sensor kinase in the general stress response signalling pathway. Mol Microbiol 94:913–925. doi: 10.1111/mmi.12809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 476.Sycz G, Carrica MD, Tseng TS, Bogomolni RA, Briggs WR, Goldbaum FA, Paris G. 2015. LOV histidine kinase modulates the general stress response system and affects virB operon expression in Brucella abortus. PLoS One 10:e0124058. doi: 10.1371/journal.pone.0124058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 477.Swartz TE, Tseng T-S, Frederickson MA, Paris G, Comerci DJ, Rajashekara G, Kim J-G, Mudgett MB, Splitter GA, Ugalde RA, Goldbaum FA, Briggs WR, Bogomolni RA. 2007. Blue-light-activated histidine kinases: two-component sensors in bacteria. Science 317:1090–1093. doi: 10.1126/science.1144306. [DOI] [PubMed] [Google Scholar]
- 478.Hallez R, Bellefontaine AF, Letesson JJ, De Bolle X. 2004. Morphological and functional asymmetry in alpha-proteobacteria. Trends Microbiol 12:361–365. doi: 10.1016/j.tim.2004.06.002. [DOI] [PubMed] [Google Scholar]
- 479.Brown PJ, de Pedro MA, Kysela DT, Van der Henst C, Kim J, De Bolle X, Fuqua C, Brun YV. 2012. Polar growth in the alphaproteobacterial order Rhizobiales. Proc Natl Acad Sci U S A 109:1697–1701. doi: 10.1073/pnas.1114476109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 480.Robertson GT, Reisenauer A, Wright R, Jensen RB, Jensen A, Shapiro L, Roop RM, II. 2000. The Brucella abortus CcrM DNA methyltransferase is essential for viability, and its overexpression attenuates intracellular replication in murine macrophages. J Bacteriol 182:3482–3489. doi: 10.1128/jb.182.12.3482-3489.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 481.Willett JW, Herrou J, Briegel A, Rotskoff G, Crosson S. 2015. Structural asymmetry in a conserved signaling system that regulates division, replication, and virulence of an intracellular pathogen. Proc Natl Acad Sci U S A 112:E3709–3718. doi: 10.1073/pnas.1503118112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 482.Deghelt M, Letesson JJ, De Bolle X. 2014. On the link between cell cycle and infection of the alphaproteobacterium Brucella abortus. Microb Cell 1:346–348. doi: 10.15698/mic2014.10.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 483.Bellefontaine AF, Pierreux C, Mertens P, Vandenhaute J, Letesson JJ, De Bolle X. 2002. Plasticity of a transcriptional regulation network among alpha-proteobacteria is supported by the identification of CtrA targets in Brucella abortus. Mol Microbiol 43:945–960. doi: 10.1046/j.1365-2958.2002.02777.x. [DOI] [PubMed] [Google Scholar]
- 484.Van der Henst C, Beaufay F, Mignolet J, Didembourg C, Colinet J, Hallet B, Letesson JJ, De Bolle X. 2012. The histidine kinase PdhS controls cell cycle progression of the pathogenic alphaproteobacterium Brucella abortus. J Bacteriol 194:5305–5314. doi: 10.1128/JB.00699-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 485.Haakonsen DL, Yuan AH, Laub MT. 2015. The bacterial cell cycle regulator GcrA is a σ70 cofactor that drives gene expression from a subset of methylated promoters. Genes Dev 29:2272–2286. doi: 10.1101/gad.270660.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 486.Poncin K, Roba A, Jimmidi R, Potemberg G, Fioravanti A, Francis N, Willemart K, Zeippen N, Machelart A, Biondi EG, Muraille E, Vincent SP, De Bolle X. 2019. Occurrence and repair of alkylating stress in the intracellular pathogen Brucella abortus. Nat Commun 10:4847. doi: 10.1038/s41467-019-12516-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 487.Arenas-Gamboa AM, Rice-Ficht AC, Kahl-McDonagh MM, Ficht TA. 2011. Protective efficacy and safety of Brucella melitensis 16MΔmucR against intraperitoneal and aerosol challenge in BALB/c mice. Infect Immun 79:3653–3658. doi: 10.1128/IAI.05330-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 488.Close TJ, Rogowsky PM, Kado CI, Winans SC, Yanofsky MF, Nester EW. 1987. Dual control of Agrobacterium tumefaciens Ti virulence genes. J Bacteriol 169:5113–5118. doi: 10.1128/jb.169.11.5113-5118.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 489.Mueller K, González JE. 2011. Complex regulation of symbiotic functions is coordinated by MucR and quorum sensing in Sinorhizobium meliloti. J Bacteriol 193:485–496. doi: 10.1128/JB.01129-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 490.Fumeaux C, Radhakrishnan SK, Ardissone S, Theraulaz L, Frandi A, Martins D, Nesper J, Abel S, Jenal U, Viollier PH. 2014. Cell cycle transition from S-phase to G1 in Caulobacter is mediated by ancestral virulence regulators. Nat Commun 5:4081. doi: 10.1038/ncomms5081. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 491.Hoskisson PA, Rigali S. 2009. Variation in form and function: the helix-turn-helix regulators of the GntR superfamily. Adv Appl Microbiol 69:1–22. doi: 10.1016/S0065-2164(09)69001-8. [DOI] [PubMed] [Google Scholar]
- 492.Zhou D, Zhi FJ, Qi MZ, Bai FR, Zhang G, Li JM, Liu H, Chen MT, Lin PF, Tang KQ, Liu W, Jin YP, Wang AH. 2018. Brucella induces unfolded protein response and inflammatory response via GntR in alveolar macrophages. Oncotarget 9:5184–5196. doi: 10.18632/oncotarget.23706. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 493.Jain D. 2015. Allosteric control of transcription in GntR family of transcription regulators: a structural overview. IUBMB Life 67:556–563. doi: 10.1002/iub.1401. [DOI] [PubMed] [Google Scholar]
- 494.Li Z, Wang W, Zhang H, Zhang J, Xi L, Zhang J, Chen C. 2017. Transcriptional regulator GntR of Brucella abortus regulates cytotoxicity, induces the secretion of inflammatory cytokines and affects expression of the type IV secretion system and quorum sensing in macrophages. World J Microbiol Biotechnol 33:60. doi: 10.1007/s11274-017-2230-9. [DOI] [PubMed] [Google Scholar]
- 495.Skerker JM, Prasol MS, Perchuk BS, Biondi EG, Laub MT. 2005. Two-component signal transduction pathways regulating growth and cell cycle progression in a bacterium: a system-level analysis. PLoS Biol 3:e334. doi: 10.1371/journal.pbio.0030334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 496.Zhang Z, Ren J, Li N, Liu W, Wu Q. 2009. Disruption of the BMEI0066 gene attenuates the virulence of Brucella melitensis and decreases its stress tolerance. Int J Biol Sci 5:570–577. doi: 10.7150/ijbs.5.570. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 497.Liu W, Dong H, Liu W, Gao X, Zhang C, Wu Q. 2012. OtpR regulated the growth, cell morphology of B. melitensis and tolerance to β-lactam antibiotics. Vet Microbiol 159:90–98. doi: 10.1016/j.vetmic.2012.03.022. [DOI] [PubMed] [Google Scholar]
- 498.Liu W, Dong H, Peng X, Wu Q. 2014. The cyclic AMP-binding protein CbpB in Brucella melitensis and its role in cell envelope integrity, resistance to detergent and virulence. FEMS Microbiol Lett 356:79–88. doi: 10.1111/1574-6968.12472. [DOI] [PubMed] [Google Scholar]
- 499.Lavín JL, Binnewies TT, Pisabarro AG, Ussery DW, García-Lobo JM, Oguiza JA. 2010. Differences in two-component signal transduction proteins among the genus Brucella: implications for host preference and pathogenesis. Vet Microbiol 144:478–483. doi: 10.1016/j.vetmic.2010.01.007. [DOI] [PubMed] [Google Scholar]
- 500.Roset MS, Almirón MA. 2013. FixL-like sensor FlbS of Brucella abortus binds haem and is necessary for survival within eukaryotic cells. FEBS Lett 587:3102–3107. doi: 10.1016/j.febslet.2013.07.047. [DOI] [PubMed] [Google Scholar]
- 501.Li Z, Fu Q, Wang Z, Li T, Zhang H, Guo F, Wang Y, Zhang J, Chen C. 2015. TceSR two-component regulatory system of Brucella melitensis 16M is involved in invasion, intracellular survival and regulated cytotoxicity for macrophages. Lett Appl Microbiol 60:565–571. doi: 10.1111/lam.12408. [DOI] [PubMed] [Google Scholar]
- 502.Li Z, Wang S, Zhang J, Yang G, Yuan B, Huang J, Han J, Xi L, Xiao Y, Chen C, Zhang H. 2017. Brucella abortus 2308 ΔNodVΔNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice. Microb Pathog 106:30–39. doi: 10.1016/j.micpath.2017.01.043. [DOI] [PubMed] [Google Scholar]
- 503.Göttfert M, Grob P, Hennecke H. 1990. Proposed regulatory pathway encoded by the nodV and nodW genes, determinants of host specificity in Bradyrhizobium japonicum. Proc Natl Acad Sci U S A 87:2680–2684. doi: 10.1073/pnas.87.7.2680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 504.Loh J, Garcia M, Stacey G. 1997. NodV and NodW, a second flavonoid recognition system regulating nod gene expression in Bradyrhizobium japonicum. J Bacteriol 179:3013–3020. doi: 10.1128/jb.179.9.3013-3020.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 505.Mirabella A, Yañez Villanueva RM, Delrue RM, Uzureau S, Zygmunt MS, Cloeckaert A, De Bolle X, Letesson JJ. 2012. The two-component system PrlS/PrlR of Brucella melitensis is required for persistence in mice and appears to respond to ionic strength. Microbiology (Reading) 158:2642–2651. doi: 10.1099/mic.0.060863-0. [DOI] [PubMed] [Google Scholar]
- 506.Boutte CC, Crosson S. 2013. Bacterial lifestyle shapes stringent response activation. Trends Microbiol 21:174–180. doi: 10.1016/j.tim.2013.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 507.Kim S, Watanabe K, Suzuki H, Watarai T. 2005. Roles of Brucella abortus SpoT in morphological differentiation and intramacrophagic replication. Microbiology (Reading) 151:1607–1617. doi: 10.1099/mic.0.27782-0. [DOI] [PubMed] [Google Scholar]
- 508.Van der Henst M, Carlier E, De Bolle X. 2020. Intracellular growth and cell cycle progression are dependent on (p)ppGpp synthetase/hydrolase in Brucella abortus. Pathogens 9:571. doi: 10.3390/pathogens9070571. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 509.Varesio LM, Willett JW, Fiebig A, Crosson S. 2019. A carbonic anhydrase pseudogene sensitizes select Brucella lineages to low CO2 tension. J Bacteriol 201:e00509-19. doi: 10.1128/JB.00509-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 510.Römling U, Galperin MY, Gomelsky M. 2013. Cyclic di-GMP: the first 25 years of a universal bacterial second messenger. Microbiol Mol Biol Rev 77:1–52. doi: 10.1128/MMBR.00043-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 511.Jenal U, Reinders A, Lori C. 2017. Cyclic di-GMP: second messenger extraordinaire. Nat Rev Microbiol 15:271–284. doi: 10.1038/nrmicro.2016.190. [DOI] [PubMed] [Google Scholar]
- 512.Conner JG, Zamorano-Sánchez D, Park JH, Sondermann H, Yildiz FH. 2017. The ins and outs of cyclic di-GMP signaling in Vibrio cholerae. Curr Opin Microbiol 36:20–29. doi: 10.1016/j.mib.2017.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 513.Hall CL, Lee VT. 2018. Cyclic-di-GMP regulation of virulence in bacterial pathogens. Wiley Interdiscip Rev RNA 9:e1454. doi: 10.1002/wrna.1454. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 514.Xu J, Kim J, Koestler BJ, Choi JH, Waters CM, Fuqua C. 2013. Genetic analysis of Agrobacterium tumefaciens unipolar polysaccharide production reveals complex integrated control of the motile-to-sessile switch. Mol Microbiol 89:929–948. doi: 10.1111/mmi.12321. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 515.Schäper S, Krol E, Skotnicka D, Kaever V, Hilker R, Søgaard-Andersen L, Becker A. 2016. Cyclic di-GMP regulates multiple cellular functions in the symbiotic alphaproteobacterium Sinorhizobium meliloti. J Bacteriol 198:521–535. doi: 10.1128/JB.00795-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 516.Hallez R, Delaby M, Sanselicio S, Viollier PH. 2017. Hit the right spots: cell cycle control by phosphorylated guanosines in alphaproteobacteria. Nat Rev Microbiol 15:137–148. doi: 10.1038/nrmicro.2016.183. [DOI] [PubMed] [Google Scholar]
- 517.Feirer N, Kim DH, Xu J, Fernandez N, Waters CM, Fuqua C. 2017. The Agrobacterium tumefaciens CheY-like protein ClaR regulates biofilm formation. Microbiology (Reading) 163:1680–1691. doi: 10.1099/mic.0.000558. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 518.Burdette DL, Monroe KM, Sotelo-Troha K, Iwig JS, Eckert B, Hyodo M, Hayakawa Y, Vance RE. 2011. STING is a direct innate immune sensor of cyclic di-GMP. Nature 478:515–518. doi: 10.1038/nature10429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 519.Cui T, Cang H, Yang B, He ZG. 2019. Cyclic dimeric guanosine monophosphate: activation and inhibition of innate immune response. J Innate Immun 11:242–248. doi: 10.1159/000492679. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 520.Costa Franco MM, Marim F, Guimarães ES, Assis N, Cerqueira DM, Alves-Silva J, Harms J, Splitter G, Smith J, Kanneganti TD, de Queiroz N, Gutman N, Barber GN, Oliveira SC. 2018. Brucella abortus triggers a cGAS-independent STING pathway to induce host protection that involves guanylate-binding proteins and inflammasome activation. J Immunol 200:607–622. doi: 10.4049/jimmunol.1700725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 521.Guimarães ES, Gomes M, Campos PC, Mansur DS, Dos Santos AA, Harms J, Splitter G, Smith JA, Barber GN, Oliveira SC. 2019. Brucella abortus cyclic dinucleotides trigger STING-dependent unfolded protein response that favors bacterial replication. J Immunol 202:2671–2681. doi: 10.4049/jimmunol.1801233. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 522.Storz G, Vogel J, Wassarman KM. 2011. Regulation of small RNAs in bacteria: expanding frontiers. Mol Cell 43:880–891. doi: 10.1016/j.molcel.2011.08.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 523.Updegrove TB, Zhang A, Storz G. 2016. Hfq: the flexible RNA matchmaker. Curr Opin Microbiol 30:133–138. doi: 10.1016/j.mib.2016.02.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 524.Valderas MW, Alcantara RB, Baumgartner JE, Bellaire BH, Robertson GT, Ng WL, Richardson JM, Winkler ME, Roop RM, II. 2005. Role of HdeA in acid resistance and virulence in Brucella abortus 2308. Vet Microbiol 107:307–312. doi: 10.1016/j.vetmic.2005.01.018. [DOI] [PubMed] [Google Scholar]
- 525.Lei S, Zhong Z, Ke Y, Yang M, Xu X, Ren H, An C, Yuan J, Yu J, Xu J, Qiu Y, Shi Y, Wang Y, Peng G, Chen Z. 2016. Deletion of the small RNA chaperone protein Hfq down regulates genes related to virulence and confers protection against wild-type Brucella challenge in mice. Front Microbiol 6:1570. doi: 10.3389/fmicb.2015.01570. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 526.Robertson GT, Roop RM, II. 1999. The Brucella abortus host factor I (HF-I) protein contributes to stress resistance during stationary phase and is a major determinant of virulence in mice. Mol Microbiol 34:690–700. doi: 10.1046/j.1365-2958.1999.01629.x. [DOI] [PubMed] [Google Scholar]
- 527.Zhang J, Guo F, Chen C, Li Z, Zhang H, Wang Y, Zhang K, Du G, Li Y, Wang J, Jian T, Wang Z. 2013. Brucella melitensis 16MΔhfq attenuation confers protection against wild-type challenge in BALB/c mice. Microbiol Immunol 57:502–510. doi: 10.1111/1348-0421.12065. [DOI] [PubMed] [Google Scholar]
- 528.Caswell CC, Gaines JM, Ciborowski P, Smith D, Borchers CH, Roux CM, Sayood K, Dunman PM, Roop RM, II. 2012. Identification of two small regulatory RNAs linked to virulence in Brucella abortus 2308. Mol Microbiol 85:345–360. doi: 10.1111/j.1365-2958.2012.08117.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 529.Sheehan LM, Caswell CC. 2017. A 6-nucleotide regulatory motif within the AbcR small RNAs of Brucella abortus mediates host-pathogen interactions. mBio 8:e00473-17. doi: 10.1128/mBio.00473-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 530.Sheehan LM, Budnick JA, Blanchard C, Dunman PM, Caswell CC. 2015. A LysR-family transcriptional regulator required for virulence in Brucella abortus in highly conserved among the α-proteobacteria. Mol Microbiol 98:318–328. doi: 10.1111/mmi.13123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 531.Sheehan LM, Caswell CC. 2018. An account of evolutionary specialization: the AbcR small RNAs in the Rhizobiales. Mol Microbiol 107:24–33. doi: 10.1111/mmi.13869. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 532.Budnick JA, Sheehan LM, Ginder MJ, Failor KC, Perkowski JM, Pinto JF, Kohl KA, Kang L, Michalak P, Luo L, Heindl JE, Caswell CC. 2020. A central role for the transcriptional regulator VtlR in small RNA-mediated gene regulation in Agrobacterium tumefaciens. Sci Rep 10:14968. doi: 10.1038/s41598-020-72117-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 533.Dong H, Peng X, Wang N, Wu Q. 2014. Identification of novel sRNAs in Brucella abortus 2308. FEMS Microbiol Lett 354:119–125. doi: 10.1111/1574-6968.12433. [DOI] [PubMed] [Google Scholar]
- 534.Peng X, Dong H, Wu Q. 2015. A new cis-encoded sRNA, BsrH, regulating the expression of hemH gene in Brucella abortus 2308. FEMS Microbiol Lett 362:1–7. doi: 10.1093/femsle/fnu017. [DOI] [PubMed] [Google Scholar]
- 535.Wang Y, Ke Y, Xu J, Wang L, Wang T, Liang H, Zhang W, Gong C, Yuan J, Zhuang Y, An C, Lei S, Du X, Wang Z, Li W, Yuan X, Huang L, Yang X, Chen Z. 2015. Identification of a novel small non-coding RNA modulating the intracellular survival of Brucella melitensis. Front Microbiol 6:164. doi: 10.3389/fmicb.2015.00164. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 536.Saadeh B, Caswell CC, Chao Y, Berta P, Wattam AR, Roop RM, O'Callaghan D. 2016. Transcriptome-wide identification of Hfq-associated RNAs in Brucella suis by deep sequencing. J Bacteriol 198:427–435. doi: 10.1128/JB.00711-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 537.Zhong Z, Xu X, Li X, Liu S, Lei S, Yang M, Yu J, Yuan J, Ke Y, Du X, Wang Z, Ren Z, Peng G, Wang Y, Chen Z. 2016. Large-scale identification of small noncoding RNA with strand-specific deep sequencing and characterization of a novel virulence-related sRNA in Brucella melitensis. Sci Rep 6:25123. doi: 10.1038/srep25123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 538.Dong H, Peng X, Liu Y, Wu T, Wang X, De Y, Han T, Yuan L, Ding J, Wang C, Wu Q. 2018. BASI74, a virulence-related sRNA in Brucella abortus. Front Microbiol 9:2173. doi: 10.3389/fmicb.2018.02173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 539.Xu D, Song J, Li G, Cai W, Zong S, Li Z, Liu W, Hu S, Bu Z. 2018. A novel small RNA Bmsr1 enhances virulence in Brucella melitensis M28. Vet Microbiol 223:1–8. doi: 10.1016/j.vetmic.2018.07.007. [DOI] [PubMed] [Google Scholar]
- 540.Wang Y, Ke Y, Duan C, Ma X, Hao Q, Song L, Guo X, Sun T, Zhang W, Zhang J, Zhao Y, Zhong Z, Yang X, Chen Z. 2019. A small non-coding RNA facilitates Brucella melitensis intracellular survival by regulating the expression of virulence factor. Int J Med Microbiol 309:225–231. doi: 10.1016/j.ijmm.2019.04.002. [DOI] [PubMed] [Google Scholar]
- 541.Sheehan LM, Budnick JA, Fyffe-Blair J, King KA, Settlage RE, Caswell CC. 2020. The endonuclease RNase I coordinates expression of mRNAs and small regulatory RNAs and is critical for the virulence of Brucella abortus. J Bacteriol 202:e00240-20. doi: 10.1128/JB.00240-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 542.Grilló MJ, Blasco JM, Gorvel JP, Moriyón I, Moreno E. 2012. What have we learned from brucellosis in the mouse model? Vet Res 43:29. doi: 10.1186/1297-9716-43-29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 543.Baldwin CL, Goenka R. 2006. Host immune responses to the intracellular bacteria Brucella: do the bacteria instruct the host to facilitate chronic infection? Crit Rev Immunol 26:407–442. doi: 10.1615/critrevimmunol.v26.i5.30. [DOI] [PubMed] [Google Scholar]
- 544.Gomes MTR, Campos PC, de Almeida LA, Oliveira FS, Costa MMS, Marim FM, Pereira GSM, Oliveira SC. 2012. The role of innate immune signals in immunity to Brucella abortus. Front Cell Infect Microbiol 2:130. doi: 10.3389/fcimb.2012.00130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 545.Dorneles EMS, Teixeira-Carvalho A, Araújo MSS, Sriranganathan N, Lage AP. 2015. Immune response triggered by Brucella abortus following infection or vaccination. Vaccine 33:3659–3666. doi: 10.1016/j.vaccine.2015.05.057. [DOI] [PubMed] [Google Scholar]
- 546.Marim FM, Franco MMC, Gomes MTR, Miraglia MC, Giambartolomei GH, Oliveira SC. 2017. The role of NLRP3 and AIM2 in inflammasome activation during Brucella abortus infection. Semin Immunopathol 39:215–233. doi: 10.1007/s00281-016-0581-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 547.Avila-Calderón ED, Flores-Romo L, Witonsky S, Donis-Maturano L, Becerril-García MA, Arreola MGA, Reynoso BA, Güemes FS, Contreras-Rodríguez A. 2020. Dendritic cells and Brucella spp interaction: the sentinel host and the stealthy pathogen. Folia Microbiol (Praha) 65:1–16. doi: 10.1007/s12223-019-00691-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 548.Ferrero MC, Paiva IMA, González FM, Baldi PC. 2020. Pathogenesis and immune response in Brucella infection acquired by the respiratory route. Microbes Infect 22:407–415. doi: 10.1016/j.micinf.2020.06.001. [DOI] [PubMed] [Google Scholar]
- 549.Dorneles EMS, Sriranganathan N, Lage AP. 2015. Recent advances in Brucella abortus vaccines. Vet Res 46:76. doi: 10.1186/s13567-015-0199-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 550.Pandey A, Cabello A, Akoolo L, Rice-Ficht A, Arenas-Gamboa A, McMurray D, Ficht TA, de Figueiredo P. 2016. The case for live attenuated vaccines against the neglected zoonotic diseases brucellosis and bovine tuberculosis. PLoS Negl Trop Dis 10:e0004572. doi: 10.1371/journal.pntd.0004572. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 551.Pascual DW, Yang X, Wang H, Goodwin Z, Hoffman C, Clapp B. 2018. Alternative strategies for vaccination to brucellosis. Microbes Infect 20:599–605. doi: 10.1016/j.micinf.2017.12.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 552.Hou H, Liu X, Peng Q. 2019. The advances in brucellosis vaccines. Vaccine 37:3981–3988. doi: 10.1016/j.vaccine.2019.05.084. [DOI] [PubMed] [Google Scholar]
- 553.Ariza J, Bosilkovski M, Cascio A, Colmenero JD, Corbel MJ, Falagas ME, Memish ZA, Roushan MRH, Rubinstein E, Sipsas NV, Solera J, Young EJ, Pappas G, Institute of Continuing Medical Education of Ioannina. 2007. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med 4:e317. doi: 10.1371/journal.pmed.0040317. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 554.Solera J. 2010. Update on brucellosis: therapeutic challenges. Int J Antimicrob Agents 36:S18–S20. doi: 10.1016/j.ijantimicag.2010.06.015. [DOI] [PubMed] [Google Scholar]














